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BACKGROUND
Epidemiology of Gallstone Disease
Prevalence and incidence
Gallstones (i.e. cholelithiasis) are very common in western society. Estimates of the 
prevalence of gallstones in the general population range between 8% and 25%, but they 
can be seen in up to 73% in certain subpopulations, implying a genetic factor.1-3 The 
true prevalence of gallstones is difficult to determine, as they manifest in only around 
10 to 20% of gallstone carriers.4 Often, they are incidental findings on radiological 
exams. Asymptomatic gallstone carriers have an annual risk of developing symptoms 
of 2 to 3%.2 When the presence of stones in the gallbladder (i.e. cholecystolithiasis) 
is suspected, abdominal ultrasound is the most simple and frequently used imaging 
modality. The most accurate methods to diagnose gallstones in the common bile 
duct (i.e. choledocholithiasis) are magnetic resonance cholangiopancreatography and 
endoscopic ultrasound.5 
 In most symptomatic patients, gallstones classically manifest after ingesting a 
meal with high fat content, as the gallbladder wall contracts against the solid stone(s). 
When this pain lasts for at least 30 minutes, it is defined as ‘biliary colic’ according to 
the Rome criteria.6 It is not unusual for gallstones to migrate along the biliary tract, 
often passing into the duodenum spontaneously.9 Complications arise when gallstones 
get lodged during this passage. A stone obstructing the cystic duct, common bile duct 
or ampulla of Vater can respectively cause acute cholecystitis, choledocholithiasis with 
or without cholangitis or pancreatitis. In rare cases, a large gallstone migrates into the 
duodenum or further down the small intestine, eventually obstructing the lumen causing 
ileus, often some 20cm proximal to the ileocoecal valve. Finally, a history of gallstone 
disease appears to carry a small increase in the risk of developing gallbladder cancer.2 
Pathophysiology of Gallstone Disease and Biliary Pancreatitis
Gallstones, sludge and the biliary tract
Gallstones are solidified accumulations of cholesterol crystals (cholesterol stones), 
bilirubin and calcium deposits (black pigment stones) or compositions of cholesterol 
and calcium salts (brown pigment stones).7 The different types of stones are formed 
as a result of a cascade involving various genetic, biological, dietary and other factors. 
Known risk factors for developing gallstones include increasing age, female sex, obesity 
and rapid weight loss.2 Starting out as microscopic aggregations of crystals, they can grow 
to the size of small pebbles or up to several centimeters. Sludge consists of cholesterol 
crystals with or without calcium granules of up to 2mm embedded in the mucus layering 
the gallbladder wall, and can be found in the presence or absence of larger gallstones.8 
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Cholesterol stones are the most prevalent type in Western populations, accounting for 
approximately 70% of the found stones. This type of stone forms in the gallbladder, in 
part as a result of stasis of bile in between postprandial gallbladder emptying. In most 
cases (80 to 90%), these gallstones are asymptomatic and only found incidentally on 
imaging for other indications than to confirm the presence of gallstones.4 Peristaltic 
contractions of the gallbladder and biliary tract drive these stones or sludge through the 
cystic, common bile and hepatopancreatic ducts into the duodenum.9 
Choledocholithiasis
The presence of common bile duct stones can be appraised through various 
methods. Biochemical testing can indicate cholestasis through elevated serum 
bilirubin levels. Serum levels exceeding 70umol/l are considered highly suggestive 
of concurrent choledocholithiasis, as are moderately raised levels with dilatation of 
the bile duct on imaging.10 Endoscopic ultrasound (EUS) and magnetic resonance 
cholangiopancreatography (MRCP) are both highly accurate imaging modalities to 
assess the bile ducts. Abdominal ultrasound or computed tomography (CT) can also be 
used, although their positive predictive value is less than the aforementioned methods.5 
Endoscopic retrograde cholangiopancreatography (ERCP) is nowadays used in an almost 
exclusively therapeutic capacity in the treatment of gallstone disease. Besides gallstone 
extraction and clearance of the bile ducts, it has the additional advantage of performing 
sphincterotomy of the ampulla of Vater, providing decent long-term protection 
from future gallstone-related complications.11 Patients with suspected or confirmed 
choledocholithiasis with increasing signs of clinical and biochemical inflammation 
(i.e. fever and leukocytosis or c-reactive protein) should be suspected of cholangitis, 
a life-threatening complication of choledocholithiasis. Urgent decompression through 
endoscopic biliary tract clearance with sphincterotomy is advised in these patients.12
Biliary pancreatitis
Blockage of the ampulla of Vater, whether from gallstones or sludge, is thought 
to cause pancreatitis by either reflux of bile into the pancreatic duct or by ductular 
hypertension. Be it through chemical or mechanical stimulation, digestive enzymes 
produced by the pancreatic acinar cells are activated prematurely, leading to parenchymal 
autodigestion.10 The subsequent inflammation of the pancreatic gland sets off a cascade 
of which the exact mechanisms remains incompletely understood. In most patients this 
inflammation will be confined to the pancreas, diminish and terminate in the span of a 
few days. In others it may lead to a systemic inflammatory reaction, causing end-organ 
hypoxemia and necrosis of the pancreas and peripancreatic tissue and failure of one or 
more distant organ systems. This state of acute pancreatic inflammation is a common 
disease, affecting around 15/100.000 persons per year in the Netherlands.11 In part due 
to increasing gallstone prevalence, incidence rates have been steadily increasing over the 
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last few decades. In population-based studies in Western societies, gallstones represent 
the cause of acute pancreatitis in between a third to half of all cases.12-14 In around 
85% of these patients, the disease resolves spontaneously and patients can be discharged 
within a week of supporting care. This type of pancreatitis is termed ‘mild’ pancreatitis, 
as opposed to the ‘moderately severe’ or ‘severe’ types of pancreatitis which cause the 
patient to develop (peri)pancreatic necrosis and fluid collections with or without organ 
failure.15 
 Pancreatitis is diagnosed when two of the three following items are present: 
pain in the abdomen, an elevated serum amylase or lipase level at least three times 
the upper limit of normal and, if performed, cross-sectional imaging showing signs 
of inflammation.18 Imaging is usually only indicated in case of diagnostic uncertainty 
or when pancreatic necrosis is suspected based on clinical signs of extreme distress or 
excessive serum inflammatory values (i.e. c-reactive protein and leukocyte counts).
 Initial management after the diagnosis starts with supporting therapy. 
Analgesics and aggressive intravenous fluid replacement to counteract hypovolemia 
and subsequently impaired end-organ microperfusion due to third spacing will suffice 
in most patients.19,20 During the first 48 hours after admission, close monitoring of 
vital and biochemical characteristics is critical, as the systemic inflammation reaction 
secondary to the pancreatitis will induce organ failure in up to 38% of patients with 
pancreatic necrosis. A multitude of scoring systems have been devised to predict which 
patients are going to develop organ failure, but thus fare none is accurate enough to 
supplant frequent clinical evaluation.21
 When primary care has been initiated, the next step is establishing the etiology as 
this has implications for further short- and long-term management. The patient history 
should include queries for pre-existing gallstone disease or gallstone-like symptoms and 
alcohol use. Blood testing should be performed for serum liver biochemistry for signs 
of biliary obstruction and serum calcium and triglycerides to rule out less common 
etiologies. Imaging studies can then be done to establish the presence of cholecystolithiasis 
or choledocholithiasis. Abdominal ultrasound is traditionally the modality of choice for 
cholecystolithiasis as it is reliable, fast and readily available. If negative, but suspicion of 
gallstones persists, computed tomography, magnetic resonance imaging and endoscopic 
ultrasound can be employed, in increasing order of accuracy for choledocholithiasis.5 
Endoscopic retrograde cholangiopancreatography should be reserved for patients in 
whom ascending cholangitis is suspected, but to date there is no evidence for its use in 
the amelioration of pancreatic inflammation in the acute phase in patients with mild 
disease.22 Its role in patients at high risk of developing pancreatic necrosis or other 
complications is debated and currently under investigation. As most gallstones pass into 
the duodenum spontaneously, stone extraction is often not necessary.9 In patients with 
persisting choledocholithiasis stone extraction can be planned electively.
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Cholecystectomy
First performed for biliary colics by Carl Langenbuch in Berlin, 1882, cholecystectomy 
has become one of the most performed operations in the Western world.17,18 Removing 
the gallbladder reduces the residence time of bile in the biliary tree, thereby allowing 
less time for gallstone formation.19 Introduction of the laparoscopic technique in the 
late 1980’s was met with great enthusiasm by the surgical community and a surge in 
the number of cholecystectomies was seen.20,21 However, as no standardized techniques 
or adequate safety measures existed for identification of the cystic and common hepatic 
ducts, a rise in the number of iatrogenic biliary tract injuries was observed alongside 
this development.22,23 To reduce the risk of this complication, various methods to 
intraoperatively assess biliary anatomy were developed. These include innovative and 
experimental equipment such as laparoscopic ultrasound, near-infrared fluorescence 
cholangiography and hyperspectral cholangiography. Only two have found widespread 
adoption; intraoperative cholangiography and the critical view of safety.24 Intraoperative 
cholangiography (IOC) is performed by introducing a cannula into the cystic duct after 
dissecting Calot’s triangle (i.e. the anatomic space bordered by the liver and the cystic 
and common hepatic ducts), and injecting the choledochus with a radiolucent fluid 
followed by X-ray fluoroscopy. Its proponents praise the technique’s ability to provide 
both information on biliary tract anatomy as well as the presence of choledocholithiasis, 
leading some to perform it routinely. Opponents, however, criticize the low yield of 
clinically relevant information against the extra effort and operating time. As a result, 
the indications and applications of this technique continue to be subject to debate. The 
most commonly used method of establishing biliary anatomy is by achieving the ‘critical 
view of safety’. This standardized operative technique requires the surgeon to dissect 
the hepatocystic triangle, separate the lower third of the gallbladder from the liver and 
confirm that only two tubular structures can be seen entering the gallbladder (i.e. the 
cystic duct and cystic artery).25 Achievement of these steps is ideally recorded using 
videoscopic imaging but always in the operation report. Despite these innovations, the 
overall rate of iatrogenic bile duct injuries is still between 0.5 and 1.4%.26 In part, this 
is due to human error and misinterpretation of anatomical structures. However, risks of 
this type of injury also increase when local acute or chronic inflammation has reduced 
normal biliary anatomy to an unrecognizable adhesive mass of structures.
MOTIVATION FOR AND AIMS OF THIS THESIS
With its self-limiting character and low complication rate, the short-term treatment 
for mild acute pancreatitis leaves little room for improvement. Because of its long-term 
protection against recurrent disease, cholecystectomy has been the strategy of choice for 
decades. More recently developed alternatives such as endoscopic sphincterotomy fail to 
provide the same level of protection for recurrent events. On the one hand, the advent 
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of laparoscopy has led to an increase in the popularity of cholecystectomy. On the other, 
however, it has sown dissent and doubt regarding indications and, most importantly, 
timing of surgery. The surgical community at large currently performs cholecystectomy 
after an interval of around 6 weeks. This is despite many retrospective studies reporting 
high readmission rates for patients during this interval. 
 Considering the current increased emphasis on efficient and patient-oriented 
care, effective allocation of hospital resources and lowering healthcare costs, this thesis 
is aimed at improving surgical strategies for mild gallstone pancreatitis. To this end, the 
following questions were posed:
1. Does same-admission cholecystectomy safely reduce morbidity from recurrent 
disease compared with the current standard of interval cholecystectomy? What are 
the economic repercussions of same-admission cholecystectomy?
2. What is the prevalence of recurrent biliary events after cholecystectomy? And can 
we predict or prevent these events?
3. Are there any grounds to the notion that acute pancreatitis would obscure biliary 
anatomy, thereby increasing technical difficulty of the procedure? Can this be 
predicted according to preoperatively available variables?
4. What surgical techniques can be applied to safely complete a difficult 
cholecystectomy? 
OUTLINE OF THIS THESIS
The role of cholecystectomy in the treatment of mild biliary pancreatitis is central in this 
thesis. Many consider pancreatitis an absolute indication for gallbladder removal, but 
several strategic and technical aspects of this approach require clarification. In this thesis 
the following issues will be investigated.
 Chapter 2 delineates current insights in pancreatitis incidence, diagnosis 
and biliary tract management. Indication for endoscopic sphincterotomy and 
cholecystectomy are addressed in greater detail. Furthermore, overall recurrence rates 
of pancreatitis and other biliary events following conservative management, endoscopic 
sphincterotomy and cholecystectomy are investigated. 
 Chapter 3 investigates the issue of timing of cholecystectomy after mild 
acute pancreatitis in a randomized controlled trial. Having confirmed that early 
cholecystectomy is the strategy of choice as far as morbidity is concerned, the question 
whether this strategy is also cost-effective will be addressed in Chapter 4.
 The role of cholecystectomy following gallstone pancreatitis is investigated 
in more detail in Chapters 5, 6 and 7. Knowing that cholecystectomy is not a failsafe 
procedure to prevent future gallstone-related complications, we studied the frequency, 
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type and severity of gallstone-related events following surgery in a cohort of patients 
with mild gallstone pancreatitis in Chapter 5. 
 Chapter 6 addresses the technical aspects of cholecystectomy following mild 
pancreatitis more specifically, because in the past decades the discussion on timing of 
cholecystectomy has been dominated by the fear of inducing additional complications 
by early surgery. 
 As discussed in the previous chapter, inflammation of the gallbladder and 
surrounding tissue can lead to adhesions, scarring, and ultimately disfigurement of 
normal anatomy. Chapter 7 provides an overview of the literature on outcomes after 
partial or subtotal cholecystectomy, an increasingly used alternative to conversion to 
open surgery.
 In Chapter 8, we discuss current insights on the diagnosis and management of 
patients in whom pancreatic inflammation has resulted in pancreatic necrosis with or 
without failure of vital organ systems. 
 In Chapters 9 and 10, an overall Summary and a General Discussion will be 
presented, respectively.
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Endoscopic sphincterotomy and cholecystectomy in acute biliary pancreatitis
ABSTRACT
Background: This review discusses current insights with regard to biliary tract management 
during and after acute biliary pancreatitis. 
Methods:  A MEDLINE and EMBASE search was done and studies were selected 
based on methodological quality and publication date. The recommendations of recent 
guidelines are incorporated in this review. In absence of consensus in the literature, 
expert opinion is expressed.
Results: There is no role for early endoscopic retrograde cholangiopancreatography 
(ERCP) in patients with (predicted) mild biliary pancreatitis to improve outcome. 
In case of persisting choledocholithiasis, ERCP with stone extraction is scheduled 
electively when the acute event has subsided. Whether early ERCP with sphincterotomy 
is beneficial in patients with predicted severe pancreatitis remains subject to debate. 
Regardless of disease severity, in case of concomitant cholangitis urgent endoscopic 
sphincterotomy (ES) is recommended. As a definitive treatment to reduce the risk of 
recurrent biliary events in the long term, ES is inferior to cholecystectomy and should 
be reserved for patients considered unfit for surgery. After severe biliary pancreatitis, 
cholecystectomy should be postponed until all signs of inflammation have subsided. In 
patients with mild pancreatitis, cholecystectomy during the primary admission reduces 
the risk of recurrent biliary complications. 
Conclusion: Recent research has provided valuable data to guide biliary tract management 
in the setting of acute biliary pancreatitis with great value and benefit for patients and 
clinicians. Some important clinical dilemmas remain, but it is anticipated that on-going 
clinical trials will deliver some important insights and additional guidance soon.
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INTRODUCTION
Gallstones cause substantial morbidity in the western world.1, 2 Ranging from relatively 
harmless colics to potentially lethal pancreatitis, biliary disorders represent some of the 
most prevalent benign abdominal diseases.3 Especially small gallstones and sludge are 
wont to migrate from the gallbladder into the duodenum.4, 5 In the proximity of the 
ampulla of Vater, gallstones obstructing the biliopancreatic duct are a frequent cause of 
acute pancreatitis.6 Most stones migrate into the duodenum spontaneously,7 but persisting 
obstruction of the ampulla can theoretically aggravate pancreatic inflammation.8 
 Long-term management of symptomatic cholelithiasis aims at minimizing the 
risk of new biliary events. Recurrence rates of biliary pancreatitis up to 61% have been 
described when no definitive treatment was provided.9 Cholecystectomy and endoscopic 
retrograde cholangiopancreatography (ERCP) are widely used to this end, although 
some aspects such as the timing and indication of these interventions remain unclear. 
This review discusses current insights in acute biliary pancreatitis and its management.
METHODS
Pubmed searches were conducted by N.J.S. and D.d.C. using the following medical search 
headings: “Pancreatitis” and “Acute Pancreatitis”, “Biliary Tract Diseases”, “Endoscopic 
retrograde cholangiography”, “Cholecystectomy” and “Laparoscopic cholecystectomy”. 
These MeSH terms, in combination with title and abstract review, with subheadings such 
as “diagnosis” and “epidemiology”, were employed for the various topics included in this 
review. A secondary search was performed in Embase, using combinations of the Emtree 
terms “Acute Pancreatitis”, “Biliary Tract Diseases”, “Epidemiology”, “Endoscopic 
Retrograde Cholangiopancreatography” and “Cholecystectomy”. The search was limited 
to English language literature and to subtopics ‘diagnosis’, ‘aetiology’, ‘prevention’, ‘disease 
management’ and ‘surgery’. Articles were selected based on study type, methodological 
quality and publication date. Where possible, we selected population-based studies for 
epidemiological data, whereas for treatment recommendations a hierarchical selection 
strategy was applied based on the level of evidence. Additional articles were explored by 
cross-referencing the articles found through the literature searches.
 The recommendations of the recently revised guidelines from the International 
Association of Pancreatology / American Pancreatic Association (IAP/APA guidelines) 
as well as the American College of Gastroenterologists guidelines were incorporated in 
this review.10, 11 Regarding the aspects of treatment in which no clear consensus exists 
or decent quality evidence lacks, recommendations in this article were based on expert 
opinion and consensus within the Dutch Pancreatitis Study Group.
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RESULTS
Incidence, classification and diagnosis
Gallstones are listed as the most common cause of pancreatitis, accounting for 27 
to 62% of all cases.12, 13 Either reflux of bile or increased pressure in the pancreatic 
duct resulting from gallstones or microlithiasis obstructing Vater’s ampulla is believed 
to trigger pancreatic inflammation.14, 15 Gallstones are more prevalent in women than 
in men. Consequently, women are twice as likely to develop biliary pancreatitis.16-18 
Population studies have revealed growing incidence numbers for acute pancreatitis over 
the past few decades, attributed at least in part to the higher prevalence of gallstones 
associated with obesity. Overall incidence rates of acute pancreatitis increase with age 
and are between 13 and 50 per 100.000.19-22 Overall mortality of acute pancreatitis is 
low (1-4%),21, 23 but mortality rates increase 5 to 10 fold when organ failure or infected 
pancreatic necrosis complicate the disease course.24
 A flow chart with management steps for patients with (suspected) biliary 
pancreatitis is presented in Figure 1. The diagnosis of acute biliary pancreatitis is made 
by visualisation of gallstones or sludge in addition to at least two of the following three 
items: 1) pain in the upper abdomen, 2) serum amylase or lipase at least three times 
Figure 1. Management of acute biliary pancreatitis.
Acute Pancreatitis
On Admission
l Establish biliary etiology, at least 1 of 3:
- gallstones or sludge on imaging
- elevated ALT at least twice upper limit of normal 
- dilated common bile duct
l ERCP
- Concomitant cholangitis à urgent ERC with 
sphincterotomy
- Predicted mild disease course à no ERCP
- Predicted severe disease course à probably no ERCP
- Cholestasis à ERCP probably indicated
l General supportive measures for patients with acute pancreatitis
Following days to weeks l Monitoring for organ failure and local complications
l Progressive cholestasis
- Suspicion of cholangitis à cholangitis à urgent ERCP
- No fever à imaging for choledocholithiasis (EUS, MRCP) 
and / or ERCP to identify and clear bile duct stone, after initial 
pancreatiits attack
Before discharge l Define treatment strategy to prevent recurrent biliary events
Cholecystectomy
YES
Timing cholecystectomy is related to 
disease course: l Mild: during 
hospital admission 
l Severe: after resolution local 
complications
NO cholecystectomy 
in case of severe co-morbidity
l Previous sphincteromy should 
be taken into account
After discharge l Beware of recurrent biliary events:
- Recurrent pancreatitis
- Cholangitis 
- Cholecystitis
- Biliary colics
l Cholecystectomy after severe pancreatitis 
ALT: Alanine aminotransferase, ERCP: Endoscopic Retrograde Cholangiopancreatography, EUS: 
Endoscopic Ultrasound, MRCP: Magnetic Resonance Cholangiopancreatography
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the upper limit of normal and 3) characteristics of acute pancreatic inflammation on 
cross-sectional imaging (if performed).25 Confirmation of the presence of gallstones is 
usually done by transabdominal ultrasound of the gallbladder (positive predictive value: 
100%), but this is ineffective for detecting microlithiasis.26 Unless a significant dilatation 
of the common bile duct is found (i.e. more than 8 mm in patients under 75 years, 
more than 10 mm in patients aged 75 and over), transabdominal ultrasound cannot be 
used to reliably assess choledocholithiasis.27 Aggregate studies have found endoscopic 
ultrasound (EUS) and magnetic resonance cholangiopancreatography (MRCP) to be 
excellent modalities for detection of intraductal gallstones.28-32 A systematic review 
comparing EUS and MRCP for choledocholithiasis found positive predictive value 
scores of 93 and 87% respectively.31 EUS, while more invasive, has greater potential 
for finding small gallstones and sludge, especially distally in the common bile duct.29 
Additionally, more recent studies have called into question the ability of MRCP to 
detect choledocholithiasis in the setting of acute gallstone pancreatitis, as sensitivity 
dropped to 62%.33, 34 However, as these are retrospective studies, further investigation is 
needed for a definitive appraisal of MRCP in this setting.
 In addition to imaging, serum liver biochemistry can be highly predictive of a 
biliary origin. Several studies have identified a strong correlation between the presence 
of gallstones and raised serum alanine aminotransferase (ALT).13, 27, 35 ALT levels twice 
the upper limit of normal have a positive predictive value of 82%, increasing to 92% if 
raised three times.13, 27
 Disease severity can be classified into three categories according to the 
presence or absence of organ failure and pathological features of the pancreas.25 ‘Mild’ 
pancreatitis is characterised by an absence of organ failure and no complications such as 
extrapancreatic or pancreatic parenchymal necrosis. Patients with organ failure lasting 
less than 48 hours or pancreatic or systemic complications (e.g. exacerbation of previous 
illness such as chronic heart or lung disease) are classified as ‘moderately severe’. Organ 
failure persisting beyond 48 hours is classified as ‘severe’ pancreatitis and is frequently 
accompanied by pancreatic necrosis or fluid collections.25 Patients with biliary 
pancreatitis seem to develop organ failure less often compared to alcoholic pancreatitis.36 
Recurrent biliary events
Literature specifically addressing the incidence of recurrent biliary events is scarce and 
the few studies available only describe specific subgroups of patients (Table 1). Studies 
have reported recurrence rates of biliary pancreatitis between 18-61% whilst awaiting 
cholecystectomy.9, 37 Readmissions for cholecystitis and simple biliary colics occur less 
often (around 3% and 7%, respectively).37 A prospective study including 233 patients 
with acute biliary pancreatitis reported a 31-fold risk of recurrence in patients in whom 
the gallbladder was left in situ.38 Severity and mortality rates of the recurrent episodes 
are similar to those of the primary attack. Nevertheless, some 9% of patients have 
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been reported as having a serious complication during follow-up after an initial mild 
episode.38, 39 It should be noted that cholecystectomy does not completely obviate the 
risk of recurrent disease. Gallstones retained in the biliary tract may cause morbidity in 
up to 10% of patients who underwent surgery, although their prevalence is unknown.37, 
40-42
Endoscopic Sphincterotomy
The role of ERCP with sphincterotomy as early intervention in biliary pancreatitis has 
been the subject of debate for years. The potential benefit of early decompression of 
the pancreaticobiliary system is weighed against the risks associated with ERCP with 
sphincterotomy (i.e. bleeding, perforation). In acute biliary pancreatitis, sphincterotomy 
can be performed; 1) as early intervention to potentially ameliorate the disease course, 
2) to extract retrained common bile duct stones or 3) as prophylactic treatment to 
prevent recurrent biliary events. 
ERCP as early intervention
Urgent ERCP is indicated in acute biliary pancreatitis and concomitant cholangitis.10, 
11 A randomized trial of 82 patients with acute cholangitis due to choledocholithiasis 
showed that early endoscopic biliary drainage decreases mortality compared to surgery.43 
However, these patients did not suffer from concomitant pancreatitis. The undisputed 
role of ERCP in patients with pancreatitis and cholangitis is based on non-randomized 
trials and subgroup analysis of randomized trials in biliary pancreatitis.44, 45 Although 
consensus exists on performing an ERCP in case of concomitant cholangitis, the 
definitions for cholangitis vary in the available literature. As such, diagnosing cholangitis 
is challenging, as signs of inflammation and biliary obstruction are also frequently 
observed in acute biliary pancreatitis. 
 Early ERCP is not indicated in patients with mild biliary pancreatitis.10, 11 As 
spontaneous stone passage usually occurs, potential benefits do not outweigh the risks 
for ERCP related complications.7 Guideline recommendations on ERCP in patients 
with acute biliary pancreatitis and at high risk for complications are conflicting.10, 11 
In a recent meta-analysis, early ERCP was not beneficial in patients who were at high 
risk for developing complications.44 This suggests that either this subgroup may truly 
not benefit from early decompression, or that this subgroup analysis might lack the 
statistical power to show an effect. However, several limitations of this meta-analysis 
should be taken into account. Foremost, it includes randomized trials with widely 
varying patient selection criteria, resulting in the pooling of patients with cholangitis, 
non-biliary pancreatitis and patients with low risk of complications. 8, 46-48 Furthermore, 
endoscopic sphincterotomy was only performed in case of proven common bile duct 
stones, which resulted in a low percentage of actual sphincterotomy. The beneficial effect 
of sphincterotomy, however, has been observed regardless of the presence of common 
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bile duct stones.46, 47, 49, 50 Additionally, ERCPs were performed during a wide time frame 
(i.e., within 48 to 72 hours) and no criteria were set to guarantee that ERCPs were 
performed by experienced endoscopists.8, 46, 47 A randomized trial investigating the role 
of early ERCP with sphincterotomy in patients with acute biliary pancreatitis and at 
high risk for complications is underway (ISRCTN97372133). 
 Guidelines suggest that early ERCP may be beneficial in patients with on-
going cholestasis due to biliary obstruction.10, 11 In line, a meta-analysis comprising 
519 patients with pancreatitis and biliary obstruction found that a strategy with the 
routine use of ERCP reduced local complications as defined by authors of the primary 
study compared to conservative treatment.44 The indication for ERCP in case of biliary 
obstruction is not yet fully established due to limitations of available evidence. These 
include heterogeneous study populations, the use of various definitions and relatively 
small, pooled sample sizes. A stone detected on imaging may pass spontaneously, 
in which case an ERCP would probably be redundant. Furthermore, biochemical 
and radiological signs of biliary obstruction can be unreliable in the acute phase of 
pancreatitis.51 The recent guidelines acknowledge these limitations.
Extraction of common bile duct stones
Following an attack of biliary pancreatitis, extraction of retained stones can be scheduled 
electively by means of ERCP with sphincterotomy. In patients without pancreatitis 
removal of identified retained stones is generally recommended.52, 53 Depending on 
the probability of retained bile duct stones, EUS or MRCP should be performed 
prior to ERCP in case biochemical tests and dilation of the common bile duct 
suggest choledocholithiasis.54 If EUS or MRCP are negative, ERCP and its potential 
complications can be avoided. 
Prevention of recurrent attacks
After the patient has recovered from the initial acute pancreatitis episode, sphincterotomy 
can be performed to prevent recurrent biliary events. Without endoscopic or surgical 
intervention, the risk of recurrent biliary events is high (Table 1).37, 55 Sphincterotomy 
reduces the risk of recurrent pancreatitis, however not of other biliary events.37, 
40, 56, 57 A large meta-analysis in patients without pancreatitis demonstrated that 
additional cholecystectomy reduced mortality compared to a wait-and-see-policy.58 
Furthermore, a randomized trial in patients without pancreatitis that successfully 
underwent sphincterotomy, early cholecystectomy was associated with less recurrent 
biliary events compared to delayed cholecystectomy.42 In patients with pancreatitis 
that have undergone sphincterotomy, no randomized trial has been performed to 
evaluate the effect of cholecystectomy. Non-randomized studies evaluating the effect 
of cholecystectomy and additional sphincterotomy in patients with pancreatitis show 
conflicting results.57 However, a recent large-scale study using data from over five 
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thousand patients showed that cholecystectomy and sphincterotomy offers the best 
long-term results for preventing recurrent biliary pancreatitis.59 Therefore, guidelines 
agree that definitive management should include cholecystectomy.10, 11 Prophylactic 
sphincterotomy as definitive treatment is currently only recommended in certain 
subgroups in which cholecystectomy cannot be performed, e.g. patients with severe co-
morbidity or in case of necrotising pancreatitis. 10, 11 60-63 However, studies investigating 
the added benefit of cholecystectomy after sphincterotomy in elderly patients with high 
risk of anaesthesiological or other perioperative complications are lacking.
Cholecystectomy
Cholecystectomy is the treatment of choice for preventing recurrent biliary events.10, 
11 Despite the recommendations by the guidelines, up to 25 to 50% of patients do 
not undergo gallbladder removal for various reasons.55, 64, 65 With similar mortality 
and complication rates as open cholecystectomy, laparoscopic surgery has become the 
primary approach in the western world.66 Iatrogenic injury to the bile duct system is 
the major surgical complication in cholecystectomy. To avoid bile duct injury, several 
surgical and technical strategies have been developed. The main goal in gallbladder 
surgery is acquiring the critical-view-of-safety (CVS), a standardised operative technique 
for positive identification of the gallbladder, cystic duct and cystic artery. Obtaining 
CVS considerably reduces the chance of misinterpretation of anatomy, even in case of 
severe inflammation changes or anatomical anomalies. The CVS technique has been 
adopted as the standard by most guidelines.67
 Additionally, several imaging modalities have been developed for intraoperative 
assessment of bile duct anatomy. The most popular technique in this field is intraoperative 
cholangiography (IOC). This technique has the added potential of detecting persisting 
intraductal gallstones. Although some advocate routine use of IOC, evidence for this 
is lacking to generate international support.68 A recent systematic review including 8 
randomised trials and two large retrospective cohort studies all concluded that routine 
IOC does not prevent bile duct injury.69-71 Furthermore, conflicting results have been 
shown in detecting persisting bile duct stones with routine use of IOC.69, 72 Moreover, 
as many of these stones pass spontaneously, the relevance of finding retained stones is 
debatable.73, 74 In summary, IOC may be helpful in selected cases, for example when 
an aberrant anatomy is suspected or with persisting biochemical markers of biliary 
obstruction. To date there is no solid evidence for the routine use of IOC. 
 When symptomatic choledocholithiasis is confirmed on IOC (or preoperative 
EUS or MRCP), some surgeons advocate laparoscopic common bile duct exploration.75 
Two meta-analyses found this one-stage strategy to be as effective and safe as when 
the bile duct is cleared postoperatively through ERCP.76, 77 However, laparoscopic bile 
duct exploration carries the risk of bile duct injury and should only be performed by 
highly experienced surgeons.78 Conversely, pre- or postoperative ERCP is not without 
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risk itself and may be complicated by post-ERCP pancreatitis, haemorrhage or duodenal 
perforation.76
Timing of cholecystectomy
In severe pancreatitis current international guidelines recommend postponing 
cholecystectomy until after resolution of local or systemic complications. This is usually 
not before the sixth week after onset of the disease.10, 11, 79 Performing cholecystectomy 
earlier is associated with significantly higher complication rates.81
 Regarding mild pancreatitis, optimal timing of cholecystectomy is a much-
discussed topic. International guidelines advise performing cholecystectomy during 
index admission for mild pancreatitis.10, 11 However, studies have indicated that 
adherence to these guidelines in common daily practice is as low as 5%.37, 40, 41, 55 A recent 
systematic review including 998 patients indicated that cholecystectomy was performed 
after a median of 40 days in more than half of all patients.37 Aside from the logistical 
challenges that may be encountered with same-admission cholecystectomy,81, 82 there 
are two common explanations for this lack of compliance. First, reports from the early 
laparoscopic era cautioned the use of surgery in the (post)acute phase of pancreatitis, 
based on the presumption that  biliary anatomy is distorted by the inflammation , 
increasing the risk of surgical complications.83-85 However, it should be noted that these 
results were based on findings in patients with severe pancreatitis.
 Another important reason why the guidelines have not found widespread 
adoption is that the recommendations are based on low quality evidence.11 Except for 
one randomised trial, all available evidence is based on retrospective studies prone to 
selection and other forms of bias.37 The only randomised trial concerning the timing of 
laparoscopy after mild biliary pancreatitis was terminated halfway through and included 
only 50 patients.86 Moreover, the patients in the early arm of this trial were randomised 
for cholecystectomy within 48 hours after onset (i.e. during pancreatitis). During this 
period disease severity may still progress from mild to severe, the latter being considered 
a contraindication for early surgery.87
 Recently a multicentre randomised trial conducted by the Dutch Pancreatitis 
Study Group addressing the timing of cholecystectomy was completed (the PONCHO 
trial, ISRCTN72764151).88 In total 264 patients admitted for mild biliary pancreatitis 
(i.e. no organ failure, no pancreatic necrosis) were randomised to cholecystectomy during 
the same admission (N=128) or discharge and cholecystectomy after an interval of 25 to 
30 days (N=136). The primary outcome consisted of a combined endpoint of mortality 
or acute readmission for recurrent biliary complications (i.e. pancreatitis, cholecystitis, 
choledocholithiasis or colics). The primary endpoint occurred significantly less often 
after same-admission cholecystectomy as compared with interval cholecystectomy (5% 
vs. 17%, P=0.002). This included a reduction in the onset of recurrent biliary pancreatitis 
(2% vs. 9%, P=0.03). In addition, more than half of the patients (51%) in the interval 
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group reported to have suffered gallstone colics at home during the waiting period, 
compared with only 3% in the same-admission group (P<0.001). Very few surgical 
complications occurred, indicating that cholecystectomy can and should be performed 
safely during the same admission.
CONCLUSION
Biliary pancreatitis is a potentially fatal disease and is an increasing cause for major 
morbidity worldwide. Concomitant cholangitis is an indication to perform urgent 
biliary decompression by ERCP with sphincterotomy. Early ERCP with sphincterotomy 
should not be performed in patients with mild pancreatitis. Whether early biliary 
decompression in patients with predicted severe pancreatitis is indicated is currently 
under investigation. Current literature is conflicting on the role and timing of ERCP in 
the setting of biliary obstruction in patients with pancreatitis. To prevent recurrent biliary 
events, definitive treatment consists of cholecystectomy, or endoscopic sphincterotomy 
in selected cases. Current consensus is to postpone cholecystectomy in patients with 
severe pancreatitis until all signs of inflammation have subsided, usually not before six 
weeks after onset. The question whether sphincterotomy should be performed to avert 
the risk of recurrence during this period has not been addressed properly. In patients with 
mild pancreatitis, cholecystectomy before discharge reduces readmissions for recurrent 
disease. Furthermore, studies are needed to investigate whether those at high risk of 
surgical or anaesthesiological complications (due to comorbidity) should be subjected 
to the risk of cholecystectomy, especially if sphincterotomy has already been performed.
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Same-admission versus interval cholecystectomy for mild gallstone pancreatitis: 
a multicentre randomised controlled trial
ABSTRACT
Background In patients with mild gallstone pancreatitis, cholecystectomy during 
the same admission may reduce the risk of recurrent gallstone-related complications, 
compared with the more common strategy of interval cholecystectomy. However, 
evidence to support same-admission cholecystectomy is poor and concerns exist about 
an increased risk of cholecystectomy-related complications with this approach. In this 
study, we aimed to compare same-admission and interval cholecystectomy, with the 
hypothesis that same-admission cholecystectomy would reduce the risk of recurrent 
gallstone-related complications without increasing the difficulty of surgery.
Methods For this multicentre, parallel group, assessor-masked, randomised controlled 
superiority trial, inpatients recovering from mild gallstone pancreatitis at 23 hospitals 
in the Netherlands (with hospital discharge foreseen within 48 h) were assessed for 
eligibility. Adult patients (aged ≥ 18 years) were eligible for randomisation if they had 
a serum C-reactive protein concentration of less than 100 mg/L, no need for opioid 
analgesics, and could tolerate a normal oral diet. Patients with an American Society of 
Anesthesiologists (ASA) class III physical status who were older than 75 years of age, all 
ASA class IV patients, those with chronic pancreatitis, and those with ongoing alcohol 
misuse were excluded. A central study coordinator randomly assigned eligible patients 
(1:1) by computer based randomisation, with varying block sizes of two and four patients, 
to cholecystectomy within 3 days of randomisation (‘same-admission’) or to discharge 
and cholecystectomy after 25 to 30 days after randomisation (‘interval’). Randomisation 
was stratified by centre and by whether or not endoscopic sphincterotomy had been 
done. Neither investigators nor participants were masked to group assignment. The 
primary endpoint was a composite of readmission for recurrent gallstone-related 
complications (pancreatitis, cholangitis, cholecystitis, choledocholithiasis needing 
endoscopic intervention or gallstone colics) or mortality within 6 months after 
randomisation, analysed by intention to treat. The trial was designed to reduce the 
incidence of the primary endpoint from 8% in the interval group to 1% in the same-
admission group. Safety endpoints included bile duct leakage and other complications 
necessitating re-intervention. This trial is registered with Current Controlled Trials, 
number ISRCTN72764151, and is complete.
Findings Between Dec 22, 2010 and Aug 19, 2013, 266 inpatients from 23 Dutch 
hospitals were randomly assigned to interval cholecystectomy (N=137) or same-
admission cholecystectomy (N=129). One patient from each group was excluded from 
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the final analyses, because of an incorrect diagnosis of pancreatitis in one patient (interval 
group) and discontinued follow-up in the other patient (same-admission group). The 
primary endpoint occurred in 23 (17%) of 136 patients in the interval group and in 
six (5%) of 128 patients in the same-admission group (risk ratio 0.28; 95% confidence 
interval [CI] 0.12-0.66; p=0.002). Safety endpoints occurred in four patients: one case 
of bile duct leakage and one case of postoperative bleeding in each group. All of these 
were serious adverse events and were judged to be treatment related, but none led to 
death
Interpretation Compared with interval cholecystectomy, same-admission 
cholecystectomy, reduced the rate of recurrent gallstone-related complications in 
patients with mild gallstone pancreatitis, with a very low risk of cholecystectomy-related 
complications.
Chapter 3
40
INTRODUCTION
Acute pancreatitis is a common gastrointestinal disorder, mostly caused by gallstones 
or biliary sludge.1,2 Around 80% of affected patients have mild pancreatitis.3 
Cholecystectomy is indicated in these patients to reduce the risk of recurrent gallstone-
related complications such as pancreatitis, cholecystitis, cholangitis or gallstone colics.4,5
 Several nationwide audits from both Europe and the United States have shown 
that laparoscopic cholecystectomy is usually done around 6 weeks after discharge 
from hospital admission for mild gallstone pancreatitis.6-11 Recent studies from the 
United Kingdom have reported that up to one third of all patients do not receive any 
definitive treatment within 1 year after discharge.9,12 This finding conflicts with the 
recommendation of cholecystectomy during the same admission or at least within two 
weeks after discharged, as proposed by the British Society of Gastroenterology.13 The 
main reason for this delay in cholecystectomy is a perceived danger of perioperative 
complications in early cholecystectomy after acute pancreatitis.7,14 Inflammation and 
oedema are believed to distort biliary tract anatomy, thereby complicating dissection 
with an increased risk of conversion and surgical complications such as bile duct 
injury.12,15 A delayed approach also helps surgical scheduling, since emergency theatre 
capacity is often scarce.14
 The drawback cholecystectomy being postponed until several weeks after 
discharge is that during this period patients are at risk of developing recurrent gallstone-
related complications. For example, recurrent pancreatitis reportedly occurs in up to 33% 
of patients in observational studies.16,17 As a result, the recently revised guidelines from 
both the International Association of Pancreatology / American Pancreatic Association 
(IAP/APA) and the American Gastroenterology Association (AGA) recommend that 
cholecystectomy is done during the same hospital admission.4,5 However, no randomised 
studies have compared same-admission cholecystectomy to the existing practice of 
interval cholecystectomy.16 This absence of high-quality evidence might also contribute 
to the reported low adherence to guidelines.7-9,12,18 
 We did a nationwide randomised study to investigate whether or not same-
admission cholecystectomy, as compared with interval cholecystectomy, reduces 
recurrent gallstone-related complications in patients with mild gallstone pancreatitis.
METHODS
Study design and participants
The PONCHO (Pancreatitis of biliary origin: Optimal timiNg of CHOlecystectomy) 
study was designed as a randomised controlled, parallel group, superiority multicenter 
trial. The rationale and design of the PONCHO trial have been described in detail.19 
The study was done at 23 study sites in the Netherlands, including seven university 
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medical centres and 16 teaching hospitals (appendix p2). All adult patients (aged ≥ 18 
years) admitted to these centres between Dec 7, 2010, and Aug 14, 2013, diagnosed 
with a first episode of gallstone pancreatitis were assessed for eligibility. The diagnosis 
of pancreatitis needed at least two of the following three features: epigastric pain, serum 
amylase or lipase levels at least three times the upper limit of normal, and, if done, 
characteristic findings of acute pancreatitis on cross-sectional abdominal imaging. 
‘Mild’ pancreatitis was defined by absence of persistent organ failure (ie >48 h), and 
local complications such as pancreatic necrosis or peripancreatic fluid collections on 
computed tomography (CT).20 A biliary cause was defined by gallstones, biliary sludge, 
or a dilated common bile duct on imaging, or based on biochemical signs of cholestasis 
(for details, see the Supplementary Appendix Box S1).
 Patients were enrolled by the local physicians at each hospital and were 
randomised to the two treatment groups once discharge from hospital was foreseen 
within 48 h. Additional eligibility criteria were a serum C-reactive protein (CRP) 
concentration less than 100 mg/L, no need for opioid analgesics, and tolerance of a 
normal oral diet, all at the time of randomisation. Patients with American Society of 
Anaesthesiologists (ASA) class III physical status who were over 75 years of age and all 
ASA class IV patients (ie irrespective of age) were excluded because of their inherently 
high risk of complications from anaesthesia or surgery.21 Other exclusion criteria were 
chronic pancreatitis and on-going alcohol misuse. After initiation of the trial, pregnancy 
was added as exclusion criterion in January 2012, both for ethical reasons and because 
of the paucity of evidence about cholecystectomy in this subgroup.
 The study was investigator initiated and was undertaken following the principles 
of the Declaration of Helsinki (originally adopted in 1964, with the last amendment 
before this trial in October, 2008) and the Dutch Medical Research Involving Human 
Subjects Act (1998; last revised in 2006). The central committee for research for research 
in Nijmegen, the Netherlands (CMO) approved the study protocol. A data safety 
monitoring committee of four independent, non-participating physicians assessed all 
serious adverse events after inclusion of every 50 patients in an unmasked fashion. All 
patients provided written informed consent.
Randomisation and masking
Randomisation was done by the central study coordinator using a web-based 
randomisation module. Randomisation was stratified according to centre and by whether 
or not endoscopic sphincterotomy had been done. Computer-generated permutated 
block randomisation with a 1:1 allocation ratio and concealed varying permuted block 
sizes of 2 and 4 patients was used. Owing to the invasive nature of the intervention 
and the logistics involved, neither the trial participants nor the investigators could be 
masked to group allocation.
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Procedures
In the interval cholecystectomy group, patients were discharged and cholecystectomy 
was electively scheduled 25-30 days after randomisation. This time interval is in line 
with the maximum waiting period recommended by the American and Dutch treatment 
guidelines at the time of the design of the trial.22,23 Same-admission cholecystectomy was 
done within 3 days after randomisation. All cholecystectomies were done by, or under 
direct supervision of, a surgeon who had undertaken at least 100 cholecystectomies in 
the past five years. Intraoperative cholangiography was not mandatory because only 
about 3% of Dutch surgeons routinely do this procedure.24 The strategy of preoperative 
stone extraction through endoscopic retrograde cholangiopancreatography is much 
more prevalent than intraoperative cholangiography because of the excellent widespread 
availability of this procedure in the Netherlands.
 Data were collected on case record forms by the local physicians in the 23 
participating study sites. All data for primary and secondary endpoints were checked for 
completeness by the study coordinators with source data at each participating centre. 
Patients were instructed to record all episodes of gallstone colics (ie, irrespective of 
readmission), that occurred during the six-month follow-up period in the study diary, 
with reminders via telephone calls from the study research nurse (see Appendix pp 5, 6 
and 10 for details). The central study coordinators (SAB and DWdC) drafted reports for 
all potential primary and safety endpoints, using the primary clinical and biochemical 
data as collected by the study nurse. An adjudication committee of five gastrointestinal 
surgeons (DB, MGB, HCvS, HvG and CHD) who were masked to treatment allocation 
then individually assessed primary and safety endpoints using all available data. Any 
disagreements were resolved in a consensus meeting.
Outcomes
The primary endpoint was a composite of gallstone-related complications or mortality 
occurring within six months after randomisation, before or after cholecystectomy, 
analysed by intention to treat. Gallstone-related complications were defined as 
acute readmission for recurrent pancreatitis, cholecystitis, cholangitis, obstructive 
choledocholithiasis needing endoscopic retrograde cholangiopancreatography or 
gallstone colic.25, Secondary endpoints were the individual components of the primary 
endpoint, difficulty of cholecystectomy as assessed by the most experienced surgeon on 
a 0-10 visual analogue scale, conversion to open cholecystectomy, health-care use such 
as total length of hospital stay after randomisation (including readmission), and the 
number of patient-reported colics irrespective of readmission.
 Predefined safety endpoints included cholecystectomy-related complications 
such as bile duct injury and bleeding; the need for additional surgical, endoscopic or 
radiological intervention; and other complications such as pneumonia, bacteraemia, 
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and new-onset organ failure.26 The Appendix provides definitions for the primary and 
secondary outcomes.
Statistical Analysis
The sample size calculation was based on an expected reduction of the primary endpoint 
from 8% within 4 weeks after discharge in the interval cholecystectomy group to 1% 
in the same-admission cholecystectomy group, as reported in a recent nationwide 
retrospective study.6 To show this effect with 80% power, a two-sided α-level of 5% and 
0.5% loss to follow up, 266 patients were needed.
 An intention-to-treat-analysis was done. We tested differences in dichotomous 
data between the groups were tested using the χ2 test or Fisher’s exact test (eg, the 
data for primary outcome, and need for intensive care unit admission), and used the 
Mann-Whitney U test to assess differences in continuous data (eg, length of stay after 
randomisation, and duration of surgery). Predefined subgroup analyses were done 
based on age (< 75 years vs ≥ 75 years) and endoscopic sphincterotomy (yes vs no) 
before randomisation. We chose these subgroups because we postulated that elderly 
patients would be more prone to complications (ie both gallstone-related and non-
gallstone-related) than younger patients, and to assess a potential protective effect of 
sphincterotomy on the occurrence of gallstone-related complications.16 We used logistic 
regression to test for interactions between subgroups.
 An interim analysis of the primary endpoint was performed by an independent 
statistician after 50% of the patients had completed the six-month follow-up period, 
which used the Peto approach with symmetric stopping boundaries at a p value of less 
than 0.001.27 A futility rule was not used, since this study is the first randomised trial 
on this topic and we felt strongly that, irrespective of the outcome, the results of the 
trial would be informative. The central study coordinator and steering committee were 
informed that the Peto criteria were not met and that the trial could continue as planned.
 For the final analyses, a two-sided p value of less than 0.05 was judged to be 
statistically significant. We did not adjust p values for multiple testing.
IBM SPSS Statistics version 22 was used for statistical analyses.
This trial is register with Current Controlled Trials number ISRCTN72764151.
Role of the funding source
The funder of the study had no role in the study design, execution, data analysis or 
publication. The joint first authors (DdC and SAB), second author (NJS), statistical and 
methodological expert (MGD) and last author (DB) had full access to all the data. DB 
had final responsibility for the decision to submit for publication.
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RESULTS
Enrolment and randomisation
Between December 2010 and August 2013, 713 patients with gallstone pancreatitis 
were assessed for eligibility (Figure 1). After 447 patients were excluded, 266 patients 
were enrolled and randomly assigned: 137 in the interval cholecystectomy group and 
129 patients in the same-admission cholecystectomy group. The masked adjudication 
committee excluded one patient in the interval group from the final analysis because of 
an incorrect diagnosis of acute pancreatitis, since the serum amylase level did not exceed 
three times the upper limit of normal. One patient in the same-admission group was 
lost to follow up at three months after randomisation. Before randomisation 42 patients 
in the interval group (31%) and 36 patients in the same-admission group (28%) had 
undergone endoscopic sphincterotomy (p=0.6). In both groups sphincterotomy was 
done a median of one day (IQR 0-2 days in the interval group and 0-1 day in the same 
Figure 1. Enrolment, allocation and follow-up of patients
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admission group) after admission. The baseline characteristics of the participants did 
not differ significantly between the two treatment groups (Table 1).
 In the interval group, median time to cholecystectomy after randomisation 
was 27 days (interquartile range [IQR] 26 to 29 days) and 100 of the patients (74%) 
underwent surgery within the designated 25 to 30 days. Recurrent gallstone-related 
complications required emergency or earlier cholecystectomy in 13 patients (10%). One 
patient in the interval group ultimately refused cholecystectomy. In the same-admission 
group, median time to cholecystectomy following randomisation was 1 day (IQR 1 
to 2 days), and 119 of the patients (93%) underwent surgery within the designated 3 
Table 1. Baseline characteristics.
Characteristic
Interval 
cholecystectomy
(N=136)
Same admission 
cholecystectomy
(N=128)
Age in years; median (IQR) 54 (41-68) 53 (38-66)
Female sex; No. (%) 84 (62) 76 (59)
Body Mass Index (kg/m2); median (IQR) 28 (25-31) 27 (24-32)
Medical History; No. (%)
Upper abdominal surgery 6 (4) 8(6)
History of gallstone colics 35 (26) 38 (30)
History of cholecystitis 2 (1) 3 (2)
Diabetes 7 (5) 11 (9)
American Society of Anaesthesiologists class; No. (%)
I: healthy status 51 (38) 43 (34)
II: mild systemic disease 74 (54) 72 (56)
III: severe systemic disease 11 (8) 13 (10)
Endoscopic sphincterotomy prior to randomisation; No. (%) 42 (31) 35 (27)
CRP (mg/l) on the day of randomisation; median (IQR) 36 (15-69) 31 (11-66)
Days of admission prior to randomisation; median (IQR) 5 (3-9) 5 (3-8)
Days between randomisation and cholecystectomy; median (IQR) 27 (26-29) 1 (1-2)
IQR: Inter Quartile Range. CRP: C-Reactive Protein. 
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days. The experience of the surgeons performing cholecystectomy did not differ between 
groups (further details are found in the Supplementary Appendix).
Outcomes
Primary and secondary endpoints
The composite primary endpoint of acute readmission for a gallstone-related 
complication or mortality occurred in 23 of 136 patients (17%) in the interval group, 
as compared with 6 of 128 patients (5%) in the same-admission group (risk ratio 0.28; 
95% confidence interval [CI] 0.12 to 0.66; p=0.002) (Table 2). In the interval group, 
21 of the 23 primary endpoints (91%) occurred before cholecystectomy, with a median 
time from discharge to readmission of 15 days (IQR 8 to 21 days). In the same-admission 
group all primary endpoints occurred after cholecystectomy and within the first 3 weeks 
after discharge (median 12 days, IQR 5 to 18).
 Recurrent gallstone pancreatitis occurred in 12 patients in the interval group 
(9%) versus 3 patients in the same-admission group (2%; risk ratio 0.27; 95% CI 0.08 
to 0.92; p=0.03). These 15 patients were readmitted for a median of 6 days (IQR 4 to 
10) and did not develop pancreatic necrosis or organ failure. In the same admission 
group, a 75-year-old patient with a recent carotid endarterectomy died at home one 
week after cholecystectomy because of ischemic stroke.
 In the interval group, 62 patients (51%) of 121 responding patients reported 
gallstone colics before cholecystectomy, irrespective of the need for readmission, versus 
3 patients (3%) of 93 responding patients in the same-admission group (risk ratio 0.06; 
95% CI 0.02 to 0.19; p<0.0001). In the interval group this was reported as “severe pain” 
by 39 out of 62 patients (63%). (Table S2 in the Supplementary Appendix).
 Length of hospital stay after randomisation did not differ between groups (Table 
2). Difficulty of cholecystectomy, the number of conversions, or healthcare use did not 
differ between the groups (details on the secondary endpoints and cholecystectomies are 
provided in the Supplementary Appendix).
Safety endpoints
In each group one patient developed a cystic duct leakage. This was treated by endoscopic 
sphincterotomy in one patient and by percutaneous catheter drainage in the other. 
A hematoma was evacuated by percutaneous drainage in one patient in the interval 
group, and by laparoscopic drainage in another patient in the same-admission group. 
No differences in the number of other complications that needed treatment were seen 
(Table 2). 
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Table 2. Primary, secondary and safety endpoints
Interval 
cholecystectomy
(N=136)
Same-admission 
cholecystectomy
(N=128)
Risk Ratio 
(95% CI)
p Value
Primary Endpoint; No. (%)
Mortality or readmission for gallstone-
related complications 23 (17) 6 (5) 0.28 (0.12-0.66) 0.002
Secondary Endpoints
Readmission for gallstone-related 
complications; No. (%)
Recurrent pancreatitis 12 (9) 3 (2) 0.27 (0.08-0.92) 0.03
Cholecystitis 2 (1) 0 0.50
Choledocholithiasis needing ERCP 2 (1) 1 (1) 0.53 (0.05-5.79) 1.00
Gallstone colics 7 (5) 2 (1) 0.30 (0.06-1.43) 0.17
Mortality 0 1 (1) 0.48
Patients reporting colics during waiting 
period; No. (%)* 62 (51) 3 (3) 0.06 (0.02-0.19) <0.0001
Difficulty of cholecystectomy; median 
(IQR) 6 (4-7) 6 (4-7) 0.70
Conversion to open cholecystectomy; 
No (%)¶ 4 (3) 5 (4) 1.31 (0.36-4.77) 0.74
Operating time; median (IQR) 60 (44-78) 58 (44-70) 0.47
Total length of stay after randomisation; 
median (IQR) 3 (2-5) 3 (2-4) 0.94
Need for ICU admission; No. (%) 1 (1) 1 (1) 1.00
Safety Endpoints; No. (%)
Cystic duct leakage 1 (1) 1 (1) 1.00
Bleeding needing reoperation or 
transfusion; No. (%) 1 (1) 1 (1) 1.00
Need for additional intervention
Surgical 0 1 (1) 0.48
Endoscopic 0 1 (1) 0.48
Radiological 2 (1) 0 0.50
Pneumonia 0 2 (1) 0.23
Pulmonary embolism§ 1 (1) 0 1.00
CI: Confidence Interval. N/A: Not applicable. ICU: Intensive Care Unit. SD: standard deviation. IQR: 
Interquartile range. ERCP: Endoscopic Retrograde Cholangiopancreatography. 
* Interval cholecystectomy N=121, same-admission cholecystectomy N=93 
¶ 4 patients in interval and 2 in same-admission group not included in analysis due to primary open 
cholecystectomy. 
§Endpoint not previously defined in the protocol
Chapter 3
48
Subgroup analysis
In a subgroup analysis, formal statistical tests showed no interaction between the different 
subgroups and the effect of same-admission cholecystectomy in the occurrence of the 
primary endpoint (p>0.05 for all). In the subgroup of patients who had undergone 
endoscopic sphincterotomy, the primary endpoint occurred in seven of 42 patients 
(17%) compared with one of 35 in the same-admission group (3%; p=0.07; Table S4 in 
the Supplementary Appendix). In the interval group, one patient developed recurrent 
pancreatitis, two cholecystitis, one choledocholithiasis, and three were readmitted 
for gallstone colic. One patient in the same-admission group was readmitted for 
choledocholithiasis.
DISCUSSION
This study demonstrates that in patients with mild gallstone pancreatitis, same-admission 
cholecystectomy reduces the risk of recurrent gallstone-related complications, including 
pancreatitis. The very low incidence of cholecystectomy-related complications suggests 
that cholecystectomy can be done safely during the same hospital admission.
 Several observational and mostly retrospective studies also showed a reduced 
risk of gallstone-related complications following same-admission cholecystectomy in 
mild gallstone pancreatitis.12,16,18 However, because of their non-randomised design, 
these studies are prone to selection bias. For example, elderly patients, patients with 
considerable co-morbidity, or patients with a more severe course of pancreatitis may have 
undergone interval cholecystectomy. Only one small, randomised study has been done 
on timing of cholecystectomy in patients with mild gallstone pancreatitis.28 In this trial 
patients were randomised between cholecystectomy within 48 hours and cholecystectomy 
after 48 hours after admission. The study was designed with length of hospital stay 
as primary endpoint and was not powered to detect differences in clinically relevant 
outcomes such as recurrent gallstone-related complications. Moreover, cholecystectomy 
within 48 hours after admission in gallstone pancreatitis is controversial because 
patients may still develop pancreatic necrosis or organ failure during this phase of the 
disease, which both are considered contraindications for early surgery.15,29,30 Conversely, 
the randomisation criteria as applied in this study (most notably a C-reactive protein 
concentration of <100 mg/l) may have unnecessarily increased length of stay in some 
patients. Therefore, although our study has demonstrated the benefit of performing 
cholecystectomy before discharge, future studies should be directed at exploring the 
optimal timing of cholecystectomy during a hospital stay.
 Although current guidelines recommend conservative management in case of 
mild gallstone pancreatitis without cholangitis, quite a large percentage of patients in 
our study population underwent endoscopic sphincterotomy. However, these rates are 
similar to those reported in large, nationwide studies from the United Kingdom and 
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United States.7,12,18 In view of the protective effect of sphincterotomy on the recurrence 
of pancreatitis, this may have moderated the contrast in primary endpoints between the 
groups in favour of interval cholecystectomy.18 More importantly, our results showed that 
these patients remained at risk for recurrent gallstone-related complications even after 
sphincterotomy. This finding differs from previous retrospective studies that suggested 
that patients after sphincterotomy do not need to undergo early cholecystectomy.31 
Although sphincterotomy may reduce the risk of recurrent pancreatitis, it evidently 
does not provide adequate protection from other events such as cholecystitis and 
colics to warrant interval cholecystectomy.10,17,18 The findings of our study are in line 
with a recent meta-analysis on prophylactic cholecystectomy after sphincterotomy for 
gallstone-related complications other than pancreatitis.32 Some have advocated the use 
of endoscopic sphincterotomy as a bridge to cholecystectomy in patients with more 
severe pancreatitis, complicated by local complications such as parenchymal necrosis 
or peripancreatic fluid collections.31,33 This issue has not been addressed in prospective 
trials and needs further study. 
Although our study was not powered to detect significant differences in cholecystectomy-
related complications (e.g. bile duct leakage), the overall low incidence of these 
complications challenges the notion that cholecystectomy in the early phase after 
recovery from acute pancreatitis is not safe.15,30 This hypothesis is supported by the 
similar scores of surgical difficulty obtained between the same-admission and interval 
group. Studies on patients with other gallstone-related diseases such as cholecystitis 
or choledocholithiasis also showed no differences in technical difficulty between early 
and delayed cholecystectomy.34,35 Nevertheless, large, population based studies may 
provide more comprehensive data for a definitive appraisal of the relative risk of surgical 
complications between same-admission and interval cholecystectomy.
Same-admission cholecystectomy has several benefits for both patients and healthcare 
providers.
 Foremost, the risk of readmission for recurrent pancreatitis and other gallstone-
related complications is minimised. Furthermore, same admission cholecystectomy 
prevents disabling colics that would otherwise have occurred in more than half of those 
patients awaiting elective surgery. An additional advantage is that both treatment and 
prevention of future gallstone-related complications for acute pancreatitis is provided 
during a single hospital stay. From a healthcare utilisation perspective, however, 
widespread implementation of this strategy may be challenging, since it demands a 
shift from elective to acute-care surgery, which will necessitate a change in both the 
mindset towards the urgency of cholecystectomy in this particular patient group and 
in logistics and infrastructure. In the setting of a randomised trial, same-admission 
cholecystectomy did not prove an obstacle for the 23 participating Dutch centres, but 
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this obviously does not guarantee worldwide implementation. However, several recent 
international studies have shown that quite straightforward organisational adjustments, 
such as direct admission to the surgical ward, can lead to improved efficiency in care 
for gallstone pancreatitis patients.7,14,36 With respect to external validity, we should note 
that our results can not be extrapolated to patients over 75 years of age and ASA class 
III or any patients with a higher ASA classification. These patients are poor surgical 
candidates in whom the risk of perioperative complications can outweigh the long-
term protective effect of cholecystectomy, especially if endoscopic sphincterotomy has 
already been done. The optimum strategy in this vulnerable patient group needs further 
investigation.
 In conclusion, the results of this multicentre trial show that same-admission 
cholecystectomy in patients with mild gallstone pancreatitis was safe and reduced the risk 
of recurrent gallstone-related complications, as compared with interval cholecystectomy.
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Supplementary Appendix to manuscript:
Same-admission versus interval cholecystectomy for mild gallstone pancreatitis: a multi-
centre randomised controlled trial 
Additional information:
- Definitions
- Treatment allocation
- Imaging studies and gallstone aetiology
- Assessment of the probability of choledocholithiasis
- Gallstone questionnaires and patient reported outcomes
- Surgeon reported outcomes and intraoperative cholangiography
- Timing of readmissions
-Length of stay
- Cost comparison
Box S1: Definitions
Table S1: Data on imaging studies prior to randomisation
Table S2: Gallstone colics before and after cholecystectomy
Table S3: Healthcare utilization 
Table S4: Distribution of end points in predefined subgroups 
Figure S1: Length of stay per treatment group
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Additional information: definitions
In absence of gallstones or sludge on imaging, and not other cause for pancreatitis, 
gallstone pancreatitis was defined by a serum alanine aminotransferase (ALT) at least 
twice the level of normal and exceeding the aspartate aminotransferase (AST) level.1,2 Bile 
duct injuries were classified according to the Amsterdam criteria (see Box S1).3 Organ 
failure was defined according to the modified Marshall score, as proposed in the revised 
Atlanta classification.4 Concerning the secondary end points, for recurrent pancreatitis 
the same criteria as for regular pancreatitis were used. The diagnosis of cholecystitis 
and cholangitis was made using the 2007 Tokyo guidelines (with modifications to the 
cholangitis criteria).2,5 For the diagnosis of gallstone colics the Rome criteria were used.6 
In patients in whom chronic pancreatitis was suspected, the diagnostic criteria from the 
M-ANNHEIM classification system were applied.7
Additional information: treatment allocation
The median number of days between admission and cholecystectomy was 32 in the 
interval group (interquartile range [IQR] 29-37) and 7 in the same-admission group 
(IQR 5-10; p<0.0001). The median number of days between sphincterotomy and 
randomisation was 4 days in the interval group (IQR 2-6) and 5 days in the same-
admission group (IQR 2-8; p=0.38).
 In 22 patients in the interval group, the time-window was not met due to 
various reasons: in 17 patients because of logistical issues. In 5 patients cholecystectomy 
was postponed due to medical issues: in 1 patient cholecystectomy was suspended 
in order to recuperate from severe colics, 1 patient underwent elective ERCP for 
choledocholithiasis and 1 experienced a psychosis. In the remaining 2 patients other 
medical conditions were treated before cholecystectomy.
 Nine patients in the same-admission group underwent cholecystectomy outside 
the 72-hour time window: 3 patients were operated on the fourth day after randomization 
day due to scheduling difficulties and 1 after 17 days for personal reasons. In 3 others the 
surgeon postponed cholecystectomy, deeming surgery unsafe after palpating extensive 
infiltration of the tissue surrounding the gallbladder. In the remaining 2 patients the 
operation was suspended due to medical reasons; 1 patient had high risk of bleeding 
due to the use of multiple platelet aggregation inhibitors. The second patient developed 
symptoms of carotid artery occlusion on the day of randomization for which he first 
underwent carotid endarterectomy.
Additional information: imaging studies and gallstone aetiology
Abdominal ultrasound was performed prior to randomisation in 241 out of the 264 
patients (91%), 45 underwent abdominal CT (17%), endoscopic ultrasound in 20 
(8%) and magnetic resonance cholangiopancreatography in 35 patients (13%) (Table 
S1). Gallstones or sludge were found in 260 patients (98%), a dilated common bile duct 
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in 2 (diameter of 9 and 11mm on ultrasound and computed tomography, respectively; 
1%) and elevated ALT levels in 2 patients (1%). In these last 2 patients, imaging 
studies were inconclusive for gallstones or sludge, but they were clinically suspected of 
gallstone disease and had exceedingly high alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST) serum levels (ALT 945 IU/l with AST 474 IU/l and ALT 453 
IU/l with AST 171 IU/l, respectively).
Additional information: assessment of the probability of choledocholithiasis
A risk assessment of the presence of common bile duct stones was performed in which 
patients have a high probability (>50%) of choledocholithiasis and should undergo 
preoperative evaluation of the bile duct when:9 
1. an intraductal gallstone is present on imaging or 
2. serum bilirubin levels exceed 70 μmol/l or 
3. imaging reveals a common bile duct diameter exceeding 6mm and a serum bilirubin 
level between 30 and 70 μmol or
4. the patient exhibits signs of ascending cholangitis. 
The central study coordinator encouraged a proactive bile duct evaluation strategy 
whenever the suspicion of choledocholithiasis arose. However, the final decision for 
performing ERCP with or without sphincterotomy was left to the discretion of the 
treating physician.
Of the 264 patients, 29 patients had high risk of choledocholithiasis due to bile duct 
stones on imaging, 28 of whom underwent ERCP prior to cholecystectomy (24 with 
stone extraction). The last patient was managed conservatively, as the gallstone seen 
previously on abdominal ultrasound was not detected on MRCP 5 days later and 
the bilirubin declined spontaneously to under 30 μmol/l. The patient underwent an 
uncomplicated cholecystectomy and had an uneventful recovery.
 An additional 50 patients had bilirubin levels exceeding 70 μmol/l without 
intraductal stones on imaging. Of these, 20 were treated with ERCP (13 with stone 
extraction) while in the remaining 30 patients, 28 showed normal bilirubin levels (i.e. 
<30 μmol/l) or receding bile duct diameters on new imaging over the next few days, 
indicative of spontaneous bile duct clearance. One of these patients was nonetheless 
readmitted postoperatively due to gallstone colics and ERCP was performed. Of the 
other two conservatively treated patients, one had asymptomatic but persisting high 
bilirubin levels until the day of randomisation (110 μmol /l) while the other had a 
common bile duct of 7mm on MRCP along with a declining serum bilirubin level of 35 
μmol/l on the day of randomisation. These two patients had uneventful recoveries.
 Furthermore, 25 patients had common bile duct dilatation on imaging with 
bilirubin levels between 30 and 70 μmol/l, without intraductal stones. In 11 ERCP 
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was performed (6 with stone extraction), while the remaining 14 recovered with 
conservative treatment, with normalised bilirubin levels at the time of randomisation 
(i.e. <30 μmol/l). All had uneventful recoveries.
 No patients in the study developed cholangitis.
In summary, 104 patients (39%) were at high risk of choledocholithiasis at some point 
before randomisation. Of these, 59 underwent bile duct evaluation through ERCP 
while 43 out of the remaining 45 patients had spontaneous resolution of radiologic or 
biochemical signs of choledocholithiasis and therefore did not need bile duct evaluation.
The two patients who were at risk of choledocholithiasis at the time of randomisation, 
according to the Maple criteria, recovered without any signs of potentially retained 
common bile duct stones. 
Additional information: gallstone colic questionnaires and patient reported outcomes
After randomization, all patients received a diary with instructions to document colics 
they experienced in the following three months. A second diary was provided during 
follow up to document the next three months. Patients were instructed to rate the 
pain on a 0 to 10 numeric rating scale (NRS). Responses in the gallstone diaries were 
categorized as ‘no pain’ (NRS: 0), ‘mild pain’ (NRS: 1 to 3), ‘moderate pain’ (NRS: 4 to 
6) and ‘severe pain’ (NRS: 7 to 10).10
 Gallstone diaries were received from 103 patients in the interval group, 
with another 18 patients reporting no complaints at follow-up by telephone before 
cholecystectomy (total response rate 89%). In the same-admission group diaries were 
received from 93 patients, with an additional 13 in the following 3 months (total 
response rate 91%). No differences in post-procedural pain scores were found (data not 
shown). The responses are presented in Table S1 using the χ2 test for categorical data.
Additional information: surgeon reported outcomes 
Surgeons with at least 100 laparoscopic interventions in the past 5 years carried out 
or supervised 236 of the 265 operations (89% in both groups; p=0.96). Difficulty of 
cholecystectomy was rated similar between groups, although more cholecystectomies 
were scored 8 or higher in the interval group (15% versus 19%, p=0.73). Difficult 
dissection (both 37%), conversion (3% interval versus 4% same-admission) and 
operating time (60 minutes interval versus median 58 minutes same-admission) were 
similar between groups.
 In 17 patients, an intraoperative cholangiography (IOC) was performed: 9 in 
the interval and 8 in the same-admission group. Median duration of IOC was similar 
(13 and 14 minutes, respectively, p=0.28) No stone extractions were performed and no 
bile duct injuries exposed. In 1 patient in the interval group a filling defect was seen on 
IOC that was managed conservatively. The post-hoc analysis did not reveal significant 
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differences in the primary end point between patients in who underwent the procedure 
was performed and in those who did not. The primary endpoint occurred in 26 of 246 
patients (11%) who did not undergo IOC versus in 3 of 17 patients who did (18%; risk 
ratio 1.67; 95% confidence interval 0.56 to 4.96; p=0.4).
Additional information: timing of readmissions
In the interval group, 18 of the 21 readmissions (78%) occurred within 3 weeks after 
the first discharge. In the same-admission group all primary end points occurred within 
3 weeks after cholecystectomy. Previous endoscopic sphincterotomy (ES) had no 
influence on the median number of days to readmission (ES; 9 days versus No ES; 15 
days, p=0.11).
Additional information: length of stay
The median number of days between admission and randomisation was 5 in both groups 
(interquartile range [IQR] same-admission group 3-8, IQR interval 3-9). The median 
number of days between randomisation and discharge in the same-admission group 
was 2 (IQR 2-3). As mentioned in Table 1 in the manuscript, cholecystectomy was 
performed after a median of 1 day in this group (IQR 1-2). Almost all patients in the 
interval group were discharged on the day of randomisation (median 0, IQR 0-1). The 
median length of stay for elective cholecystectomy was 2 days (IQR 1-2). Furthermore, 
in the same-admission group, there were a few patients with lengthy admission periods 
due to various complications (e.g. bleeding, pneumonia, see the figure below). Median 
length of stay after randomisation was 2 days in both groups if readmissions were left 
out, but this increased to 3 when readmission days were included.
Additional information: Costs
Costs were based on the number of admission days, costs of surgery, radiological and 
endoscopic procedures, emergency room and outpatient visits and indirect costs through 
missed hours of work. Table S3 contains an overview of consumption of these healthcare 
resources.
 We found that total mean costs for patients in the same-admission group 
were €4993, compared with €5226 in the interval group (cost difference -€234, 95% 
confidence interval -€1249 to €738). The mean direct medical costs were slightly higher 
in the same-admission group due to the number of days of admission (€3389 same 
admission versus €3224 interval; cost difference €144, 95% CI -€393 to €722). Indirect 
costs on account of missed hours of work were lower in the same-admission group: 
€1604 versus €1982 in the interval group (cost difference -€378, 95%CI -€1045 to 
€251).
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Box S1: List of definitions
Gallstone aetiology
Gallstones or sludge on imaging
Bile duct dilatation (>8 mm in patients ≤75 years old or >10 mm in patients >75 
years old)
ALT levels raised >2 times upper level of normal and higher than ALT
Bile duct injury
Type A: cystic duct leaks or leakage from aberrant or peripheral hepatic radicals;
Type B: major bile duct leaks with or without concomitant biliary strictures;
Type C: bile duct strictures without bile leakage;
Type D: complete transection of the duct with or without excision of some 
portion of the bile duct.
Gallstone related complications
Cholecystitis
Local signs of inflammation: positive Murphy’s sign or right upper quadrant mass, 
pain or tenderness
Systemic signs of inflammation: fever, elevated C-reactive protein or elevated 
white blood cell count
Signs of local and systemic inflammation with characteristics of cholecystitis on 
imaging
Cholangitis
Serum total bilirubin level >40 μmol/l (>2.3 mg/dl) or dilated common bile duct 
(>8 mm) on imaging and
Temperature >38.5°C
Symptomatic 
choledocholithiasis
Biochemical signs of cholestasis with bile duct dilatation or intraductal gallstones 
on imaging
Gallstone colic Upper abdominal pain (either right upper quadrant or epigastric pain) lasting at least 30 minutes
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Table S1. Data on imaging studies prior to randomisation.
Characteristic
Interval 
cholecystectomy
(N=136)
Same admission 
cholecystectomy
(N=128)
Imaging studies prior to randomisation; No. (%)
Abdominal ultrasound 126 (93) 115 (90)
Endoscopic ultrasound 11 (8) 9 (7)
Computed tomography 26 (19) 18 (14)
Magnetic resonance cholangiopancreatography 18 (13) 17 (13)
Biliary aetiology; No. (%)
Gallstones or sludge 134 (98) 126 (98)
Dilated common bile duct on imaging* 1 (1) 1 (1)
Biochemical data§ 1 (1) 1 (1)
*Diameter of the common bile duct of >8 mm in patients ≤75 years old or >10 mm in patients >75 years 
old.
§ Serum alanine aminotransferase of at least 2 times the upper limit of normal and higher than serum 
aspartate aminotransferase level
Table S2. Gallstone colics before cholecystectomy as reported in the gallstone questionnaire
Interval 
cholecystectomy 
(N=121)
Same-admission 
cholecystectomy 
(N=93)
p value
Pain before cholecystectomy*; N (%) <0.0001
Mild pain 10 (8) 1 (1)
Moderate pain 13 (11) 0
Severe pain 39 (32) 2 (2)
*Mild pain: NRS 1 to 3; Moderate pain: NRS 4 to 6; Severe pain: NRS 7 to 10.
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Table S3. Healthcare utilization after randomization
Healthcare utilization
Interval 
cholecystectomy
(N=136)
Same-admission 
cholecystectomy 
(N=128)
p value^
Endoscopic procedures
Gastroscopy 4 (0-1) 5 (0-1) 0.67
EUS 3 (0-1) 0 0.09
ERCP 7 (0-1) 3 (0-1) 0.23
Colonoscopy 3 (0-1) 1 (0-1) 0.60
Radiology
Ultrasound 34 (0-4) 23 (0-3) 0.34
X-ray (chest and abdominal) 10 (0-2) 22 (0-4) 0.20
CT scans 11 (0-2) 16 (0-3) 0.53
MRCP 1 (0-1) 4 (0-1) 0.20
Other
ER visits 10 (0-3) 5 (0-1) 0.81
^ p value calculated with Mann-Whitney U test
Continuous data are total number per study group and range per patient.
EUS denotes endoscopic ultrasound; ERCP endoscopic retrograde cholangiopancreatography; CT 
computed tomography; MRCP magnetic resonance cholangiopancreatography; ER emergency room.
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Figure S1. Length of stay after randomisation per treatment group.
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Cost-effectiveness of same-admission versus interval cholecystectomy after mild gallsto-
ne pancreatitis in a multicentre, randomised controlled trial
ABSTRACT
Background: Same-admission cholecystectomy is indicated after gallstone pancreatitis 
to reduce the risk of recurrent disease or other gallstone-related complications but its 
impact on overall costs are unclear. This study analysed cost-effectiveness of same-
admission versus interval cholecystectomy after mild gallstone pancreatitis.
Methods: In a multicentre RCT (Pancreatitis of biliary Origin: optimal timiNg 
of CHOlecystectomy; PONCHO) patients with mild gallstone pancreatitis were 
randomized before discharge to either cholecystectomy within 72h (‘same-admission 
cholecystectomy’) or cholecystectomy after 25 to 30 days (‘interval cholecystectomy’). 
Healthcare use of all patients was recorded prospectively with clinical report forms. 
Unit costs of used resources were determined and patients completed multiple Health 
and Labour Questionnaires to record pancreatitis-related absence from work. Cost-
effectiveness analyses were performed from societal and health care perspectives with the 
costs per readmission prevented as primary outcome with a time horizon of 6 months.
Results:  All 264 trial participants were included in the present analysis, 128 
randomized to same-admission cholecystectomy and 136 to interval cholecystectomy. 
Same-admission cholecystectomy reduced the risk of acute readmission for recurrent 
gallstone-related complications from 17 to 5% (p=0.002). Mean costs from a societal 
perspective were €234 less per patient in the same-admission cholecystectomy group 
(95% confidence interval [CI] -1249 to 738). Same-admission cholecystectomy was 
superior to interval cholecystectomy with a societal incremental cost-effectiveness ratio 
of -€1918 to prevent one readmission for gallstone-related complications.
Conclusion: From a societal perspective same-admission cholecystectomy was both 
more effective and less costly than interval cholecystectomy.
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INTRODUCTION
With its growing incidence, acute pancreatitis is becoming an increasingly large burden 
on healthcare services and their resources worldwide1-3. The disease leads to 26 000 
annual hospital admissions in England and 270 000 in the United States (US), where 
it has become the most common gastrointestinal reason for emergency admission4, 5. 
Epidemiological studies are increasingly being published worldwide, and report growing 
incidence of acute pancreatitis ranging between 13 and 45 cases per 100 000 persons per 
year6. The majority of patients with pancreatitis need only supportive care and recover 
within 1 week7. The remainder, approximately 15%, develop more severe disease, 
characterised by (peri)pancreatic necrosis, fluid collections and organ failure. Long 
hospital stays, intensive care unit admission and various diagnostic and therapeutic 
procedures often result in high treatment costs in these patients8. The volume of patients 
with mild disease and the expensive care of patients with severe disease means that acute 
pancreatitis generates vast financial costs, amounting to over $2 billion in the US in 
20109.
 In up to 62% of patients, migrating gallstones or sludge obstructing the 
pancreatic duct are the cause of pancreatic inflammation10. Cholecystectomy is indicated 
in these patients to reduce the risk of recurrence or other gallstone related complications 
(biliary events). Several studies have shown that cholecystectomy should be performed 
before discharge to minimise this risk11-14. However, reports from several international 
audits have shown that cholecystectomy is often not carried out until 6 weeks after 
discharge, and not at all in many patients15-17. Delaying surgery exposes the patient to a 
higher risk of readmission for recurrent biliary events. For this reason, cholecystectomy 
is recommended during the same admission by the international guidelines, or at least 
within two weeks after discharge according to the British Society of Gastroenterology18-20. 
Same-admission cholecystectomy may reduce the number of readmissions but its impact 
on healthcare costs is unclear. Two recent model-based studies from the United Kingdom 
found that early cholecystectomy could be cost-effective, but substantial adjustments of 
logistics and resource allocation would be needed21, 22. 
 The aim of this study was to carry out a cost-effectiveness analysis on the two 
strategies using actual resource data from a Dutch randomised trial.
METHODS
Patients and treatment protocol
The rationale and design for the clinical trial23 and the primary endpoint results11 
have been described previously. In brief, patients with a first episode of mild biliary 
pancreatitis were eligible for inclusion7. Among the 23 participating medical centres 
were seven university hospitals and 16 teaching hospitals. Randomization took place 
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when the treating physician foresaw discharge within 24 to 48 hours. Additional criteria 
for randomization included cessation of opioid analgesics, a normal oral diet and a 
maximal C-reactive protein serum level of 100 mg/l. Patients randomized to same-
admission cholecystectomy underwent surgery within 72 hours after randomization, 
whereas patients in the interval group were discharged and planned for cholecystectomy 
25 to 30 days later. The primary outcome was a combined endpoint of mortality 
or acute readmission for a biliary complication, defined as recurrent pancreatitis, 
cholecystitis, symptomatic choledocholithiasis requiring endoscopic retrograde 
cholangiopancreatography (ERCP) and biliary colic.
Design of the cost-effectiveness analysis
Cost-effectiveness analyses from societal and health care perspectives were performed 
with the costs per prevented acute readmission as primary outcome. Mortality was not 
included in this outcome, as only one elderly patient in the same-admission group died 
due to an unrelated cause. Costs until the moment of death were included for this 
patient. Direct medical and indirect medical and non-medical, pancreatitis-related costs 
during a follow-up period of six months after randomization were taken into account. 
For the reporting of this study, the Consolidated Health Economic Evaluation Reporting 
Standards (CHEERS) guidelines were adhered24.
 The following health care resources consumed after randomization were 
prospectively registered for each patient: the number of days of admission (on the general 
ward and intensive care unit [ICU]), surgical procedures, radiography (ultrasound, 
computed tomography [CT], plain X-rays, magnetic resonance imaging [MRI], 
radiological drainage procedures), endoscopic procedures (gastroscopy, enteral feeding 
tube placement, endoscopic retrograde cholangiopancreatography [ERCP], endoscopic 
ultrasound, colonoscopy), and the use of other medical services (outpatient clinic visits, 
telephonic consultations and emergency room visits). Volumes of haematological, 
biochemical or microbiological blood tests were not taken into account, as no differences 
were expected based on their low unit costs. For patients without any record of a visit in 
the outpatient clinic was found, the mean volume of the treatment group was imputed. 
 Unit costs for admission days (general ward and ICU), outpatient and 
emergency room visits were based on the 2010 Dutch manual for costing in health care 
research.25 Unit costs of radiologic and endoscopic procedures were derived from the 
St. Antonius Hospital tariffs ledger, which included personnel, material and overhead 
costs. Unit costs for cholecystectomy were calculated from specialists’ fees for surgeon 
and anaesthesiologist, personnel costs, purchase prices of materials used and overhead 
costs. As in the Netherlands personnel is entitled to overtime pay between 19.00 and 
22.00 hours on weekdays and during the weekend, adjusted unit costs were calculated 
for surgery done during off hours. A correction was made for differences in overtime rate 
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between university and general hospitals. Unit costs were (general) price-indexed for the 
year 2013 and are presented in Table 1 in euros. 
 Costs were calculated as the product of the volumes of resources used and their 
respective unit costs. The main analysis includes costs made after occurrence of the 
primary outcome (i.e. the costs of readmission), but these downstream costs are also 
reported separately. No discounting was applied as follow-up consisted of 6 months.
Indirect non-medical costs
To enable calculation of indirect costs of sick leave from work, all patients were sent a 
Health and Labour Questionnaire (HLQ; Institute for Medical Technology Assessment, 
Erasmus University, Rotterdam, the Netherlands) at one and three months after 
randomization on which employment status and number of missed hours at work from 
that month were registered26, 27. Data from the second questionnaire were doubled to 
account for the number of missed hours in the second month after discharge. As no 
further cholecystectomy- or pancreatitis-related sick leave was expected from a clinical 
perspective, no questionnaires were issued for the last three months of follow up.
 Missing questionnaires from non-responders over the age of 65 years were 
assessed as non-informative given the legal retirement age at the time of the study period 
of 65. For the non-responders under 66 years of age, missing data were handled by 
Table 1. Baseline characteristics.
Same-admission 
cholecystectomy (N=128)
Interval cholecystectomy 
(N=136)
Age in years; median (IQR) 53 (38-66) 54 (41-68)
Female sex; No. (%) 76 (59) 84 (62)
Body Mass Index (kg/m2); median (IQR) 27 (24-32) 28 (25-31)
Medical History; No. (%)
Cardiovascular disease 23 (18) 21 (15)
Pulmonary disease 16 (12) 8 (6)
Chronic renal insufficiency 2 (2) 2 (2)
Diabetes 12 (9) 7 (5)
Endoscopic sphincterotomy prior to 
randomisation; No. (%) 37 (29) 42 (31)
IQR, interquartile range
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imputing the mean of each group per questionnaire. The friction cost approach was used 
to value the total number of missed hours. Productivity loss was valued by multiplying 
the number of missed hours by the average wage per hour in 2013 (€32.68)25. 
Statistical analysis
Analyses were performed on the intention to treat principle. Group contrasts were 
assessed by calculating 95 % confidence intervals (CI) for the mean differences after 
bias-corrected, accelerated non-parametric bootstrapping, drawing 1000 samples of 
the same size as the original sample for each group. The incremental cost-effectiveness 
ratio for the two strategies was calculated by dividing the difference in mean costs per 
patient by the treatment effect (i.e. the difference in event rates of the primary end 
point). The results were visualized by means of a cost-effectiveness plane in which each 
of the quadrants represents one of the following four possible scenarios: same-admission 
strategy is more costly and more effective (upper right quadrant, Q1), same-admission 
strategy is costlier and less effective (upper left, Q2) same-admission strategy is cheaper 
and less effective (lower left, Q3), same-admission strategy is cheaper and more effective 
(lower right, Q4). A cost-effectiveness acceptability curve was drawn, showing the 
probability of same-admission cholecystectomy being cost-effective for various levels 
of willingness to pay per prevented acute readmission. The willingness-to-pay level at 
which about 95% of the decisions for same-admission cholecystectomy would be cost-
effective was reported separately. Both societal and healthcare perspective curves are 
reported, the former including the costs of production loss. A sensitivity analysis was 
using gender and age-specific wages per lost working hour rather than a general average. 
An exploratory subgroup analysis was performed for patients below and at or above 66 
years of age as the age of retirement. 
RESULTS
Between December 2010 and August 2013, 266 patients in 23 Dutch hospitals were 
randomly assigned to same-admission (N=129) or interval (N=137) cholecystectomy. In 
the same-admission group one patient was lost to follow up. In the interval group, one 
patient was excluded due to an incorrect diagnosis of pancreatitis. Baseline characteristics 
were similar between the two groups (Table 1). Patients randomized to same-admission 
cholecystectomy underwent surgery a median of 1 day (interquartile range [IQR] 1 to 2 
days) after randomization, compared with 27 days (IQR 26 to 29 days) in the interval 
group. In the latter group, one patient ultimately refused cholecystectomy. 
The total and mean volumes per healthcare item were calculated for each group (Table 
2). In the same-admission cholecystectomy group, mean societal costs per patient were 
€4993, compared with €5226 in the interval group (mean difference of -€234, 95% 
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confidence interval [CI] -1294 to 738; Table 2). The number of days of admission 
following randomization was slightly higher in the same-admission group (mean of 
4.1 versus 3.8 days, see also Figure S1 in the supplementary appendix). Because of the 
72-hour time limit for same-admission cholecystectomy, more patients in this group 
underwent cholecystectomy out of hours. A diagnostic laparoscopy was performed post 
cholecystectomy in one patient in the same-admission group for suspected bleeding. 
Overall, health care costs were marginally higher (mean difference of €144, 95% CI 
-393 to 722) in the same-admission group, mainly due to the difference in hospital 
length of stay. The mean (downstream) costs of readmission per randomised patient 
were €271 in the same-admission group versus €471 in the interval group, again mostly 
as a result of admission days (mean of 14 days in the same-admission group versus 6 in 
the interval group). The relative impact of each cost component on the total costs for 
each treatment group can be found in the Supplementary Appendix.
Health and Labour Questionnaires
The response rates of the two Health and Labour Questionnaires were 82.5% and 
73.4%, respectively. There were no differences between groups in response rates or 
baseline characteristics, including employment status and educational level (data not 
shown). Patients in the same-admission group reported fewer missed hours of work, and 
so lower indirect costs of productivity loss (-€378, 95% CI -1045 to 251). 
Clinical outcome and cost difference
The primary clinical endpoint of mortality or acute readmission for biliary events 
occurred in 6 out of 128 patients (4.7%) in the same-admission group, compared with 
23 out of 136 patients (16.9%) randomized to interval cholecystectomy (absolute risk 
reduction of 12.2%; p<0.002). The incremental societal costs per prevented readmission 
was -€1918 (-€234/0.122). Figure 1a shows the cost-effectiveness plane from the 
societal perspective. Most bootstrap results (69.8%) are in Q4, signifying both superior 
treatment effect and lower costs. A superior treatment effect (right half of the plane) was 
seen in all bootstraps. If society would be willing to pay a maximum of €5000 to prevent 
the next case of acute readmission for recurrence of a biliary event, the probability of 
same-admission cholecystectomy being cost-effective was 94.5% (Figure 1b). 
Scenario analysis
When only the health care costs were considered, the incremental cost-effectiveness 
ratio increased to €1180 per acute readmission prevented (€144/0.122). In the cost-
effectiveness plane all bootstrap results again were in the right half of the plane, but 
with 70.3% of the cases in Q1, signifying higher costs (Figure 2a). To achieve a 95% 
probability of same-admission cholecystectomy being cost-effective in this scenario 
would now require a willingness-to-pay of €7000 (Figure 2b).
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Figure 1a. Cost-effectiveness plane from a societal perspective.
Cost effectiveness plane from a societal perspective at 6 months. Y-axis: difference in costs (i.e. positive 
costs denote more costs for same-admission cholecystectomy. X-axis: difference in effect (i.e. positive effect 
denotes readmissions prevented). The majority of bootstrap results (69.8 %) are in Q4, signifying both 
superior treatment effect and lower costs.
Figure 1b. Cost-effectiveness acceptability curve from a societal perspective.
Cost-effectiveness acceptability curve, showing the probability that same-admission cholecystectomy is 
cost-effective for different values of the societal willingness to pay per readmission prevented.
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Figure 2a. Cost-effectiveness plane from a health care perspective.
Cost effectiveness plane from a healthcare perspective at 6 months. Y-axis: difference in costs (i.e. positive 
costs denote more costs for same-admission cholecystectomy. X-axis: difference in effect (i.e. positive effect 
denotes readmissions prevented). The majority of the bootstrap results (70.3 %) are in Q1, signifying still 
a superior treatment effect but higher medical costs for same-admission cholecystectomy
Figure 2b. Cost-effectiveness acceptability curve from a health care perspective.
Cost-effectiveness acceptability curve, showing the probability that same-admission cholecystectomy is 
cost-effective for different values of the societal willingness to pay per readmission prevented. Costs of 
production losses are not taken into account. 
Chapter 4
78
Sensitivity analysis
Cost differences between treatment groups decreased if gender and age-specific wages 
rather than average wages per lost working hour were applied. The wages for males 
ranged from €19.33 for the 20-24 age group via €42.88 for the 55-59 age group to 
€42.60 for the 60-65 age group, whereas the wages for females ranged from €18.70 
via €32.12 to €31.23 respectively (Table S2). The difference of -€378 (95% CI 
-1045 to 251) per patient for costs of productivity loss in favour of same admission 
cholecystectomy decreased to -€299 (95% CI -1039 to 513). The difference in societal 
costs per patient decreased from -€234 (95% CI -1249 to 738) to -€154 (95% CI -1202 
to 879), resulting in an incremental societal costs per prevented readmission of -€1262 
(-€154/0.122).
Subgroup analysis
Among patients under the age of 66, 5.2% (95% CI 1.1 to 10.6) of patients in the 
same-admission group and 20% (95% CI 13 to 27.3) of patients in the interval group 
were readmitted, with a difference in prevented readmissions of 14.8% (95% CI 5.6 to 
24) in favour of the same-admission group. The incremental societal costs per prevented 
readmission were -€2311 (-€342/0.148; see also Table S3). 
 Among patients aged 66 or more, 3.1% (95% CI 0 to 9.4) and 8.3% (95% 
CI 0 to 18.3) patients in the same-admission and interval groups were readmitted 
respectively, with a difference in prevented readmissions of 5.2% (95% CI -6.3 to 16.7) 
tending in favour of the same-admission group. The incremental societal costs per 
prevented readmission were -€577 (-€30/0.052; Table S4). 
DISCUSSION
In this cost-effectiveness analysis within a randomized controlled multicentre trial, 
same-admission cholecystectomy was more effective and overall less costly per patient 
by a mean of €234 than interval cholecystectomy in patients with mild gallstone 
pancreatitis. Health care costs were marginally higher in the same-admission group, but 
this difference was reversed by lower indirect costs on account of reduced missed hours 
at work. These results build substantial confidence in same-admission cholecystectomy 
not only being an effective, but also efficient treatment modality.
The economic effects of timing of cholecystectomy after mild gallstone pancreatitis have 
been explored in two previous studies. In a retrospective study from 2009, readmission 
costs of 21 patients were determined based on bed occupancy, radiology and other 
diagnostic testing21. These costs were compared with the theoretical costs of reserving 
a half-day operating list every fortnight, which would be needed to comply with the 
recommendations from the British Society of Gastroenterology. The authors concluded 
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that instigating such an operating list would both be cost neutral and facilitate surgery 
within the recommendations. In a model-based cost-utility analysis was performed 
comparing cholecystectomy within 3 days of admission, beyond 3 days but before 
discharge or elective cholecystectomy22, both cholecystectomy within 3 days of admission 
and cholecystectomy before discharge generated less costs than elective cholecystectomy 
as a result of shorter length of stay and readmission costs. 
The clinical results from the PONCHO trial have demonstrated that same-admission 
cholecystectomy reduces morbidity from recurrent gallstone-related complications, 
thereby decreasing the number of readmissions from 17 to 5 %11. In contrast with previous 
research, we did not find that same-admission cholecystectomy leads to a reduction in 
length of stay12, 13, 28. This may be the result of two factors. First, mean length of stay 
in this group was increased substantially by 7 patients with long admission periods, 
resulting from various types of complications (gallstone-related, cholecystectomy-related 
and others). Second, patients were eligible for randomization after normalization of 
biochemical signs of inflammation (i.e. a C-reactive protein level below 100 mg/l) and 
when discharge was expected within 24 to 48 hours. Furthermore, to assist surgical 
planning, a time window of 72 hours within randomisation was set for same-admission 
cholecystectomy. This resulted in 1 or 2 in-hospital waiting days in many patients in this 
group. Combined, these aspects of the trial design may have inadvertently led to admission 
periods longer than strictly necessary. If same-admission cholecystectomy is successfully 
implemented in daily practice, patients can be scheduled for cholecystectomy as soon as 
it becomes apparent that pancreatitis severity will remain mild. It is therefore likely that 
actual healthcare costs for same-admission cholecystectomy may be lower than we found 
in our study. Yet, we still observed an economic advantage in this group, as patients 
reported less days of sick leave. It is the author’s belief that efficiency of care for these 
patients can improve substantially by creating clear pathways from admission to surgery. 
For example, admitting patients directly to a surgical ward has already been shown to 
decrease the time to surgery and overall healthcare costs29. By placing the patients under 
the direct care of a surgeon, fitness for surgery can be assessed on a daily basis. Likewise, 
hospitals in which high volumes of cholecystectomies are performed have been shown 
to adhere to the guidelines to a higher degree than low volume centres, signifying the 
importance of hospital infrastructure30. For lower volume centres, a possible solution 
would be to create fortnightly surgery lists, as described above21.
Several limitations of the study should be addressed. A full economic evaluation from 
the societal perspective generally includes a cost-utility analysis with the costs per quality 
adjusted life year (QALY) as the primary outcome. No data were gathered with health 
utility instruments such as the EQ-5D, so a calculation of QALYs could not be derived 
empirically. The economic evaluation was  therefore restricted to a cost-effectiveness 
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analysis with the costs per readmission as primary outcome. As a result, the presented 
data are valuable for assessment and comparisons of treatments for acute pancreatitis in 
particular and other areas in gastroenterology (or even in medicine as a whole) where the 
same outcome measures might apply.
 Furthermore, for practical reasons, unit costs of in-hospital procedures were 
determined in a single Dutch hospital. Although this may only have a marginal 
negative impact on the external validity for the Netherlands is marginal, it may limit 
the applicability of the results to other countries. However, the similar proportions 
of the individual components of the health care costs suggest that same-admission 
cholecystectomy would be roughly cost neutral in any setting. 
 A third limitation is that no direct information from the second month after 
discharge was available because only two questionnaires were sent out. However, the 
moments of measurement were chosen based on discussions with clinicians about the 
process of patients’ recovery and periods of relative stability, allowing for extrapolation 
of observed data. 
Cost effectiveness analyses may not always translate well into different settings and should 
always be interpreted with caution. However, the treatment of patients with mild acute 
biliary pancreatitis is quite universal. Furthermore, as evident from Table 1, healthcare 
consumption after randomisation was similar between the two groups. The authors believe 
that these volumes can be used globally for comparative purposes. In the same-admission 
group, these costs were accrued primarily by a small number of patients with various 
complications. As such, the results can be seen as something of a worst-case scenario for 
same-admission cholecystectomy. Still, the strategy was more effective and approximately 
cost neutral in terms of direct medical costs. Regarding sick days, this aspect of the present 
analysis may be most susceptible to differences in other healthcare systems. However, 
it seems reasonable to assume that, from the employer perspective, same-admission 
cholecystectomy should be as effective, if not more, than interval cholecystectomy. It 
should further be noted that the applied friction cost method to productivity losses 
following the Dutch costing guideline coincides with the internationally more common 
human capital approach to productivity losses, because the durations of production losses 
were smaller than the current Dutch friction cost period of 85 days at maximum. Hence, 
no truncation of costs of productivity losses took place. 
In conclusion, the present study is the first to compare actual instead of hypothetical 
costs for different strategies in patients with gallstone pancreatitis. We found same-
admission cholecystectomy to be the superior treatment for patients with mild gallstone 
pancreatitis, both from clinical and economic perspectives. The economic benefits are 
potentially even higher when same-admission cholecystectomy is fully incorporated in 
the treatment protocol for gallstone pancreatitis. 
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Table S1 Mean costs per unit
Table S2 Gender and age group specific productivity costs
Table S3 Mean volumes and costs per patient under 66 years 
Table S4 Mean volumes and costs per patient of 66 years or older 
Figure S1 Box plot for length of stay after randomisation per treatment group
Figure S2 Costs of same-admission cholecystectomy per item
Figure S3 Costs of interval cholecystectomy per item
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Table S1. Mean costs per unit.
Cost per unit  
(€, adjusted for 2013)
Source
Hospital stay
General ward (per day) 435 Dutch manual for costing (2010)
Intensive care unit (per day) 2183 Dutch manual for costing (2010)
Surgery
Cholecystectomy (office hours) 1 228 Top down cost calculation
Cholecystectomy (irregular hours) 1 283 Top down cost calculation
Diagnostic laparoscopy 1114 Top down cost calculation
Radiology
Abdominal ultrasound 76 Hospital ledger
X-ray thorax 52 Hospital ledger
X-ray abdomen 52 Hospital ledger
CT scan 216 Hospital ledger
MRI scan 279 Hospital ledger
Ultrasound guided drainage 437 Hospital ledger
CT guided drainage 437 Hospital ledger
Endoscopy
Gastroscopy 405 Hospital ledger
Enteral feeding tube placement 459 Hospital ledger
ERCP 876 Hospital ledger
Endoscopic ultrasound 125 Hospital ledger
Colonoscopy 459 Hospital ledger
Other
Outpatient clinic 69 Dutch manual for costing (2010)
Telephonic outpatient consultation 15 Dutch manual for costing (2010)
Emergency room visit 152 Dutch manual for costing (2010)
Indirect non-medical costs
Productivity loss (per hour) 33 Dutch manual for costing (2010)
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Table S2. Gender and age group specific productivity costs.
Age group Male (€) Female (€)
15-19 10.51 9.54
20-24 19.33 18.70
25-29 26.34 25.72
30-34 32.28 29.98
35-39 37.05 31.85
40-44 39.92 31.64
45-49 41.72 31.48
50-54 42.53 31.85
55-59 42.88 32.12
60-65 42.60 31.23
Figures are based on the 2009 gender and age group specific productivity costs published in the Dutch 
costing manual (Hakkaart et al, 2010), corrected for 2013.
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Figure S1. Box plot of length of stay after randomisation per treatment group.
 
Figure S2. Costs of same-admission cholecystectomy per item.
Figure S3. Costs of interval cholecystectomy per item.
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Recurrent gallstone colics and related complications after cholecystectomy 
for mild gallstone pancreatitis
ABSTRACT  
Background: Same-admission cholecystectomy is advised after mild gallstone 
pancreatitis to prevent recurrence. Data on recurrent gallstone colics and related 
complications after cholecystectomy for gallstone pancreatitis are lacking. 
Methods: Patients participating in a previously published randomized controlled 
multicenter trial (PONCHO) on the timing of cholecystectomy after mild gallstone 
pancreatitis were included. Data on healthcare consumption for recurrent biliary events 
and questionnaires regarding gallstone related symptoms were obtained during 6 months 
follow up after cholecystectomy. Risk factors for recurrent biliary events were analyzed 
through regression analysis.
Results:  In 25 of 262 patients (10%) postoperative abdominal symptoms 
necessitated biochemical testing or imaging for persisting common bile duct stones. 
Acute readmission for recurrent biliary events was required in 7 of these patients (3%); 
pancreatitis in 4 (2%), biliary colics in 2 (1%) and choledocholithiasis in 1 (<1%). 
Endoscopic retrograde cholangiopancreatography was performed in 2 patients, with 
stone extraction in 1 patient. In the remaining 18 patients, tests failed to confirm a 
biliary cause. Questionnaires were obtained from 191 patients (73%). Postoperative 
gallstone colics were reported by 28 of 191 patients (15%); 16 (57%) experienced these 
colics in the first month after cholecystectomy and 6 (21%) in the second month. Only 
4 patients (2%) reported gallstone colics during the sixth month of follow-up. Most 
of these were single events and self-limiting. No predictors for the development of 
postoperative colics were identified.
Conclusion: While the risk of readmission for recurrent biliary events after 
cholecystectomy was low (3%), a substantial portion of patients (15%) reported 
postoperative colics.
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INTRODUCTION
Cholecystectomy is among the most common surgical procedures in the Western 
World.1 A recent systematic review reported that up to one third of patients who undergo 
this procedure for symptomatic gallbladder stones have persisting or new abdominal 
symptoms, such as upper abdominal pain.2 These findings have raised concerns about the 
appropriateness of cholecystectomy in uncomplicated symptomatic gallstone disease.3,4
 In patients with complicated gallstone disease such as gallstone pancreatitis or 
acute cholecystitis, the general consensus is that the risk of recurrence of these gallstone 
related complications outweighs the risk of surgery or postoperative symptoms.5-7 
Several studies have demonstrated that cholecystectomy following gallstone pancreatitis 
does not completely eliminate the risk of recurrent disease, as this may occur in 5% 
of patients.8-12 Detailed data on the frequency and natural history of these recurrent 
symptoms after cholecystectomy for gallstone pancreatitis are lacking.13 One study 
reported persisting pain in 10 out of 34 patients who underwent cholecystectomy for 
acute cholecystitis.14 In daily practice cholecystectomy is often presented to patients with 
gallstone pancreatitis as a means to completely prevent recurrent biliary colics or related 
complications. In business terms, we may be overpromising and under-delivering, and 
if this is true, we would consequently need to inform our patients better of the risks of 
recurrent biliary colics or related complications.
 To this end, we prospectively investigated the risk of recurrent gallstone colics 
and related complications after cholecystectomy for mild gallstone pancreatitis, both 
from a patient and healthcare perspective. Furthermore, we explored potential risk 
factors for postoperative colics in these patients.
METHODS
Study design 
This was a prospective analysis in patients enrolled in the randomized controlled 
multicenter PONCHO trial on timing of cholecystectomy after mild gallstone 
pancreatitis.11,15 Patients were enrolled between December 2010 and August 2013 in 
23 Dutch hospitals, including 7 university medical centers and 16 teaching hospitals. 
Adult patients admitted with a first episode of gallstone pancreatitis were screened for 
eligibility, excluding those with severe gallstone pancreatitis (i.e. organ failure for more 
than 48 hours, pancreatic necrosis or peripancreatic fluid collections on imaging), 
chronic pancreatitis, pregnancy or a priori high risk of perioperative complications 
(American Society of Anesthesiologists [ASA] class III and age over 75, all those with 
ASA class IV or V).16,17 Once discharge was foreseen within 48 hours, participants 
were randomized to cholecystectomy within 3 days (i.e. same-admission) or interval 
cholecystectomy after 25 to 30 days. The primary analysis of the trial was performed on 
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the occurrence of death or acute readmission for gallstone-related complications during 
a 6-month follow-up period. In the present study, outcomes after cholecystectomy with 
a time horizon of 6 months were investigated from a healthcare and patient perspective. 
Healthcare based outcomes
Health care utilization of all participants was prospectively registered during the 
6-month follow-up period. The following healthcare components were included in this 
study: hospital visits for gallstone-related disease (e.g. recurrent gallstone pancreatitis), 
diagnostics for suspected persisting common bile duct stones (e.g. ultrasound, endoscopic 
retrograde cholangiopancreatography). Hospital visits for surgical complications (such 
as wound infections) or diagnostics revealing an unrelated cause of symptoms were 
excluded, as the focus of this study was on postoperative gallstone-related complications. 
Patient-reported symptoms
Upon inclusion in the PONCHO trial, all patients were given questionnaires with 
instructions to prospectively document what they considered to be gallstone colics 
during a 6-month period. Events were rated on a 0 to 10 numeric rating scale (NRS), 
with 0 representing ‘no pain’ and 10 ‘the worst pain imaginable’. Duration of the 
event was documented dichotomously as either shorter or longer than 30 minutes. 
We defined postoperative gallstone colics as 1) persisting pain of at least 30 minutes, 
corresponding with the Rome criteria, and 2) pain with an NRS score of 5 or higher, 
which we considered a reasonable cut-off value for colicky pain.18 The trial study nurse 
contacted all participants by telephone approximately every 2 months and at the end of 
the 6-month follow-up period. 
Risk factors for recurrent gallstone colics
The following variables were examined for a potential effect on the development of 
postoperative colics or other symptoms: age, sex, body mass index (BMI), overall health 
status based on ASA classification, a history of gallstone colics, endoscopic sphincterotomy 
prior to surgery, the number of days between onset of pancreatitis and cholecystectomy, 
conversion to open cholecystectomy and difficulty of cholecystectomy according to the 
surgeon. This last variable was included because difficult cholecystectomy, with much 
manipulation of the gallbladder, could theoretically increase the risk of gallbladder stones 
being forced into the common bile duct. Difficulty of cholecystectomy was assessed by 
the surgeon on a 0 to 10 NRS (10 being most difficult). Additionally, risk factors for 
common bile duct stones were assessed using the guidelines of the American Society 
for Gastrointestinal Endoscopy (ASGE).19 According to this stratification system, 
factors associated with high risk (i.e. >50%) for choledocholithiasis are 1) gallstones in 
the common bile duct on imaging, 2) serum bilirubin levels exceeding 70 μmol/l, 3) 
dilatation of the common bile duct ≥7mm AND serum bilirubin levels between 30 and 
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70 μmol/l. or 4) signs of cholangitis. Finally, the findings of patients who underwent 
intraoperative cholangiography (IOC) were evaluated. 
Statistical analysis
Only investigations or hospital visits for (suspected) recurrent gallstone colics and 
related complications were included in this study. Patients were dichotomized based on 
post-cholecystectomy healthcare resource utilization. Patients who made a completely 
uneventful recovery were grouped as ‘no additional care’; those with postoperative 
symptoms needing additional medical care through diagnostics or treatment as 
‘additional care’. In the latter category, all diagnostics and treatment for direct surgical 
complications such as bleeding or wound infections were excluded.
 All continuous data were non-normally distributed and therefore reported as 
median with interquartile range (IQR). For differences in distribution of categorical 
variables the χ2 was used. Relationships between the variables of interest and outcomes 
were tested through univariable logistic regression. Results from these analyses were 
reported as odds ratios (ORs) with 95% confidence intervals (CI) and p value. Regarding 
the patient-reported outcomes, the analyses included all patients who had returned the 
questionnaires. All analyses were performed in SPSS version 22 (Chicago, IL).
RESULTS
Patients
Of the 266 participants in the PONCHO trial, 4 patients were excluded, due to incorrect 
diagnosis of pancreatitis, declined cholecystectomy, withdrawn informed consent and 
death due to ischemic stroke. Baseline characteristics of the included patients are listed 
in Table 1. 
Healthcare based outcomes
Twenty-five out of the 262 patients (10%) needed postoperative hospital care for gallstone 
colics or related complications. Table 2 presents an overview of the type and total number 
of diagnostic procedures and emergency room visits. Gallstone-related complications led 
to acute readmissions in 7 of these patients (3%); 4 with recurrent pancreatitis (2%), 2 
with gallstone colics (1%) and 1 with choledocholithiasis (<1%). Two of these 7 patients 
underwent post-operative ERCP for suspected choledocholithiasis, which was found in 
one. All other patients were treated conservatively. Recurrent pancreatitis was mild in all 
patients. All re-admissions occurred within one month after cholecystectomy. 
 In the remaining 18 patients, biochemical testing and imaging failed to confirm 
remnant common bile duct stones as the cause of the complaints.
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Table 1. Baseline characteristics. 
Total cohort 
(N=262)
Questionnaire 
Respondents 
(N=191)
Age; median (IQR) 53 (40-66) 54 (42-68)
Sex (male); N (%) 103 (39) 76 (40)
Body mass index; median (IQR) 28 (24-31) 27 (24-30)
ASA class; N (%)
1 94 (36) 68 (36)
2 145 (55) 108 (57)
3 23 (9) 15 (8)
History of gallstone colics; N (%) 77 (29) 54 (28)
Endoscopic sphincterotomy prior to cholecystectomy; N (%) 80 (31) 49 (26)
Days from onset of pancreatitis to cholecystectomy; median (IQR) 22 (7-33) 20 (7-33)
Difficulty of cholecystectomy; NRS score median (IQR) 6 (4-7) 6 (4-7)
Conversion§; N (%) 9 (3) 6 (3)
§ excluding 4 patients in whom primary open cholecystectomy was performed
IQR, interquartile range; ASA, American Society of Anesthesiologists; NRS, numeric rating scale
Table 2. Health care consumption during 6 months follow up after cholecystectomy for mild gallstone 
pancreatitis.
Procedure Total no. Range per patient
Ultrasound 24 1-3
CT 8 1
ERCP 2 1
MRCP 4 1
Endoscopic ultrasound 1 1
Emergency room visit 7 1-2
CT Computed Tomography; MRCP Magnetic Resonance Cholangiopancreatography; ERCP Endoscopic 
Retrograde Cholangiopancreatography
Note: This table does not include diagnostics performed postoperatively for (suspected) surgical 
complications or other, unrelated causes of symptoms.
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Patient reported symptoms
Questionnaires were returned by 191 of the 262 patients (73%). Baseline characteristics 
of these 191 patients are shown in Table 1. During the 6-month follow-up period, 28 
patients (15%) reported postoperative gallstone colics. This was one event in 14 patients, 
two events in 5 patients and the other 9 patients reported three or more events (range 
1-12 events). Seven patients (25%) had a history of gallstone colics prior to admission 
for pancreatitis. Of the 28 patients, 16 (57%) developed colics during the first month 
after cholecystectomy, 6 (21%) in the second month and 2 (7%) in the third, fourth and 
fifth months (Figure 1). One patient (4%) reported colics in four consecutive months, 
6 patients (21%) over the course of 2 months and the remaining 21 patients (75%) 
had colics during 1 month. Only 4 (2%) of the 191 responding patients reported colics 
during the final month of follow-up. 
Common bile duct stones
Excluding the 80 patients who had undergone preoperative biliary tract clearance 
with endoscopic sphincterotomy prior to surgery, only one patient had documented 
common bile duct stones on imaging prior to cholecystectomy. Endoscopic retrograde 
cholangiopancreatography was unsuccessful in this patient due to previous bariatric 
surgery and the patient was managed conservatively. This patient had an uneventful 
recovery without additional care or colics. Likewise, only one patient had a preoperative 
serum bilirubin level exceeding 70 μmol/l. This patient was not re-admitted and did not 
report colics in the questionnaire. One patient had a common bile duct of 7 mm on 
magnetic resonance cholangiopancreatography with slightly elevated serum bilirubin of 
35 μmol/l prior to surgery. As the bilirubin level decreased spontaneously, the patient 
was managed conservatively and recovered without needing additional care or reporting 
colics. There were no patients with signs of cholangitis.
Figure 1. Timing of patient-reported recurrent gallstone colics per month after cholecystectomy for 
mild gallstone pancreatitis.
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 Intraoperative cholangiography was attempted in 17 patients (6%). Cannulation 
of the cystic duct was unsuccessful in 2 patients. In 1 of the 15 remaining patients (7%) 
a filling defect was seen during IOC, which was managed conservatively. The patient 
made an uneventful recovery without reporting colics. 
Predictors of recurrent gallstone colics or related complications.
No predictors of gallstone colics could be identified through univariable regression 
analysis (Table 3). An additional analysis was performed including only those patients 
who underwent cholecystectomy according to the treatment protocol of the PONCHO 
trial (i.e. same-admission cholecystectomy (n=91) vs. interval cholecystectomy, (n=70)). 
No effect of treatment strategy was found, with 14 patients (15%) reporting colics after 
same-admission cholecystectomy and 13 (18%) in the interval group (odds ratio [OR] 
for interval cholecystectomy of 1.25, 95% confidence interval [CI] 0.55-2.87; p=0.59).
Table 3. Univariable logistic regression analysis of factors predicting postoperative symptoms.
Postoperative medical 
treatment
(N=262)
Postoperative gallstone 
colics 
(N=191)
Predictor OR (95% CI) p OR (95% CI) p
Age 0.98 (0.96-1.01) 0.15 0.99 (0.96-1.01) 0.33
Male Sex 0.70 (0.29-1.70) 0.43 0.68 (0.29-1.59) 0.37
Body Mass Index 1.02 (0.96-1.09) 0.50 0.95 (0.88-1.04) 0.27
ASA class 1* 0.83 (0.34-1.99) 0.67 1.01 (0.44-2.32) 0.99
History of gallstone colics 1.15 (0.47-2.78) 0.76 0.82 (0.33-2.07) 0.68
Endoscopic sphincterotomy prior to 
cholecystectomy 1.32 (0.56-3.12) 0.53 0.44 (0.14-1.33) 0.15
Days from admission to cholecystectomy 0.98 (0.96-1.01) 0.22 1.00 (0.97-1.03) 0.90
Difficulty of cholecystectomy 1.04 (0.85-1.27) 0.68 1.07 (0.87-1.32) 0.51
Conversion 1.16 (0.14-9.69) 0.89 1.14 (0.13-10.15) 0.91
ASA American Society for Anesthesiologists
* compared with ASA class 2 and 3 patients
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DISCUSSION
This analysis performed within a randomized controlled multicenter trial found that 
10% of patients after cholecystectomy for mild gallstone pancreatitis required medical 
treatment for gallstone colics or complications, and 15% of patients reported gallstone 
colics during 6 months follow-up after cholecystectomy. Recurrent pancreatitis after 
cholecystectomy occurred in 2% of patients and was mild in all cases. Postoperative 
colics were self-limiting and of short duration. No risk factors for the occurrence of 
either variable could be identified.
Previous studies in unselected cohorts have indicated that up to 33% of patients 
experience persisting upper abdominal pain after cholecystectomy.2,14 Along with 
cholecystitis, gallstone pancreatitis is generally considered an absolute indication for 
cholecystectomy. While this strategy reduces the risk of recurrent gallstone related 
complications, there is little data available on the incidence of colics or related 
complications after cholecystectomy for this indication.20,21 Although several studies 
have described postoperative symptoms in unselected cohorts including patients with 
pancreatitis or cholecystitis, the present study is the first to investigate this subgroup 
specifically.22,23 We found that a substantial proportion of patients experienced recurrent 
gallstone colics serious enough to warrant additional medical treatment. Obviously, these 
findings do not question the indication for cholecystectomy after gallstone pancreatitis: 
in the patients awaiting cholecystectomy in the interval group of the PONCHO trial, 
51% reported gallstone colics and 17% required re-admission for recurrent biliary 
events.11 Other studies have reported recurrent gallstone-related morbidity in 16 to 61% 
of patients in whom cholecystectomy was delayed.24,25 Furthermore, a recurrent attack 
of pancreatitis may be more severe in up to 9% of patients and mortality rates of relapses 
are similar to those of the first attack.26,27 
There are several potential explanations for recurrent gallstone colics or related 
complications after cholecystectomy. Although sphincter of Oddi dysfunction and 
neuropathic pain have been reported as causes of post-cholecystectomy pain28 the 
most obvious cause is persisting common bile duct stones. These stones may already 
be present before operation or forced into the common bile duct by manipulation of 
the gallbladder during surgery. The latter mechanism may explain why preoperative 
risk factors were not capable of predicting recurrent colics. Therefore, the most 
appropriate moment for evaluating the presence of common bile duct stones is during 
or immediately following cholecystectomy. Intraoperative cholangiography allows for 
confirming suspected choledocholithiasis, after which the stones can be dealt with 
through transcystic stone extraction, laparoscopic bile duct exploration or postoperative 
ERCP with stone extraction. Notably, there is no consensus on managing asymptomatic 
Chapter 5
102
common bile duct stones since most of these stones will pass spontaneously.29 Whether 
all patients undergoing cholecystectomy for gallstone pancreatitis should be subjected 
to the procedural risks of laparoscopic bile duct exploration (i.e. bile leak) or ERCP (i.e. 
perforation, bleeding, post-ERCP pancreatitis) remains subject to debate. Moreover, 
multiple studies have found similar rates of recurrent gallstone-related complications 
in patients who had undergone IOC compared to patients who had not.30-32 Therefore, 
many have argued that since stones can be missed or patients may develop symptoms 
regardless of the procedure, IOC should be reserved for clinically or biochemically 
‘high-risk’ patients.30,31,33 The question remains how to prevent postoperative gallstone 
complications. Despite all proposed strategies a small proportion of patients continue 
to develop symptomatic common bile duct stones or recurrent gallstone pancreatitis. 
Resolving this issue requires prospective studies documenting the presence of common 
bile duct stones shortly after surgery, using highly accurate imaging modalities such 
as endoscopic ultrasound or magnetic resonance cholangiopancreatography. Combined 
with biochemical investigations, these patients can then be followed to study which 
features are predictive of developing symptoms. 
This study has several strengths and limitations. We present a large, prospective cohort 
of patients with clear, uniform definitions of pancreatitis and other gallstone-related 
complications collected within the context of a randomized controlled trial. For all 
patients comprehensive pre- and postoperative clinical and healthcare usage information 
was available. Additionally, we had relatively high response rates for the questionnaires 
describing the postoperative events in great detail. Some limitations also have to be 
addressed. First, since no validated questionnaire for gallstone colics is available, such 
a questionnaire was designed by our study group. As trial participants already received 
two questionnaires to document pancreatitis-related sick leave in addition to 6 months 
worth of gallstone symptoms, no gastrointestinal quality of life form was included in 
the study. However, based on the postoperative healthcare use and patterns of colics, 
only a very small proportion of patients had persisting postoperative symptoms and we 
expect the impact on quality of life to have been only minor. Finally, it is possible that 
patients developed symptoms outside of the 6-month follow up period, although this 
seems unlikely as the majority of readmissions and postoperative colics occurred very 
shortly after cholecystectomy. 
In conclusion, in this multicenter cohort of patients followed after cholecystectomy 
for mild gallstone pancreatitis, the risk of readmission for recurrent biliary events after 
cholecystectomy was very low (3%), although a substantial subset of patients (15%) 
reported one or more postoperative gallstone colics. While these risks do not outweigh 
the benefit of cholecystectomy, they should be discussed during preoperative counseling.
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Predicting a difficult cholecystectomy after mild gallstone pancreatitis
ABSTRACT
Background:  Cholecystectomy after gallstone pancreatitis may be technically 
challenging. Preoperative identification of patients at high risk of surgery difficult 
cholecystectomy may improve surgical planning but data are lacking. We investigated 
potential risk factors for a difficult cholecystectomy after mild gallstone pancreatitis.
Methods: This was a side-study during a previously published trial on timing 
of cholecystectomy after mild gallstone pancreatitis (the PONCHO trial). Difficulty 
of cholecystectomy was scored prospectively on a 0 to 10 visual analogue scale (VAS) 
after the cholecystectomy by the most senior attending surgeon. The primary outcome 
‘difficult cholecystectomy’ was defined by presence of at least one of the following features: 
a VAS-difficulty beyond the 75th percentile, conversion, subtotal cholecystectomy or 
duration of the procedure beyond the 75th percentile. The relationship between risk 
factors and the primary outcome was investigated through multivariate analyses. Results 
are presented as odds ratios with 95% confidence intervals. Sensitivity analysis was 
performed by excluding patients operated by less experienced teams (defined as <100 
laparoscopic cholecystectomies performed).
Results: Of the 264 participants, 249 (93%) could be included in the current analysis. A 
difficult cholecystectomy occurred in 82 patients (33%). A bile duct injury was observed 
in .2 patients (1%; both cystic duct leakage). Laparoscopy was converted in 9 patients 
(3%), 2 of which were completed as subtotal cholecystectomies. After multivariate 
analysis male sex (OR 1.80, 95% CI 1.04-3.13; p=0.037), prior sphincterotomy (OR 
1.79, 95% CI 1.01-3.16; p=0.046), and delaying cholecystectomy until after 2 weeks 
after admission (OR 1.81, 95% CI 1.04-3.16; p=0.036) were independent predictors of 
a difficult cholecystectomy. The risk for a difficult cholecystectomy in women, operated 
within two weeks after onset of pancreatitis, without sphincterotomy was 16%. When 
including only surgeons with more than 100 laparoscopic operations, no predictive 
factors could be identified through uni- or multivariable analysis
Conclusion: Risk factors for a difficult cholecystectomy after mild gallstone 
pancreatitis are male sex, prior sphincterotomy and delaying cholecystectomy until after 
2 weeks after admission although the overall risk of conversion and bile duct injury was 
low.  
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INTRODUCTION
Cholecystectomy is the treatment of choice in complicated gallstone disease such as 
cholecystitis or gallstone pancreatitis.1-3 As most cholecystectomies are performed 
electively for symptomatic cholelithiasis, the procedure is one of the cornerstones of 
surgical trainee progrxams.4 In recent years a shift in treatment strategies for complicated 
gallstone disease has taken place. Current guidelines now advocate early cholecystectomy 
in acute cholecystitis and mild gallstone pancreatitis.1-3,5,6 In coming years, increasing 
numbers of cholecystectomies will be performed as acute or semi-acute care procedures. 
Accordingly, it is vital to recognize in which patients cholecystectomy is anticipated to 
be difficult.7 Cholecystectomy in patients at high risk for surgical complications can 
then be assigned or supervised by specialized gastrointestinal surgeons, instead of to 
general surgeons or surgical trainees.8 
 Studies in cohorts of unselected patients have identified several risk factors that 
may increase the technical difficulty of cholecystectomy. Among these are male sex, 
previous endoscopic sphincterotomy, high age and inflammation of the gallbladder or 
pancreas.9-17 Very few studies have focused on the difficulty of cholecystectomy after mild 
gallstone pancreatitis. Only three studies specifically report the surgeon’s intraoperative 
assessment of technical difficulty in patients after gallstone pancreatitis, two of which are 
small case series including less than 25 patients.9,18,19 Other studies that describe outcome 
of cholecystectomy after pancreatitis have not described the difficulty and complications 
of these procedures.20,21 This lack of research is especially surprising, as the concern for 
increased complexity with ensuing surgical complications after pancreatic inflammation 
has traditionally been the most important argument for delaying cholecystectomy after 
mild gallstone pancreatitis.22
 In this study we investigated which factors increase technical complexity of 
cholecystectomy after gallstone pancreatitis.
METHODS
Study design
This was a prospective side-study during the previously published multicenter 
PONCHO trial.6 In brief, 266 adult patients with mild gallstone pancreatitis from 23 
Dutch centers were randomized 24-48 hours before anticipated discharge. Patients with 
documented organ failure (persisting for more than 48 hours), pancreatic necrosis with 
peripancreatic fluid collections, chronic pancreatitis or alcohol abuse were not eligible 
for participation. Patients were randomized to either cholecystectomy within 3 days 
(‘same-admission cholecystectomy’) or discharge and cholecystectomy after 25-30 days 
(‘interval cholecystectomy’). Patients were followed up for 6 months after surgery for 
the occurrence of the primary endpoint; i.e. a combination of acute readmission for 
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gallstone related complications (recurrent pancreatitis, cholangitis, choledocholithiasis 
requiring endoscopic retrograde cholangiopancreatography or simple gallstone colic) 
or mortality. Clinical, radiological and surgical data were prospectively collected on 
case record forms and source material and entered into the trial database. Surgical data 
included the experience with laparoscopic surgery of the team, operating time, difficulty 
of cholecystectomy according to the most experienced attending surgeon on a 0 to 
10 visual analogue scale (10 being most difficult; VAS), the presence of adhesions and 
the reason for conversion or subtotal cholecystectomy. Additionally, the forms included 
questions regarding the difficulty of dissection, dichotomized as ‘easy’ or ‘difficult’, and 
the presence or absence of dense adhesions in the dissection area. As this study focuses 
on the intraoperative findings as described by the surgeon and the subjective difficulty 
of dissection, postoperative complications were not part of this analysis.
Variables, data sources and measurements
The primary outcome of this study was a difficult cholecystectomy, as defined by a VAS 
score beyond the 75th percentile, conversion, subtotal cholecystectomy or duration of 
surgery beyond the 75th percentile. In a secondary analysis, the individual components 
of this combined outcome measure were investigated. Predictive factors were sex, age, 
body mass index (BMI), significant comorbidity (defined as ASA class III), a history 
of gallstone colics, a history of upper abdominal surgery, endoscopic sphincterotomy 
before surgery, the number of days between sphincterotomy and cholecystectomy and 
the interval between pancreatitis onset and cholecystectomy. For practical applicability, 
the latter was both tested as a continuous variable and dichotomized in ‘cholecystectomy 
within or after 2 weeks of admission’. This arbitrary cut-off value was chosen, as 
cholecystectomy within this period should be possible for virtually all patients with mild 
pancreatitis. Furthermore, all computed tomography imaging (CT) performed before 
cholecystectomy was retrieved and scored according to the CT Severity Index (CTSI) by 
an experienced radiologist (T.L.B.).23 
Statistical analysis
Analyses were performed using IBM SPSS Statistics version 22.0 (IBM Corp., Armonk 
NY). The relationship between the predictive factors and difficult cholecystectomy (the 
combined endpoint) was first explored through univariable logistic regression analysis. 
Factors with a p-value less than 0.2 were then selected for a multivariable logistic 
regression model. The final multivariable model was internally validated using 5000 
bootstrap resamples and a nomogram of the model was designed. Risks are presented as 
odds ratios (OR) with 95% confidence interval (CI). Additionally, the predictive value 
of the variables on the individual components of the combined endpoint was explored. 
A sensitivity analysis was performed, excluding cases in which the most experienced 
member of the surgical team had performed 100 or less laparoscopic cholecystectomies. 
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Differences in the dichotomous outcomes ‘difficult dissection’ and the presence or 
absence of adhesions were tested through the χ2 or Mann-Whitney U test, as appropriate.
RESULTS
Of the 266 patients originally randomized in the PONCHO trial, two were excluded 
from the present study. In one patient the amylase levels on admission did not exceed 
three times the upper limit of normal required for the diagnosis acute pancreatitis, 
leading to exclusion by the adjudication committee; the other patient ultimately refused 
cholecystectomy. Baseline characteristics of the 264 included patients can be found in 
Table 1. Overall difficulty of surgery was recorded in 259 patients (98%), with a median 
VAS of 6 (interquartile range [IQR] 4 to 7). In 44 of these patients (17%), the surgeon 
scored a VAS of 8 or higher. A primary open cholecystectomy was performed in 6 
patients (2%); these patients were not included in the analysis predicting conversion or 
subtotal cholecystectomy. Laparoscopy was converted in 9 patients (3%), 2 of which 
were completed as subtotal cholecystectomies. A third subtotal cholecystectomy was 
completed laparoscopically. Duration of surgery was recorded in 250 patients (95%) 
with a median of 60 minutes (IQR 43 to 75 minutes). In 60 patients the duration of 
surgery exceeded 75 minutes (24%). When taking missing data and overlap into account, 
cholecystectomy was difficult in 82 out of 249 patients (33%). In 238 cases (90%) the 
experience of the surgeons with laparoscopic surgery exceeded 100 cholecystectomies. 
Table 1. Baseline characteristics. 
Patients (N=264)
Demographics and history
Age; median (IQR) 53 (40-66)
Male sex; N (%) 104 (39)
Body mass index; median (IQR) 28 (25-31)
Morbidly obese (BMI ≥40); N (%) 13 (5)
ASA class; N (%)
Class 1 94 (36)
Class 2 149 (55)
Class 3 25 (10)
History of gallstone colics; N (%) 74 (28)
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History of upper abdominal surgery 15 (6)
Preoperative features
Endoscopic sphincterotomy prior to cholecystectomy; N (%) 81 (31)
Complications during ERCP* 8 (9)
Number of days between sphincterotomy and cholecystectomy; 
median (IQR) 21 (7-32)
Peripancreatic fluid on CT (N=39)§
CTSI 0 9 (23)
CTSI 2 9 (23)
CTSI 3 12 (31)
CTSI 4 9 (23)
Days of pancreatitis#; median (IQR) 5 (3-8)
Days from pancreatitis onset to cholecystectomy; median (IQR) 22 (7-33)
Cholecystectomy delayed until 2 weeks after admission; N (%) 145 (55)
Surgical characteristics
Difficulty of cholecystectomy^; median (IQR) 6 (4-7)
VAS ≥8; N (%) 44 (17)
Conversion±; N (%) 9 (3)
Subtotal cholecystectomy 3 (1)
Duration of surgery in minutes$; median (IQR) 60 (43-75)
>75 minutes 60 (24)
* 5 bleedings and 3 perforations in 88 patients who underwent ERCP
§ scans were performed prior to cholecystectomy in 42 patients, 39 were retrieved for review. CTSI scores 
3 and 4 involve acute peripancreatic fluid collections.
# Calculated as the number of days between admission and randomization in the PONCHO trial.
^ Case record forms were received from 259 patients.
± Excluding 6 patients in whom a primary open cholecystectomy was performed.
$ Duration of surgery was reported in 250 patients.
IQR denotes interquartile range; ASA, American Society for Anesthesiology; ERCP, Endoscopic 
Retrograde CholangioPancreatography; CT, computed tomography; CTSI, Computed Tomography 
Severity Index; VAS, Visual Analogue Scale.
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Excluding 11 patients with missing variables, 69 out of 227 patients (30%) had difficult 
cholecystectomies. 
At univariable analysis, male sex (OR 1.75, 95% CI 1.02-3.00; p=0.042), previous 
sphincterotomy (OR 1.77, 95% CI 1.02-3.09; p=0.044) and cholecystectomy after 2 
weeks of admission (OR 1.81, 95% CI 1.05-3.11; p=0.034) were strong predictors 
of a difficult cholecystectomy (Table 2). As a continuous variable, the number of days 
between admission and cholecystectomy was significantly predictive of a difficult 
cholecystectomy with an OR of 1.02 per day (95% CI 1.00-1.04; p=0.022). However, 
this effect diminished when adjusting the cut-off value to cholecystectomy after 1 or 
3 weeks (both p>0.05). The presence of peripancreatic fluid on CT had no impact on 
difficulty of surgery. In the multivariable model, these three factors remained statistically 
significant; male sex (OR 1.88, 95% CI 1.08-3.27; p=0.025), sphincterotomy (OR 1.77, 
95% CI 1.00-3.13; p=0.046), delayed cholecystectomy (OR 1.81, 95% CI 1.04-3.16; 
p=0.036). The internal validation of the model with 5000 bootstrap resamples yielded 
no new insights. A visualization of the constructed nomogram is presented in Figure 1. 
Presence of all risk factors (i.e. a male patient who had undergone sphincterotomy and 
delayed cholecystectomy) resulted in an overall chance of a difficult cholecystectomy of 
55%; this chance was 18% in absence of these factors. When including only surgeons 
with more than 100 laparoscopic operations for the sensitivity analysis, no predictive 
factors could be identified through uni- or multivariable analysis (Table 2).
Figure 1. Nomogram for the prediction of a difficult cholecystectomy*.
*The nomogram is based on a multivariable logistic regression model including male sex, prior 
sphincterotomy and cholecystectomy performed beyond two weeks after initial admission. Depending on 
the presence or absence of these factors, the chance of a difficult procedure is between 18 and 55%.
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Analysis of the individual components of the combined endpoint
Male sex (OR 2.31, 95% CI 1.16-4.59; p=0.018), morbid obesity (OR 4.49, 95% 
CI 1.32-15.30; p=0.017) and previous sphincterotomy (OR 2.60, 95% CI 1.32-5.15; 
p=0.006) were individually associated through multivariable analysis with a VAS of 
8 or higher (Table 3). No multivariable models could be created for the other two 
endpoints. Age (OR 1.08, 95% CI 1.02-1.13; p=0.008) and male sex (OR 5.77, 95% 
CI 1.17-28.36; p=0.031) were significantly associated with conversion or subtotal 
cholecystectomy and number of days of pancreatitis (OR 1.17, 95% CI 1.02-1.19; 
p=0.017) with a long procedure in through univariable analysis. 
Difficult dissection and adhesions
Information on difficulty of dissection and the presence of adhesions was returned in 
254 patients (96%). Dissection was difficult in a significantly larger proportion of men 
(p=0.009). Dense adhesions were also found in a significantly higher proportion of men 
(p<0.001). Otherwise, no uneven distributions were found (Table 4).
DISCUSSION
In this prospective side-study within a randomized controlled multicenter trial, gallstone 
pancreatitis male sex, previous endoscopic sphincterotomy and delaying cholecystectomy 
until two weeks after admission predicted a difficult cholecystectomy after mild gallstone 
pancreatitis. When only analyzing procedures performed by experienced surgeons no 
risk factors were identified. 
Several studies demonstrated the superiority of early cholecystectomy over interval 
cholecystectomy for mild gallstone pancreatitis in terms of disease recurrence.6,19-21,24 
These studies were mainly performed to convince the surgical community to abandon 
interval cholecystectomy, which has been the approach preferred by many according 
to international reports.25,26 This strategy was advocated in the early 90’s, when early 
cholecystectomy after acute pancreatitis was associated with high conversion rates. 
Moreover, as a result of concerns of bile duct injury, mild gallstone pancreatitis and 
acute cholecystitis were generally considered a contraindication for early laparoscopic 
surgery.21,27,28 As experience and proficiency with laparoscopic surgery increased, indications 
have shifted.29 More progressive surgeons found that while severe pancreatitis did affect 
technical difficulty and risk of conversion, mild disease did not.21 Cholecystectomy 
during the same admission for mild pancreatitis became standard in some centers, but 
the majority of the surgical community continued to delay cholecystectomy.30,31 This 
can be explained in part because interval surgery has distinct logistical advantages, but 
also due to the lingering doubt regarding the safety of early surgery. Studies addressing 
the safety of cholecystectomy have largely refrained to conversion and general surgical 
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complications such as wound infections, as more specific complications like bile duct 
injury are relatively rare.32. Neither conversion nor complication rates differed between 
the two strategies in any of these studies.18,20,21,24,26,33,34
 The present study is the largest cohort so far focusing on technical difficulty of 
cholecystectomy. The finding of male sex as a risk factor for difficult cholecystectomy 
is in line with data from several reports on cholecystectomy in unselected cohorts, 
among which a systematic review including 109 studies, in which male patients were 
at a significantly higher risk of conversion.10,16,17,35 An anatomical explanation for this 
phenomenon could be a narrower costal margin in males, resulting in a more difficult 
angle for the surgeon to operate in. Likewise, previous endoscopic sphincterotomy has 
been shown to increase difficulty of laparoscopic cholecystectomy.11,14,36-38 It is difficult 
to understand why this is an independent risk factor because it raises the question why 
an uncomplicated sphincterotomy has an effect of Calot’s triangle and any impact on 
the critical view of safety. It has been hypothesized that this is the result of scarring of 
the hepatoduodenal ligament due to bacterial colonization and low-grade inflammation 
of the common bile duct, which can be seen after sphincterotomy.39,40 In our cohort 
however, the ERCP’s were performed relatively short before cholecystectomy in most 
patients. This raises the question how this scarring can occur on such short notice. 
Perhaps a reaction of the bile duct wall to the habitual presence of intraductal gallstones 
for which the ERCP is performed offers a more logical pathophysiological explanation. 
Furthermore, in contrast with the belief that cholecystectomy in the early post-acute 
phase of pancreatitis would be technically more demanding, our results rather indicate 
the opposite.41 Although we were unable to determine what the exact mechanism 
behind this effect is in our study, previous investigators found more dense adhesions 
and difficult dissection of Calot’s triangle in delayed cholecystectomy.18,19 
 This study provides a twofold argument for performing cholecystectomy during 
the same admission following mild gallstone pancreatitis. Firstly, because of the positive 
correlation we found between increasing delay to cholecystectomy and difficult surgery. 
Second, from our results it follows that the same risk factors apply for cholecystectomy 
after mild pancreatitis as for the general population needing cholecystectomy. Even 
in the small subgroup of patients with peripancreatic fluid (but not necrosis) within 
this study of mild biliary pancreatitis, which would theoretically lead to upgrading the 
pancreatitis severity status to ‘moderately severe’ according to the revised Atlanta grading 
system42, no extra difficulties were encountered. Together with the results from other 
studies on the subject, we believe this to be further evidence against the theory of mild 
pancreatitis distorting the biliary anatomy in the early post-acute phase. From a clinical 
point of view, this means that these patients do not have to be assigned to specialized 
surgeons but can be operated on by trainees, provided an experienced surgeon is present 
for supervision.14,31
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This study has some limitations. Technical ‘difficulty’ is, by definition, a subjective 
term. Quantifying and dichotomizing these outcomes is therefore inherently arbitrary. 
We believe that by combining the perceived difficulty, conversion, need for subtotal 
cholecystectomy and duration of the procedure that we have succeeded in providing a 
reasonable representation of the most difficult cholecystectomies.
In conclusion, risk factors for a difficult cholecystectomy after mild gallstone pancreatitis 
are male sex, prior sphincterotomy and delaying cholecystectomy until after 2 weeks 
after admission, although the overall risk of conversion and bile duct injury is low. 
Cholecystectomy should be performed during the same admission and, especially when 
risk factors are present, by gastrointestinal surgeons.
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Laparoscopic partial cholecystectomy for the difficult gallbladder: a systematic review
ABSTRACT
Introduction  In the setting of difficult dissection of Calot’s triangle during 
laparoscopic cholecystectomy, conversion is commonly advocated. An alternative 
approach aiming at preventing bile duct injury, is laparoscopic partial cholecystectomy 
(LPC). Safety and efficacy of this procedure are unclear.
Methods  A systematic review of the literature was performed independently 
by three researchers. Outcomes were conversion rate, hospital length-of stay (LOS), 
bile duct injury (BDI), bile leak, symptomatic gallstones in remnant gallbladder, the 
need for reoperation, postoperative endoscopic retrograde cholangiopancreaticography 
(ERCP), percutaneous intervention and mortality.
Results   The review included 15 publications, which reported on 625 patients. 
Four different operative techniques could be distinguished. Conversion to open (partial) 
cholecystectomy was performed in 10.4%. Median length of stay (LOS) was 4.5 days, 
ranging from 0-48 days. The most common complication was postoperative bile leak, 
which occurred in 66 patients (10.6%). There was one case of bile duct injury. During 
the follow-up period, 2.2% of patients experienced recurrent symptoms of gallstones. 
Eight patients (2.7%) underwent reoperation. Postoperative ERCP was performed for 
26 of 349 (7.5%) patients. A percutaneous intervention was performed in 5 of 353 
(1.4%) patients. Three deaths were described in the reviewed series (one of pulmonary 
sepsis and two of myocardial infarctions). A rough comparison showed that fewer bile 
leaks, less need for ERCP and less recurrent symptoms of gallstones seemed to occur 
when the cystic duct and the gallbladder remnant were closed.
Conclusions  Literature concerning LPC is scarce. Four different LPC techniques 
can be distinguished. LPC seems a safe and feasible alternative to conversion when 
encountering a difficult gallbladder during LC. Closing the cystic duct, gallbladder 
remnant or both seems to be preferable.
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INTRODUCTION
After the introduction of laparoscopic cholecystectomy (LC) in the mid-1980s1 the 
laparoscopic approach quickly became the standard treatment for gallstone disease. 
Currently, it is performed by most surgeons because it is standard of care in international 
guidelines2. The LC procedure was initially considered unsafe and harmful in the 
setting of acute gallbladder inflammation, but it is now the most common procedure 
performed for gallstone disease and acute cholecystitis. When the ‘critical view of safety’ 
(positive identification of biliary anatomy) cannot be obtained during dissection of 
Calot’s triangle, conversion to open surgery is advocated to prevent bile duct injury3. 
However, experienced laparoscopic surgeons may feel comfortable by proceeding 
laparoscopically using alternative approaches and techniques. Moreover, the newer 
generations of surgeons and surgical residents currently have little or no experience with 
the open procedure, and as a consequence converting may potentially pose an even more 
significant risk. Conversion per se does not always provide a better view of the anatomy 
and for those without experience using the open approach it may be even harder to 
continue safely. This eventually may lead to even more severe bile duct injury, such as 
transection or resection of the common bile duct (CBD)4. In the case of a difficult LC 
(eg in acute cholecystitis where dissection of Calot’s triangle is challenging due to severe 
adhesions or inflammation), a change of surgical strategy, such as antegrade or partial 
cholecystectomy (PC) or even drainage, may be more practical than conversion per 
se5. Because surgical skill and experience play an important role, an alternative surgical 
strategy may be especially valuable for less experienced surgical teams. A PC can be 
efficiently performed. In 1985, Bornman and Terblanche first described open PC6 and 
since 1993, laparoscopic partial cholecystectomy (LPC) has been performed as well7.
 The LPC procedure may be an alternative for conversion to open cholecystectomy 
in situations with increased risk of injury to Calot’s components. Many different 
techniques have been described such as whether to leave the posterior gallbladder wall 
in situ or not and whether to close the remnant gallbladder stump with or without 
drainage. Theoretically, leaving the cystic duct open would avoid further risk of bile duct 
injury. However, it may have some disadvantages; it could lead to higher postoperative 
bile leak rates, prolonged drainage and more frequent necessity of percutaneous drainage. 
Unfortunately, evidence is limited and no randomized trials on this subject have been 
published. Available literature consists mainly of small consecutive series. Although each 
situation may ask for a customized approach, it remains unclear what the morbidity, 
mortality, and long-term sequelae of LPC are. The current study aims to systematically 
review the available evidence on morbidity, mortality and long-term results of LPC.
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METHODS
Literature search
The Cochrane Database of systematic reviews, the Cochrane central register of controlled 
trials, and MEDLINE databases were searched by using the keywords (partial OR 
incomplete OR subtotal) AND (cholecystitis OR cholecystectomy) to identify studies 
published up to January 2012. Free text words were used instead of MeSH terms to 
avoid missing recent articles that had not been given a MeSH label. Three investigators 
(DH, DdC, SML) independently performed the literature search. Electronic links to 
related articles and references of selected articles were hand-searched as well. References 
were snowballed. A hand search of relevant journals and conference proceedings was not 
performed. The search was not restricted to any language, but in the systematic review 
only studies published in English were taken into account.
 Study selection and data extraction. From the potentially eligible inclusions, 
only studies were included if they reported on partial (or incomplete) cholecystectomy in 
patients with cholecystitis. Studies were included if they formulated a clear definition of 
PC. The definition needed to include “some portion of the gallbladder left in continuity 
with the cystic duct and not resected”8.
 The same three investigators independently searched the list of abstracts 
according to the search results and selected articles for closer reading. Subsequently, 
two investigators (DH, DdC) extracted the following outcomes, if reported, from 
the original articles using a preformatted sheet: conversion rate, hospital length-of 
stay (LOS), bile duct injury (BDI), bile leak, symptomatic gallstones in the remnant 
gallbladder, the need for reoperation, the need for postoperative endoscopic retrograde 
cholangiopancreaticography (ERCP), the need for percutaneous intervention and 
mortality. 
 Duplicate publications and papers that reported on (parts of ) the same study 
population were excluded. In that situation only the largest, most recent or most 
relevant publication was included. Each of the selected studies was critically appraised 
by the two investigators (DH, DdC), using a modified form as proposed by the Dutch 
Cochrane Collaboration. They assessed whether a study was 1. randomized, consecutive, 
prospective or retrospective; 2. whether it had similar groups and 3. whether there was an 
adequate follow up. In the case of retrospective analysis of data collected prospectively, a 
study was defined as prospective. Final inclusion was done after consensus was reached. 
Discrepancies in judgment, if any, were resolved by discussion between the investigators 
in a consensus meeting.
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RESULTS
Included studies
Using the aforementioned  search terms, 925 publications were identified. Eight-hundred 
and forty-three articles the words “subtotal/partial/incomplete” and “cholecystectomy” 
were contained in a different context and were therefore deemed irrelevant. In total, 
102 articles were selected for closer reading. Of the 102 remaining articles 18 were not 
written in English and 67 concerned PC either as case reports or as treatment only for 
other conditions than AC (e.g. Mirizzi syndrome, xanthogranulomatous cholecystitis), 
or addressed open PC, and were therefore discarded. 
 The remaining 17 articles were scrutinized and mined for data. One article was 
excluded in this phase because the indication for LPC was liver cirrhosis in all patients9. 
A paper by the same author10 was also excluded because it seemed to include mostly the 
same patients as the earlier article. Finally, 15 articles remained (Figure 1)7,8,11-23. The 
included studies had several limitations (Table 1). Most were retrospective single-centre 
studies with generally small or moderate sample sizes.
Indication for LPC
The 15 papers included 625 patients. In 13 papers that mentioned it, 352 patients (56%) 
had acute cholecystitis. Eight articles reported the incidence of Mirizzi syndrome, which 
was the indication for LPC in 28/371 patients (7.5%). 
Figure 1. Flowchart of included papers.
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Table 1. Quality of included studies.
Publication Description of Study
Median 
Follow-up 
months (range)
Quality Points Total
1 2 3 4 5 6 7 8 9 10
Beldi 2003 Prospective consecutive series 19 (6-54)
1 1 0 0 1 0 1 1 1 1 7Comparison LPC with nationwide 
LC database
Bickel 1993 Retrospective consecutive series - 0 0 0 0 0 0 0 1 0 0 1
Bonavina 2007 Retrospective consecutive series
- 0 0 0 0 0 0 0 0 0 0 0
(letter to editor)
Chowbey 2000 Retrospective consecutive series - 1 0 0 0 1 0 1 0 0 1 4
Horiuchi 2008 Retrospective study
- 1 1 0 0 0 1 0 1 0 1 5
Comparison of early and late group
Hubert 2010 Prospective consecutive series 4 (2-16) 1 0 0 0 1 0 1 1 1 1 6
Ji 2006 Retrospective consecutive series
- 1 0 0 0 1 0 0 1 0 1 4
Comparison of LPC and LC.
Michalowski 
1998 Retrospective consecutive series - 1 0 0 0 0 0 0 0 0 1 2
Nakajima 2009 Retrospective consecutive series 42(1-100)
1 1 0 0 0 0 1 0 0 1 4Comparison of LC in early and late 
(after introduction of LPC) group.
Philips 2008 Restrospective consecutive series -  1 0 0 0 1 0 1 0 0 1 4
Ransom 1998 Retrospective consecutive series -  0 0 0 0 1 0 0 1 0 0 2
Singal 2009 Prospective consecutive series 10 1 0 0 0 1 0 1 1 1 1 6
Sinha 2007 Prospective consecutive series -  1 1 0 0 1 0 1 1 1 1 7
Sharp 2009 Retrospective consecutive series. 
Telephonic follow-up. -  1 0 0 0 1 0 1 1 0 1 5
Tian 2009 Retrospective consecutive series -  1 0 0 0 0 0 1 1 0 1 4
1. Definition of study objectives    Clear:1 unclear/no: 0 points
2. Statistical method described   Yes: 1 no: 0 points
3. Possible bias in inclusion/exclusion.   Not present:1, present/unclear: 0 points
4. Different types of treatment besides the evaluated one Not present: 1, present/unclear: 0 points
5. Different technique in patients from same series  No: 1 Yes/not defined: 0 points
6. Differences in population of compared groups  No: 1 Yes/not defined: 0 points
7. Measures of outcomes    Defined: 1, had to be calculated: 0 pts
Commercial interest cited to used devices  Devices not cited: 1, cited: 0 
LC= laparoscopic cholecystectomy LPC= laparoscopic partial cholecystectomy
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Operative techniques
The described operative techniques vary per author. The differences in operative 
steps among the authors are displayed in Table 2. Four different techniques can be 
distinguished. The first method basically involves excision of most of the anterior wall 
of the gallbladder, leaving a part of the posterior wall attached to the liver. The risk 
of dangerous dissection of the posterior wall is thus avoided. When the remaining 
gallbladder stump is not closed, we categorised this method as method A. Seven of 15 
authors used this technique. All of them describe the routine use of a drain. Method B 
is similar to A but the gallbladder stump is closed. One author uses this method, and 
another author used the method in 33% of the patients. Then, the third method is 
different from A and B because it includes resection of both the anterior and posterior 
Table 2. Different operative techniques.
Author
Excision 
anterior 
wall
Excision 
anterior and 
posterior 
wall
Routine 
drain
Coagulation 
of mucosa
Closure of 
gallbladder 
stump
Closure of 
cystic duct
Method
Beldi + - + + - - A
Bickel + - + + - + (100%) A
Bonavina ? ? ? ? + ?
Chowbey - + - - + + (100%) C
Horiuchi + - + + - + (90%) A
Hubert - + + + (laser) - + (100%) D
Ji + - + +/- - + (93%) A
Michalowski + - + +/- - +(93%) A
Nakajima - + - + + - C
Philips + - + - - - A
Ransom + - - - + + (62.5%) B
Singal - + * - - * + - (10%) C
Sinha + - + - - - A
Sharp +(12%) +(88%) + - - - D
Tian 
method 1 
method 2
- 
+ (33%)
+(67%)
-
-
+
+
-
+
+
-
-
C
B
A; excision anterior wall, no gallbladder stump closure, leaving a drain in situ. +/- coagulation of remnant 
gallbladder mucosa
B; excision of anterior wall with gallbladder stump closure, with or without a drain.
C; dissection of posterior wall from liver, leaving a closed gallbladder stump without drain
D; dissection of posterior wall from liver, leaving an open gallbladder stump with a drain
*: Dissection of posterior wall when possible. If not, coagulation of mucosa of remnant posterior wall.
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gallbladder wall. It mainly differs from a conventional cholecystectomy in its the 
location of transection: at the gallbladder neck or Hartmann’s pouch, leaving a remnant 
gallbladder pouch behind. We categorised it as method C when this pouch was closed. 
The four authors advocating this technique did not use drains routinely. Method D 
resembles method C but the pouch is left open with a drain close to it. Two authors used 
this method. Finally, the technique was not described in one paper [12]. Irrespective of 
the used technique, authors chose to coagulate or not to coagulate the mucosa of the 
remnant gallbladder, or to either close the cystic duct or to leave it open. The cystic duct 
was reported to be clipped, sutured or sutured from inside. The cystic duct was closed 
in 330 of 625 patients (53%). The median operative time for LPC was 81.1 minutes 
(range 50-180 minutes). 
Outcomes
Main outcomes concerning several items of morbidity and mortality are displayed in 
Table 3. Outcomes sorted per operative method and cystic duct closure are displayed in 
Table 4. 
Conversion rate
Conversion to open partial cholecystectomy was performed in 54 of 520 patients 
(10.4%). With method D, conversion was done in 30 of 60 patients (50%), mainly 
because one author described a very high conversion rate.
Length of stay
Median length of stay (LOS) was reported in 13 studies and varied from 0-48 days with 
a median of 4.5 days. 
Bile duct injury
One case of iatrogenic bile duct injury was reported [18], all other studies had none.
Bile Leak
The most common complication was postoperative bile leak, which occurred in 66 
patients (10.6%). Three authors report a median duration of the leak of 7 days, one 
author had a median of 17 days of leakage. Ranges were not given.
 Patients in which the cystic duct was closed had a leak in 18 of 321 cases 
(5,6%), whereas with an open cystic duct, leakage occurred in 48 of 295 patients (16%). 
Method A lead to a bile leak in 54 of 332 patients (16.2%) and method B (one article, 
0 out of 8 patients) lead to no leaks. Method C showed a leak rate of 6/168 patients 
(3.5%) and method D saw a bile leak in 3 of 60 patients (5%).
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Recurrent symptomatic gallstones
In the papers that describe some follow-up, 4 (2.2%) patients experienced recurrence 
of symptomatic cholelithiasis despite the LPC. Three of these patients, all presenting 
within 6 months after the LPC, were successfully managed with endoscopic papillotomy 
[12, 15]. One patient required completion laparoscopic cholecystectomy for recurrent 
right upper quadrant pain[19]. The authors did not state at what time interval after the 
LPC this procedure took place.
Reoperation 
Eight of 292 (2.7%) patients had a reoperation. Three reoperations were done for intra-
abdominal abscess, two for persistent bile leak, one for removal of an infected residual 
stone and one patient had a reoperation for bleeding from the liver bed. 
Postoperative ERCP
Postoperative ERCP was not uncommon in the described patient group and was 
performed in 26 of 349 (7.5%) patients. Indications for ERCP were retained CBD stones 
(n=9)  and stenting in case of biliary leakage of the cystic stump (n=8). Two patients 
underwent postoperative ERCP for elevated liver enzymes, with no abnormalities found. 
Beldi et al [11] described 7 patients undergoing postoperative ERCP, all for either CBD 
stones or biliary leakage, without stating how many patients had each indication. ERCP 
was needed in 6 of 219 patients (2.7%) when the cystic duct was closed, as opposed to 
19 of 121(16%) when the cystic duct was not closed.
Percutaneous intervention
Apart from postoperative drainage, a percutaneous (radiological) intervention was 
necessary in a few patients. In 5 cases a percutaneous intervention was described because 
of subhepatic or subphrenic abcess or hematoma. All of these patients had been treated 
by using method A (5 of 332 patients, 1.5%). 
Mortality
Three deaths were described in the entire series (one of pulmonary sepsis and two of 
myocardial infarctions).
DISCUSSION
The present review shows that the laparoscopic approach at partial cholecystectomy is 
feasible in approximately 90% of patients undergoing difficult resection and only 10.4% 
of cases was converted to open procedure. In the majority of patients, the indication 
for laparoscopic partial cholecystectomy (LPC) was acute cholecystitis. Overall, LPC 
seems to be safe and effective in avoiding major bile duct injury (BDI) as only one case 
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of major BDI was reported in all reviewed papers. Also, no procedure related deaths 
occurred. Not surprisingly, the most frequent complication after LPC was not further 
specified bile leakage from an inadequate or not closed cystic duct. As part of the surgical 
strategy, ERCP and subsequent stenting can be added as elegant therapy for bile leakage 
after leaving the cystic duct or gallbladder remnant open on purpose. LPC therefore 
is associated with a relatively high number of postoperative ERCPs (7.5%). The risk 
of BDI, however, is minimized by this approach. Moreover, the majority of bile leaks 
resolved spontaneously after a mean of 9.5 days.
 Another important issue is the formation of gallstones and/or residual gallstones 
in the remnant gallbladder. Symptomatic gallstone disease recurred in 4 of 184 (2.2%) 
patients during a maximum follow-up of 100 months; with all papers reporting a 
maximum of 5% recurrent symptomatic gallstones at follow-up. Three of these patients 
were successfully treated with endoscopic papillotomy and only one patient required 
completion laparoscopic cholecystectomy. The experience of this completion procedure 
was not discussed in detail, however. It should be noted that recurrent symptoms after 
conventional cholecystectomy, the so-called post-cholecystectomy syndrome, occur in 
10 to 40% of patients and is often related to recurrent or residual gallstones24. With those 
numbers in mind, the results of LPC seem acceptable (recurrent gallstone formation 
does not seem to be a major issue). It should be kept in mind that follow-up was limited 
in most series, possibly underestimating the need for completion cholecystectomy on 
the longer term, as a remnant gallbladder has the potential to develop recurrent stones. 
Evidence of the safety and feasibility of (laparoscopic) completion cholecystectomy 
following LPC is even scarcer and is beyond the scope of this study.
The current review has its weaknesses. The selected papers include mainly retrospective 
consecutive series with small to moderate sample sizes, and poor quality. Follow-up is 
lacking in most series. Another problem that makes it hard to draw firm conclusions 
is the variety of techniques described in the reviewed series. Every author published 
his or her own interpretation of LPC, differing in part of gallbladder excised, closure 
of the stump or cystic duct, coagulation of mucosa and use of drains. Some authors 
even used different techniques in the same series. This makes it hard to pool data and 
compare the different methods statistically. For rough comparison, however, the authors 
of the current review distinguished four techniques of LPC and identified closure of 
the gallbladder remnant and/or cystic duct an important step that seems to influence 
outcome favorable. Method D (leaving the transsected gallbladder neck open) showed 
a conversion rate of 50%, but this is due to a single series with an extraordinarily high 
conversion rate. Postoperative bile leak seems to be appearing most when method A 
was used, being the minimal variant in which only the anterior gallbladder wall is 
excised, and the stump is not closed. Also, the need for ERCP seemed higher when the 
gallbladder stump was left open as with methods A or D. Therefore, closure of the cystic 
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duct seems advantageous and it minimizes the need for ERCP, reduces the amount 
of leaks, seems to reduce the associated length of hospital stay and lowers the rate of 
recurrent symptoms of gallstone disease. Whether to dissect the posterior wall (methods 
C and D) or to leave a drain is hard to conclude from the current data.
In conclusion, laparoscopic partial cholecystectomy (LPC) seems feasible and may be a 
good alternative to conversion for a difficult gallbladder at laparoscopic cholecystectomy. 
This permits the surgeon to continue the procedure laparoscopically without increasing 
the risk of BDI. There could not be dawn firm conclusions about the preferred method 
at LPC, but closure of the remnant gallbladder pouch and/or cystic duct seems favorable. 
Of course, expertise of the surgical team plays an important role.
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Staged, multidisciplinary, step-up management strategies for necrotizing pancreatitis
ABSTRACT
Background:  Some 15 % of all patients with acute pancreatitis develop necrotizing 
pancreatitis, with potentially significant consequences for both patients and healthcare 
services.
Methods:  This review summarizes the latest insights into the surgical and 
medical management of necrotizing pancreatitis. General management strategies for the 
treatment of complications are discussed in relation to the stage of the disease.
Results:  Frequent clinical evaluation of the patient’s condition remains 
paramount in the first 24–72 h of the disease. Liberal goal-directed fluid resuscitation 
and early enteral nutrition should be provided. Urgent endoscopic retrograde 
cholangiopancreatography is indicated when cholangitis is suspected, but it is unclear 
whether this is appropriate in patients with predicted severe biliary pancreatitis without 
cholangitis. Antibiotic prophylaxis does not prevent infection of necrosis and antibiotics 
are not indicated as part of initial management. Bacteriologically confirmed infections 
should receive targeted antibiotics. With the more conservative approach to necrotizing 
pancreatitis currently advocated, fine-needle aspiration culture of pancreatic or 
extrapancreatic necrosis will less often lead to a change in management and is therefore 
indicated less frequently. Optimal treatment of infected necrotizing pancreatitis 
consists of a staged multidisciplinary ‘step-up’ approach. The initial step is drainage, 
either percutaneous or transluminal, followed by surgical or endoscopic transluminal 
debridement only if needed. Debridement is delayed until the acute necrotic collection 
has become ‘walled-off’. 
Conclusion:  Outcome following necrotizing pancreatitis has improved substantially 
in recent years as a result of a shift from early surgical debridement to a staged, minimally 
invasive, multidisciplinary, step-up approach. 
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INTRODUCTION
In recent decades the incidence of acute pancreatitis has increased globally and the 
burden of acute pancreatitis on worldwide healthcare services is expected to increase even 
further1–6. Some 85% of patients with acute pancreatitis make a quick and uneventful 
recovery, requiring little more than analgesia with or without minor supportive measures 
(fluid therapy). However, around 15% develop necrosis of the pancreatic parenchyma or 
extrapancreatic tissue. Failure of one or more organ systems will ensue in approximately 
40% of these patients. Only a minority of patients without pancreatic necrosis develop 
organ failure, but it can sometimes occur7. Both complications are independently 
associated with prolonged hospital admission, and high morbidity and mortality rates. 
Should pancreatic or extrapancreatic necrosis become infected, mortality rates increase 
up to 20%8.
 In necrotizing pancreatitis, the type of complication that may develop is 
closely related to the time from symptom onset, and specific complications may be 
managed differently at different time points. Therefore, this review addresses staged 
multidisciplinary ‘step-up’ strategies for necrotizing pancreatitis according to time 
from onset of symptoms. The complications and subsequent management strategies are 
described in each phase of necrotizing pancreatitis.
METHODS
The recommendations in this review are based on the recently revised guidelines9,10 of 
the International Association of Pancreatology (IAP)/American Pancreatic Association 
(APA) and the American Gastroenterological Association. To construct the revised IAP/
APA guideline multiple systematic reviews were performed by different groups of experts 
covering the most important areas of necrotizing pancreatitis. Recommendations for 
areas of necrotizing pancreatitis that lack solid evidence are based on expert opinion 
from international experts and consensus within the Dutch Pancreatitis Study Group.
 The different events following the time after symptom onset are described in 
accordance with the most likely chronological presentation to the treating physician. 
Starting with diagnosis and management on admission, the treatment suggestions for 
the first week are described followed by those for weeks 2 and 3, weeks 4–6 and after 
week 6.
Definition 
The 2012 revised classification of acute pancreatitis11,12 is now considered the new 
standard for defining acute pancreatitis and its complications (Table 1). In the revised 
classification, mild acute pancreatitis is defined by the absence of organ failure and 
local complications. Symptoms usually resolve within the first few days after admission 
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and most patients are discharged from hospital within a week. If performed, contrast-
enhanced computed tomography (CECT) may reveal interstitial pancreatic oedema 
occasionally accompanied by extrapancreatic fatty tissue inflammation. Most often the 
result of gallstones or alcohol abuse, definitive treatment consists of cholecystectomy or 
alcohol avoidance1. Although less common, several types of drug may cause pancreatitis 
and accordingly changes in medication should be queried on admission13. Any possible 
provoking agent should be discontinued immediately. Acute pancreatitis affects men 
and women in equal proportions, although alcoholic pancreatitis seems more prevalent 
in men whereas women are more likely to develop gallstone pancreatitis. The overall 
mortality rate of acute pancreatitis does not exceed 5 % and 75 % of patients do not 
suffer a recurrence14,15. In moderately severe acute pancreatitis, patients develop either 
transient organ failure (lasting less than 48 h) or local complications, such as pancreatic 
or extrapancreatic necrosis or pancreatic fluid collections. Severe pancreatitis is marked 
by persisting organ failure (lasting more than 48 h) and is usually accompanied by local 
complications. The rationale for this cut-off value of 48 h is that organ failure persisting 
beyond this point is associated with a much higher risk of death16–19.
Evaluation and diagnosis on admission
Acute pancreatitis is diagnosed when two of the following three criteria are present: pain 
in the upper abdominal region, raised levels of lipase or amylase at least three times the 
upper limit of normal, and characteristic findings on cross-sectional abdominal imaging. 
In most patients the first two criteria suffice for the diagnosis and no imaging is needed. 
CECT should be carried out only if there is diagnostic uncertainty. The aetiology of 
pancreatitis should be determined, because it has implications for both short- and long-
term management20. 
Table 1. Overview of the revised classification of acute pancreatitis.
Category Characteristics
Mild No organ failure
No local or systemic complications
Moderate Organ failure for < 48 h
or
Local* or other systemic† complications
Severe Organ failure for more than 48 h
Local or systemic complications usually present
*Such as pancreatic necrosis, extrapancreatic fluid collection, splenic vein thrombosis; †exacerbation of 
pre-existing co-morbidity, for example chronic lung disease.
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Laboratory testing
On admission, the serum level of amylase or lipase is merely diagnostic and is not 
associated with an increased risk of developing complications21. Both parameters 
reach their peak and decrease back to normal in 2–4 days (amylase) and 8–14 days 
(lipase)22. Repeated measurements after admission are not indicated. Increased alanine 
aminotransferase levels on admission of over 60 units/l show a high probability of a biliary 
aetiology (positive predictive value 80–90%)23,24. Additional blood tests on admission 
should be carried out to rule out less common aetiologies such as hypertriglyceridaemia 
and hypercalcaemia.
Radiology
Ultrasonography is indicated in all patients with suspected gallstone disease. It is useful 
for diagnosing cholecystolithiasis, but less accurate for detecting common bile duct 
stones (Table 2)24–26. However, significant dilatation of the common bile duct (diameter 
over 8 mm in patients aged 75 or younger, and more than 10 mm in patients over 
75 years of age) is considered positive for a biliary aetiology. Both magnetic resonance 
cholangiopancreatography and endoscopic ultrasonography have excellent accuracy for 
detecting choledocholithiasis. Endoscopic ultrasonography is superior in detecting sludge 
and small stones, especially in non-dilated bile ducts24,27–29. Early CECT or magnetic 
resonance imaging (MRI) might be used to confirm the diagnosis of acute pancreatitis 
in those rare instances when the diagnosis cannot be established by clinical signs and 
biochemical parameters, for example if there clinical signs of an acute abdomen. 
Table 2. Radiological accuracy for determining biliary origin.
Sensitivity Specificity Positive predictive value Overall
Cholecystolithiasis
Ultrasonography High Moderate Excellent High
Choledocholithiasis
Ultrasonography Poor High Moderate Moderate
EUS Excellent Excellent Excellent Excellent
MRCP Excellent Excellent High Excellent
CECT High High High High
Poor, below 60 %; moderate, 60–74 %; high, 75–90 %; excellent, 91–100 %. EUS, endoscopic 
ultrasonography; MRCP, magnetic resonance cholangiopancreatography; CECT, contrast-enhanced 
computed tomography.
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Severity prediction
Several predictive scoring systems have been proposed for identification of patients at 
risk of developing organ failure or pancreatic complications30–33. Identification of these 
patients is important for institution of early supportive measures and for inclusion 
in clinical trials. Unfortunately, because the discriminatory power of most traditional 
scoring systems is moderate at best, their clinical applicability is limited34–36. More 
recent endeavours have aimed at identifying single serum markers to predict severity as 
opposed to the older, more complex systems that use multiple clinical and biochemical 
features (such as the modified Glasgow score, Ranson score and the Acute Physiology 
And Chronic Health Evaluation (APACHE) II)37. For example, serum creatinine 
concentration correlates strongly with the development of pancreatic necrosis, with a 
positive predictive value of 93 %, if blood levels rise to above 1.8 mg/dl (or 159 μmol/l) 
within 48 h of admission38. Blood urea nitrogen levels are a strong predictor of death32. 
A blood urea nitrogen level of 20 mg/l (7.14 μmol/l) or higher on admission, or any rise 
within 24 h after admission, is associated with an odds ratio for death of 4.6 and 4.3 
respectively. 
 In the first 72 h after symptom onset, necrosis of the pancreatic parenchyma 
cannot be assessed reliably on CECT34. Consequently, CECT has no role in assessing or 
predicting the severity of disease on admission in the first few days after admission30,34,39–43.
Management during the first week
Management of necrotizing pancreatitis during the first week of admission mainly 
consists of frequent clinical evaluation, analgesia and supportive measures (Fig. 1). In 
the first few days after admission, patients should be evaluated for the presence of the 
systemic inflammatory response syndrome (SIRS). Patients with persisting SIRS have 
a significantly worse outcome18,44,45. Monitoring SIRS is an effective bedside tool for 
assessment of disease progression because measurement of its components can be done 
easily and repeated9.
 In the event of deterioration or absence of clinical improvement at the end of 
the first week, CECT or MRI is indicated to assess the presence and extent of pancreatic 
or extrapancreatic necrosis, or extrapancreatic fluid collections46,47. Clinical deterioration 
during the first week is most often caused by progression of SIRS and seldom because 
of early infection of pancreatic necrosis48. As such, surgical intervention is not indicated 
during this phase unless an ischaemic or perforated viscus is the cause. If emergency 
surgery is deemed necessary, it is associated with mortality rates of 40–78 %7,49,50. Early 
emergency surgery potentially aggravates multiple organ failure, as shown by an increase 
in APACHE II scores after operation51,52. Additionally, complications (such as bleeding, 
intestinal fistula) are more prone to occur if surgery is performed before the acute 
necrotic collection has had time to progress to ‘walled-off’ necrosis (Fig. 2). Although 
there is no compelling evidence to support either of these arguments, the unfavourable 
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Figure 1. Suggested treatment algorithm for necrotizing pancreatitis according to the time after 
onset of symptoms. CECT, contrast-enhanced computed tomography; SIRS, systemic inflammatory 
response syndrome; ERCP, endoscopic retrograde cholangiopancreatography; MRI, magnetic 
resonance imaging; FNA, fine-needle aspiration
Figure 2. Example of contrast-enhanced computed tomography in a patient with necrotizing 
pancreatitis. 
a Acute necrotic collection on day 4 after the onset of symptoms. Note the heterogeneous non-liquid 
pancreatic and extrapancreatic components in the retroperitoneum. 
b On day 12 after symptom onset the acute necrotic collection is not yet fully encapsulated.  
c On day 35 after symptom onset note the enhancing wall of reactive tissue or encapsulation; this is an 
example of walled-off necrosis 
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outcomes following early debridement have driven clinicians towards more conservative 
policies in the early phase of the disease7,50,53–55.
Fluid resuscitation
Fluid resuscitation aims at counteracting the effects of hypovolaemia due to ‘third 
spacing’, and is directed at restoring the microcirculation and thereby oxygenation 
of the pancreas and other organ systems56. Adequate fluid resuscitation may prevent 
further local injury to the pancreas and so might inhibit the systemic inflammatory 
response57–59. Traditionally, liberal intravenous fluid infusion has been advocated. The 
patient’s vital signs (heart rate, blood pressure, oxygen saturation) and urinary output 
(accepted urinary output over 0.5 ml per kg per h) are monitored, taking into account 
pre-existing conditions contraindicating high-volume fluid infusion14,20,40. Fluid 
resuscitation is especially important in the first 12–24 h after admission. Thereafter, the 
amount of fluid administered can be decreased10. It is unclear what type of fluid should 
be used. A recent systematic review57 found no clinically significant differences between 
the use of isotonic crystalloid or colloid fluid. 
Role of endoscopic retrograde cholangiopancreatography
In gallstone pancreatitis, obstructing stones or biliary sludge usually pass through the 
biliary tract spontaneously60. Obstruction persists in some patients, increasing the risk 
of developing cholangitis. If progressive cholestasis and dilatation of the common bile 
duct is accompanied by fever, the patient should be suspected of cholangitis and urgent 
endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy is 
indicated61,62.
 The benefit of ERCP in patients with pancreatitis without cholangitis, however, 
is unclear. A recent meta-analysis63 with pooled data from seven randomized trials, 
including 757 patients with gallstone pancreatitis, found no significant reduction in 
morbidity or mortality by routine use of early ERCP (within 72 h after admission) 
compared with conservative treatment. Unfortunately, the subgroup of patients with 
predicted severe pancreatitis was relatively small, raising the possibility of a type II 
error. Further research is needed in this group of patients. Recently, a new randomized 
multicentre trial has been started in the Netherlands investigating routine early ERCP 
with sphincterotomy in patients with predicted severe biliary pancreatitis (APEC trial; 
ISRCTN97372133).
Nutrition
In necrotizing pancreatitis, adequate nutritional intake can be obtained through an 
oral diet or enteral nutrition. Several meta-analyses64–66 of randomized trials comparing 
enteral with parenteral nutrition showed that enteral nutrition significantly reduces 
organ failure, infections and mortality. Two small randomized studies67,68, with 31 and 
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50 patients with severe pancreatitis, concluded that nasogastric feeding was just as well 
tolerated as nasojejunal feeding. No differences were found between different types of 
enteral nutrition formulations69. 
 Enteral feeding is hypothesized to maintain the integrity of the gastrointestinal 
mucosal barrier, thus inhibiting bacterial translocation and reducing infectious 
complications70–73. Several non-randomized studies74,75 concluded that very early enteral 
feeding (within 24–48 h after onset) reduces pancreatic infections and multiple organ 
failure even further. The results are awaited from a multicentre trial76 investigating the 
effect of very early enteral feeding in patients with predicted severe pancreatitis. In this 
trial, 208 patients were assigned randomly to very early nasojejunal feeding (within 24 h 
after onset) or standard practice (oral diet after 72 h after admission or, if needed, enteral 
feeding after 72 h). 
Antibiotic prophylaxis
Secondary infection of pancreatic or extrapancreatic necrosis occurs in approximately 
one-third of patients with necrotizing pancreatitis7,77,78. Many efforts have been made 
to test antibiotic prophylaxis in prevention of infected pancreatic necrosis. Early small 
randomized trials79,80 showed promising results, reporting lower rates of mortality and 
infected necrosis. More recent placebo-controlled studies81–83, however, failed to confirm 
these results. In the past 5 years, ten meta-analyses78,84–92 have been published on the 
subject. Eight of these did not find a reduction in infected pancreatic necrosis and 
none showed a reduction in mortality.  These clinical studies have been critiqued for 
their low methodological quality93. So far, three double-blinded and placebo-controlled 
studies81–83 have been performed, showing no positive effects of antibiotic prophylaxis. 
 In the first week after admission, there is no role for routine antibiotic 
prophylaxis in the treatment of necrotizing pancreatitis. Antibiotics should be withheld 
until infection is proven with positive cultures. In most patients, infection of pancreatic 
or extrapancreatic necrosis does not occur until week 3 or 4. Antimicrobial agents 
with favourable pancreatic tissue penetration, such as carbapenems, metronidazole and 
quinolones, are recommended10,80,83.
Abdominal compartment syndrome
Abdominal compartment syndrome (ACS) is very rare in patients with necrotizing 
pancreatitis and, if the suspicion arises, it most often occurs in the first week after 
symptom onset94. Aggressive fluid resuscitation, retroperitoneal fluid accumulation 
and ascites may contribute to raised intra-abdominal pressure (transvesical pressure 
measurements exceeding 12 mmHg).  A prevalence of intra-abdominal hypertension 
up to 61% has been reported in patients with necrotizing pancreatitis95. Persisting intra-
abdominal hypertension is believed to be a precursor of ACS. The World Society of the 
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Abdominal Compartment Syndrome96 defines ACS as ‘persisting abdominal pressure 
above 20 mmHg accompanied by new onset organ failure’. 
 Several non-invasive strategies may aid in reducing the intra-abdominal pressure: 
enteral decompression through gastric or rectal tubes, recalibrating the intravenous 
fluid regimen for a zero-to-negative balance, and increasing abdominal wall compliance 
through medication. If non-invasive options are not sufficiently effective, the next step 
of treatment should be aimed at evacuation of excess intra-abdominal or retroperitoneal 
free fluids, such as ascites, by percutaneous catheter drainage (PCD). 
 Decompression laparotomy is sometimes applied as a ‘last resort’ if multiple organ 
failure escalates However, currently there is no evidence that surgical decompression has 
a beneficial effect on outcome. If there is no infected necrosis (as in most patients during 
the first week after admission) the retroperitoneum should not be opened during this 
procedure to minimize the risk of introducing pathogens96,97.  Although decompression 
laparotomy seems effective in individuals without pancreatitis13,98, ACS in patients 
with pancreatitis seems mainly associated with massive fluid resuscitation99. In these 
patients, no improvement in overall morbidity and mortality has been documented. A 
randomized trial is currently investigating the role of percutaneous drainage as a primary 
means of decompression compared with surgical decompression (DECOMPRESS trial; 
ClinicalTrials.gov NCT00793715)100.
Management during the second and third weeks
Infection of pancreatic necrosis
Infected pancreatic necrosis is usually diagnosed during the second or third week after 
onset48,81,101. Other possible sources of infection, such as pneumonia, must be ruled 
out first, as these tend to occur earlier in the course of the disease48. Cross-sectional 
imaging is indicated to assess the evolution of pancreatic necrosis and peripancreatic 
fluid collections. Occasionally, CT or MRI may reveal retroperitoneal gas bubbles inside 
pancreatic fluid collections pathognomonic for infection. These collections rarely show 
signs of complete encapsulation before the fourth week102.
Fine-needle aspiration
Fine-needle aspiration (FNA) culture of pancreatic fluid collections is useful if the 
diagnosis is uncertain and has the added value of optimizing antibacterial therapy. 
Routine FNA culture was promoted more widely in the past, but has been used more 
selectively in recent years. The reason for this shift is that, with the more conservative 
approach currently advocated, FNA results less often lead to a change in management 
and so aspiration is indicated less frequently. FNA carries a risk of false-negative results 
in up to 25% depending on timing after onset and indication103,104. Therefore, FNA 
should be used to obtain information about a collection only when the result will direct 
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the treatment plan. FNA is warranted, for instance, in patients who fail to recover 
from organ failure (and thus have persisting high inflammatory parameters so infected 
pancreatic necrosis cannot be discriminated clinically) and without signs of infection 
on CECT. A positive FNA would warrant a step up in treatment of the fluid collection.
Percutaneous catheter drainage
Percutaneous catheter drainage (PCD) (Fig. 3) is an important adjunct in the care 
of patients with infection of acute necrotic collections or walled-off necrosis.   Once 
infection occurs, the patient must be treated effectively in a timely manner for a good 
outcome.  Most patients need antibiotics and drainage.  The use of PCD is the first step of 
the step-up approach. Catheters are placed optimally by the left or right retroperitoneal 
route, depending on the anatomy of the collections.  In the absence of solid evidence 
regarding the optimal timing of PCD, different strategies are applied. A positive FNA 
during the second or third week leads to PCD in some institutions, whereas in others 
antibiotics are started first, with PCD in this disease phase only following further 
clinical deterioration. Early PCD may substantially improve a patient’s condition but 
can also introduce infection in a sterile collection, thereby leading to deterioration, so it 
is important that infection be documented clearly first. 
 In the past decade, several specialized centres have reported successful treatment 
of infected necrotizing pancreatitis with PCD alone in 35–55% of patients105–107. The 
PANTER trial compared PCD as the first step of a step-up approach with primary open 
necrosectomy for infected necrotizing pancreatitis. Interestingly, more than 30% of those 
enrolled in the step-up group did not need additional surgical necrosectomy107. Available 
evidence indicates that a subgroup of patients with infected necrotizing pancreatitis 
can be treated successfully with PCD alone. Unfortunately, it remains unclear which 
patients will recover successfully after PCD alone and which will need an additional 
Figure 3. Preferred route for percutaneous catheter placement for drainage of a typical infected 
peripancreatic collection. Via the left flank, a catheter can be manoeuvred retroperitoneally between 
the spleen, colon descendens and kidney using computed tomographic guidance.
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endoscopic or surgical necrosectomy. Therefore, the first step in treatment should be 
percutaneous or endoscopic drainage, followed by surgical or endoscopic necrosectomy 
only if clinically necessary. 
Management during the fourth, fifth and sixth weeks
A second peak in mortality is seen in this phase of the disease, mostly associated with 
infection of the pancreatic or extrapancreatic necrosis14. In general, only patients with 
infected necrosis should undergo invasive interventions14,20,108. Interventions such 
as endoscopic transluminal drainage and necrosectomy, and minimally invasive or 
open necrosectomy should be delayed if possible to around 4 weeks after the onset 
of symptoms102. This allows the collection to become walled-off, which is believed to 
facilitate necrosectomy9 (Fig. 2).
Minimally invasive surgical necrosectomy
Two minimally invasive surgical techniques have gained widespread acceptance: sinus tract 
endoscopy (also referred to as minimal access retroperitoneal pancreatic necrosectomy, 
MARPN)109,110 and video-assisted retroperitoneal debridement (VARD)106 (Fig. 4). In 
both procedures, access to the necrotic pancreas is achieved by following the tract of a 
radiologically placed drainage catheter. 
 In sinus tract endoscopy, pioneered in Glasgow, a nephroscope is inserted into 
the infected collection after dilatation of the drain tract to 30 Fr under fluoroscopic 
guidance. Debridement is carried out using long forceps, and the necrotic cavity is 
flushed using jet irrigation and suction devices. The procedure is repeated if the patient 
fails to recover and residual infected necrosis is suspected. A median of three to five 
procedures is needed for adequate necrosectomy109,110. A large retrospective cohort 
Figure 4. Using the percutaneous catheter as retroperitoneal guide, a 5-cm subcostal incision is 
made. The first solid debris that is encountered can be removed bluntly using long grasping forceps. 
Subsequently a 0º laparoscope is introduced into the necrotic cavity and more central necrotic debris 
can be removed.
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series indicated that survival rates are potentially better with MARPN compared with 
open necrosectomy (19% of 137 patients versus 38% of 52 patients)111. Additionally, 
postoperative organ failure and complication rates may be lower in the minimally 
invasive group.
 The VARD technique was developed in Seattle, USA. It uses a 5-cm subcostal 
incision in the left flank near the exit point of the percutaneous drain112. The drain is 
followed closely into the collection. After opening the collection bluntly and clearing 
the first liquid and solid debris encountered with suction and long grasping forceps, a 0° 
camera used for laparoscopy is introduced into the necrotic cavity. The camera is placed 
through a laparoscopic port, which is placed directly through the incision. Carbon 
dioxide is infused through the percutaneous drain to inflate the cavity. After surgery 
continuous lavage is started using two large-diameter drains. This technique allows 
vigorous debridement of the necrotic cavity with a median of one procedure106. In the 
years following the introduction of VARD in Seattle, it became clear that percutaneous 
drainage alone could also be sufficient in some patients, instead of just serving as a 
bridge to necrosectomy. This finding generated the hypothesis behind the PANTER 
trial113. In this trial, 88 patients were allocated randomly to either primary necrosectomy 
via laparotomy or the step-up approach. A significantly lower rate of the composite 
endpoint of major morbidity or death was found in the step-up group (40 versus 69%; 
P = 0.006). New-onset multiple organ failure was also significantly less common in the 
step-up group (12 versus 40%; P = 0.002). 
 A few case series have been published on laparoscopic necrosectomy. This 
transperitoneal route offers access to the lesser sac and simultaneous management of 
intra-abdominal organs (for example concurrent cholecystectomy)113. However, it also 
has the disadvantage of introducing a continuum between the peritoneal cavity and the 
retroperitoneum containing infected pancreatic necrosis1112114,115. 
Endoscopic transluminal drainage or necrosectomy
Parallel to the development of minimally invasive surgical strategies, endoscopic 
transluminal approaches have been developed116,117. Under direct vision or endoscopic 
ultrasound guidance, the gastric or duodenal wall is punctured to reach the walled-off 
necrosis (Fig. 5). The transluminal tract is dilated sequentially using a balloon. Short 
pigtail catheter drains or a stent can be used to prevent the access to the retroperitoneum 
from closing after the first procedure. A nasocystic catheter is placed in the necrotic 
cavity for continuous irrigation46. The use of multiple transluminal gateways has been 
suggested to improve drainage of the infected material, and successful drainage without 
the need for additional intervention was achieved in up to 90% in a small cohort of 
selected patients118. Patients in whom endoscopic drainage proves insufficient may benefit 
from endoscopic necrosectomy. Like sinus tract endoscopy, the transluminal drain tract 
is dilated further for introduction of an endoscope. Various instruments are used for the 
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actual necrosectomy, such as endoscopic baskets, snares, jet irrigation and forceps117,119. 
A recent systematic review showed that 197 (75.8%) of 260 patients were treated with 
endoscopic treatment alone, with only two reported deaths. Although these results seem 
promising, they must be interpreted with caution as they are based predominantly on 
non-randomized findings in selected patients from experienced institutions. The first 
randomized trial52 compared endoscopic necrosectomy with surgical necrosectomy 
in 22 patients with infected necrotizing pancreatitis. This pilot trial showed that the 
inflammatory response (interleukin 6 levels) and a composite endpoint of death or major 
complications were significantly reduced following endoscopy compared with surgery. 
A large clinical trial following on from this pilot study is currently being conducted. 
Ninety-eight patients will be randomized to an endoscopic step-up approach or the 
surgical step-up equivalent (percutaneous drainage followed by VARD or, if not feasible, 
open necrosectomy) (TENSION trial; ISRCTN 09186711).
Open surgical necrosectomy
Primary open surgical necrosectomy has been the standard treatment of infected 
necrosis for decades. The classical approach is to enter the retroperitoneum through 
a laparotomy, after which the necrotic tissue is removed by blunt dissection120. 
Healthy pancreatic tissue is preserved as much as possible, and by doing so the risk of 
postoperative bleeding or pancreatic fistulas is minimized. Different surgical techniques 
have been developed over the years, such as open packing, closed packing with planned 
reoperation or postoperative continuous lavage to remove any residual material108. Open 
necrosectomy remains associated with substantial morbidity121–123. These high morbidity 
rates are generally attributed to the exacerbation of stress induced by the trauma of 
Figure 5. Under direct vision or endosonographic guidance, the gastric or duodenal wall is 
punctured to evacuate the infected necrotic material. a. After serial dilatation of this transluminal 
tract two double-pigtail catheters are placed to establish a patent drain tract. b. Should the need 
for endoscopic necrosectomy arise, the tract is dilated further through which various endoscopic 
necrosectomy instruments can be introduced.
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surgery in an already critically ill patient, but are also closely associated with the timing 
of intervention and the presence of persistent organ failure107,109,124. The minimally 
invasive approaches were developed specifically for this reason, although to date no 
randomized trial has proven the superiority of minimally invasive techniques over open 
necrosectomy (or laparotomy). 
Management after the sixth week
Patients without proof of infection (even after negative FNA) who fail to recover, 
despite prolonged maximal supportive care, are suspected to have sustained a low-grade 
infection. In a recent study104 operative cultures showed proof of infection in 42% of 
53 patients who had surgery because they remained persistently unwell despite negative 
FNA results. Patients in whom a sterile fluid collection causes clinically significant 
morbidity (gastric or biliary outlet obstruction, pain) should be considered for surgical or 
endoscopic necrosectomy. A recent randomized trial125 comprising 40 patients compared 
endoscopic and open surgical cystogastrostomy. No significant differences were found 
with respect to recurrence of the fluid collection, reinterventions or complications. 
Endoscopic cystogastrostomy was associated with a significantly shorter hospital stay 
(median 2 days versus 6 days after open surgery).
 Anecdotal evidence exists of spontaneous remission of necrotic collections, 
even when infection has been proven116,126. These highly selected cases demonstrate that 
even infected pancreatic necrosis can be managed through supportive therapy alone. 
 Cholecystectomy or, if not deemed feasible, ERCP with sphincterotomy 
should be considered to minimize the risk of recurrent biliary pancreatitis and other 
gallstone-related disease. It is generally recommended to postpone intervention until all 
radiological and biochemical signs of inflammation have subsided127.
 Finally, several other complications may occur during this phase. Vascular 
complications may be seen on CECT, such as splenic or portal vein thrombosis or, less 
commonly, splenic artery pseudoaneurysm.  These must be dealt with using appropriate 
application of anticoagulant therapy, endovascular coiling, stenting or embolization, 
or sometimes even splenectomy. Pancreatic fistulas to various organs may also occur 
and can be treated quite successfully by endoscopic papillary stenting, thus facilitating 
drainage of the pancreatic secretion into the duodenum128.
 The impact of the disease and its complications on individual patients often 
reverberates for years. Psychological as well as physical sequelae, such as exocrine or 
endocrine insufficiency, may cause lifelong morbidity.
Future directions for research and improvement of outcomes
Frequent clinical evaluation of the patient’s condition is of paramount importance at 
the earliest stages of the disease, as current predictive scoring systems have a mediocre 
accuracy. New biomarkers may better predict complications in the coming years. 
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However, early adequate resuscitation in an attempt to prevent organ failure and early 
detection of any organ failure will remain most important. Based on current literature, 
liberal goal-directed fluid resuscitation and early enteral nutrition should be provided. 
Emergency ERCP with sphincterotomy is indicated when cholangitis is suspected, but it 
is unclear whether it is appropriate for patients with predicted severe biliary pancreatitis. 
Antibiotic therapy does not prevent infection of necrosis but is indicated if there is 
proven infection. ACS might occur early in the disease course, and in some critically ill 
patients decompression laparotomy may improve organ dysfunction temporarily if all 
non-surgical methods fail, although there is no solid evidence to support this. 
 In recent years, treatment of infected necrotizing pancreatitis has shifted from 
early open debridement to postponed minimally invasive step-up strategies, with initial 
catheter drainage only if needed followed by surgical or endoscopic necrosectomy. 
As PCD is a relatively simple intervention, this new strategy provides clinicians in 
general and district hospitals the tools to perform the first step in treatment. Although 
widespread adaptation of the step-up strategy should be stimulated, it must be stressed 
that the presence of a multidisciplinary team of physicians is crucial in the treatment 
of necrotizing pancreatitis. Only a multidisciplinary team including a surgeon, 
gastroenterologist, radiologist and intensivist will provide adequate care during all 
disease phases.  If such a team is not available around the clock, early transfer of the 
patient to an expert centre is advised. Several ongoing randomized trials will provide 
needed recommendations on timing of nutrition, indication for ERCP, optimal route of 
necrosectomy and indication for decompression in the foreseeable future.
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SUMMARY
The main objectives of this thesis were to evaluate and, where possible, improve 
current surgical strategies for mild gallstone pancreatitis. We addressed 1) the clinical 
and economical consequences of performing cholecystectomy before discharge, 2) the 
occurrence of gallstone-related complications after surgery and how to prevent them, 3) 
factors potentially complicating cholecystectomy and 4) strategies to deal with a difficult 
cholecystectomy. Finally, we discuss management of necrotizing pancreatitis and the 
role of cholecystectomy in these patients.
In Chapter 2 we performed a literature search to appraise the status quo regarding the 
scope of gallstone pancreatitis and its treatment. International population based studies 
have shown that the incidence of acute pancreatitis has been on the rise for at least two 
decades. This is at least in part attributable to a growing prevalence of gallstones. As 
gallstones more often occur in women than in men, they are twice as likely to develop 
gallstone pancreatitis. While its role in patients with predicted severe pancreatitis is 
still under investigation, early endoscopic retrograde cholangiopancreatography (ERCP) 
with sphincterotomy does not improve outcome in patients with mild disease. When 
signs of biliary tract obstruction persist, ERCP can be performed electively. Only in case 
of (suspected) ascending cholangitis, urgent ERCP with sphincterotomy is indicated. 
With regards to prevention of recurrent disease, sphincterotomy fails to provide the 
same level of long-term protection as cholecystectomy. Only in patients unfit for surgery 
can sphincterotomy alone be considered as definitive treatment. Overall, thanks to the 
many scientific efforts that have been made in recent years, management of the biliary 
tract stones and pancreatitis in general is becoming increasingly clear. 
Still, some major and minor issues regarding the role of cholecystectomy remain, mostly 
in relation to the timing of surgery in patients with mild disease. Chapter 3 discusses 
the results of the PONCHO study (Pancreatitis of biliary Origin: optimal timiNg of 
CHOlecystectomy). In this nationwide, randomized controlled trial, 264 patients with 
mild gallstone pancreatitis were allocated to cholecystectomy before discharge (N=128) 
or cholecystectomy after an interval of three to four weeks (N=136). The primary 
endpoint of readmission for gallstone-related complication or mortality occurred 
significantly less often in the patients who underwent same-admission cholecystectomy 
(6 patients in the same-admission group vs. 23 patients in the interval group; p=0.002). 
This included a significant reduction in the number of readmissions for pancreatitis 
(3 vs. 12; p=0.03). Furthermore, over half of all patients in the interval group (51%) 
reported to have had gallstone colics during the waiting period to cholecystectomy, 
compared to just 3% of patients in the same-admission group (p<0.001). There were 
very few surgical complications: in each group, one patient was treated for cystic duct 
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leakage and one patient underwent a re-intervention for bleeding. These results led us 
to conclude that same-admission cholecystectomy is safe and reduces the number of 
gallstone-related readmissions compared with interval cholecystectomy.
 Chapter 4 is an analysis of the two previously described strategies from a 
healthcare-economic point of view. Costs made by the patients after inclusion in the 
PONCHO trial were evaluated from a health care and societal perspective. These costs 
included days of admission, surgical costs, radiological and endoscopic examinations 
and emergency room and outpatient clinic visits. Furthermore, patients recorded 
pancreatitis-related absence from work. From the healthcare perspective, same-admission 
cholecystectomy was marginally more costly than interval cholecystectomy (€144). This 
was mainly due to six patients in the former group with protracted admission periods 
following complications, resulting in a slightly higher mean. However, patients in the 
same-admission groups reported less sick days, leading to an overall economic benefit 
of €234 per patient. Overall, in this randomized trial, same-admission cholecystectomy 
was not only more effective in patients with mild gallstone pancreatitis but also less 
costly.
From the previous chapters we have learned that gallbladder removal does not completely 
obviate the risk of new gallstone-related complications. In Chapter 5 we studied the 
frequency, type and severity of postoperative gallstone-related events. Healthcare 
resource usage was prospectively collected for the participants the PONCHO trial. 
Furthermore, patients were instructed to record postoperative gallstone colics. During 
the six-month follow-up period, 25 (10%) of the included 262 patients underwent 
postoperative hospital care. Readmission for recurrent gallstone disease was needed in 
7 of these patients (3%); 4 with recurrent pancreatitis, 2 with gallstone colics and 1 
with clinical manifestation of choledocholithiasis. Furthermore, 28 of the 191 patients 
(15%) returning the gallstone questionnaires reported to have experienced postoperative 
gallstone colics. In half of these cases this was an isolated event. Furthermore, these events 
occurred in the first two months after cholecystectomy in 22 of the 28 patients (79%). 
Only 4 of the 191 patients (2%) reported gallstone colics during the last month of 
follow-up. No risk factors for the development of postoperative complications could be 
identified. The rate and severity of these postoperative complications compare favorably 
to those of not performing cholecystectomy. However, these risks should be discussed 
properly with the patient prior to surgery. 
The technical aspects of cholecystectomy following mild pancreatitis were explored 
in Chapter 6. Data regarding surgical difficulty, the presence or absence of adhesions 
and surgeon’s experience were prospectively collected on PONCHO case record forms. 
Surgical difficulty was scored on a 0 to 10 visual analogue scale (VAS) by the most 
experienced attending surgeon. We investigated whether it was possible to predict if a 
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cholecystectomy would be technically challenging, according to risk factors identified 
in previous studies. A ‘difficult cholecystectomy’ was defined by presence of at least one 
of the following features: a VAS-difficulty beyond the 75th percentile (i.e. 8 or higher), 
conversion, subtotal cholecystectomy or duration of the procedure beyond the 75th 
percentile (i.e. 75 minutes or longer). According to these criteria, cholecystectomy was 
difficult in 82 out of the 249 participants (33%). After multivariable analysis male sex 
(OR 1.80, 95% CI 1.04-3.13; p=0.037), prior sphincterotomy (OR 1.79, 95% CI 
1.01-3.16; p=0.046), and delaying cholecystectomy until after 2 weeks after admission 
(OR 1.81, 95% CI 1.04-3.16; p=0.036) were independent predictors of the combined 
endpoint. These risk factors coincide with those predictive of a conversion in studies on 
unselected cohorts of patients. However, when including only the surgeons who had 
performed at least 100 prior laparoscopic cholecystectomies (i.e. experienced surgeons), 
no predictive factors could be identified. 
In cases where inflammation has rendered surgically important landmarks not safely 
identifiable, conversion from laparoscopy to laparotomy is traditionally advised. An 
increasingly used alternative to conversion is partial or subtotal cholecystectomy. Chapter 
7 presents an overview of the literature on the results and consequences of laparoscopic 
subtotal cholecystectomy. Using the search terms ‘partial’, ‘subtotal’ and ‘incomplete’, 
a systematic search was conducted in the Pubmed and Cochrane databases. Outcomes 
included bile duct injury or bile leak, symptomatic gallstones in the remnant gallbladder, 
need for postoperative ERCP or other additional interventions and mortality. Fifteen 
studies were included in the review, reporting on 625 patients. Multiple methods for 
performing subtotal cholecystectomy were described. In 10% of cases, conversion was 
needed nonetheless. Only one case of bile duct injury was reported, while postoperative 
bile leak occurred in 10% of patients. Recurrent symptoms from gallstones were 
reported in 2% of patients. Furthermore, postoperative ERCP was needed in 8% and 
other interventions in 4% of patients. Based on these results, subtotal cholecystectomy 
seems a feasible and safe alternative to conversion.
In Chapters 2 through 7, the focus has been on what to do when gallstones induce mild 
pancreatitis. In the Western world gallstones are also the most prominent cause of acute 
necrotizing pancreatitis. While in mild pancreatitis cholecystectomy has a dominant 
place in the prevention of further attacks, in severe necrotizing pancreatitis the role 
and timing of cholecystectomy is of lesser importance. In Chapter 8, we summarized 
current insights in the medical and surgical management of necrotizing pancreatitis. 
As these patients may develop various complications during the different stages of the 
disease, we proposed management strategies for each of these stages. The most recent 
recommendations of the American Gastroenterological Association, the International 
Association of the Pancreas and the American Pancreatic Association are incorporated 
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in this review. For issues where no clear consensus exists, the views of the international 
expert co-authors and those of the Dutch Pancreatitis Study Group were expressed. As 
the reliability of the various severity prediction models falls short, frequent clinical and 
biochemical evaluation of the patient’s condition remains critical, at least in the first 
24 to 72 hours. During this period, liberal intravenous fluid administration is advised. 
Antibiotic prophylaxis does not prevent the infection of the necrotic pancreatic tissue. 
Therefore, antibiotics should be reserved for bacteriologically confirmed infection. 
Should secondary infection occur and the patient continues to deteriorate despite 
maximal antibiotic and supportive therapy, invasive therapy is indicated. Ideally, this 
decision should be made by a multidisciplinary team consisting of at least a surgeon, 
gastroenterologist and radiologists. A step-up approach is advised, in which the first 
step is percutaneous or endoscopic drainage of the infected matter. If the patient does 
not improve despite adequate drainage and supportive therapy, endoscopic or surgical 
debridement of the remnant infected necrotic tissue can be performed. This step is 
usually delayed until the acute necrotic collection shows signs of encapsulation. Overall, 
outcome has steadily improved in these patients over the last few decades, at least in part 
due to this staged, multidisciplinary and step-up approach. Cholecystectomy comes 
into consideration once the acute necrotizing phase has been successfully dealt with 
and the patient has fully recovered. This may take 6 to 12 months. There are no reliable 
data available to guide patient and doctor through the discussion on whether or not to 
remove the gallbladder.
In the next chapter it will be discussed to what extent the questions posed in the 
introduction of this thesis have been answered, and which areas require further 
investigation.

CHAPTER 10
General Discussion and Future Perspectives
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GENERAL DISCUSSION AND FUTURE PERSPECTIVES
Acute gallstone pancreatitis remains a major cause of morbidity in Western societies. 
Its incidence has consistently increased over the last few decades, and is expected to 
continue to increase based on prevalence of gallstones presented in population studies.1 
Even though approximately half of all cases of pancreatitis are preceded by gallstone 
colics in most Western countries, these are often either treated conservatively or 
diagnosed in hindsight.2 In the majority of patients, fortunately, the disease is mild 
and self-limiting. In the absence of cholangitis, biliary tract management (i.e. removal 
of gallstones from the common bile duct) in the acute phase does not seem to affect 
outcome in terms of major morbidity or mortality in patients with mild pancreatitis.3 
Initial treatment of pancreatitis consists primarily of pain control and fluid therapy to 
restore pancreatic microcirculation and counteract hypovolemia due to third spacing. 
The next step in management is prevention of recurrence in the long-term. While 
endoscopic sphincterotomy can be helpful for both bile duct clearance and preventing 
future attacks of cholangitis and pancreatitis, it does not provide the same level of 
protection as the traditional treatment of cholecystectomy. 
 The major issue in the treatment of patients with mild gallstone pancreatitis, 
which is the timing of cholecystectomy, was extensively discussed in Chapters 3 and 
4. Following contradictory reports on the safety of cholecystectomy in the late 1980s, 
timing of surgery has been a controversial subject for years.4-6 Where some advocate a 
proactive approach in early removal of the gallbladder to reduce the risk of recurrence 
or potentially worse attacks of pancreatitis, others advise to be more patient on behalf 
of the perceived increased risk of bile duct lesion. Despite the fact that these fears of 
bile duct injury were never substantiated in patients with mild disease, doubts regarding 
the risk of surgical complications are still commonplace in clinical practice today. Both 
due to these concerns and logistical considerations (i.e. planning turns out to be easier 
than (sub)acute surgery), cholecystectomy is generally delayed until several weeks after 
discharge.7,8 However, during this interval patients remain at risk of developing new 
gallstone-related complications, such as recurrent pancreatitis. In the PONCHO trial 
(Pancreatitis of biliary Origin, optimal timiNg of CHOlecystectomy), we compared 
interval cholecystectomy with same-admission cholecystectomy.9 The latter strategy 
reduced the risk of the primary endpoint, acute readmissions for recurrent disease 
or mortality with 12 percentage points, demonstrating its superiority over interval 
cholecystectomy in terms of prevention of morbidity. Additionally, this strategy also 
proved preferable from a socioeconomic perspective, as patients in this group reported 
less pancreatitis-related sick leave. While the PONCHO trial, the cornerstone of this 
thesis, provides high-level evidence for same-admission cholecystectomy for future 
guidelines, several important questions remain for future discussion and study. 
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Optimal timing of cholecystectomy
The PONCHO trial was not specifically designed to explore the optimal moment of 
surgery, but rather to compare same-admission with fixed interval cholecystectomy. 
According to the PONCHO study protocol, patients were randomized after they had 
made complete clinical (i.e. resumed oral diet, no more need for opioid analgesics) and 
biochemical recovery (i.e. normalization of pancreatic enzymes, declining CRP levels). 
These criteria were established partly to reduce the risk of including patients with non-
mild disease, and partly to provide objective parameters to determine whether a patient 
was fit for surgery. Additionally, in the same-admission group, a 72-hour time window 
for cholecystectomy was allowed as a concession to logistical considerations of planning 
in usually very busy operating rooms in the participating centers. This effectively meant 
that patients, fully recovered and ready for discharge, could spend up to 72 hours 
awaiting cholecystectomy in the hospital for no other reason than to facilitate surgical 
planning. 
 In comparison, in an earlier trial on the timing of cholecystectomy in mild 
biliary pancreatitis, a more aggressive approach was used.10 In this study published 
in 2010, 50 patients with predicted mild gallstone pancreatitis were randomized to 
cholecystectomy within or after 48 hours of admission, irrespective of normalization of 
clinical or laboratory values (i.e. during pancreatitis). As pancreatitis may progress from 
mild to severe during the first 48 hours after onset, we believe patients should be observed 
at this stage of the disease and not be exposed to the additional risks of surgery.11,12 This 
is in line with the strategy as proposed by the international guidelines.13,14
 However, since none of the patients in this previous trial developed complications 
following this strategy of immediate cholecystectomy, the question is raised whether 
normalization of clinical and biochemical parameters are necessary before cholecystectomy 
can safely be performed. In other words, the 2010 trial and the PONCHO trial represent 
the two extremes of the concept of ‘early’ cholecystectomy, and the true optimal moment 
of surgery is likely to be somewhere in between. From a medical point of view, further 
determination of this cholecystectomy ‘sweet spot’, is not very interesting. Nevertheless, 
given the high incidence of mild gallstone pancreatitis, we believe that this step should 
be undertaken to optimize care in these patients. To illustrate, the following case is 
presented. Patient A, without a relevant medical history, is admitted to the medical 
ward with predicted mild gallstone pancreatitis. After several days of observation and 
supportive care, a surgeon is consulted. The surgeon, having concluded that the patient 
is fit for surgery, then has to start making arrangements for cholecystectomy. If the 
surgery lists permit it, he or she will undergo cholecystectomy before discharge. If not, 
the patient is discharged and planned for elective cholecystectomy. Ideally, in the near 
future, the same case will play out as follows: Patient A, with no relevant medical history, 
is admitted to the surgical ward with predicted mild gallstone pancreatitis.15 Having 
observed the patient for 48 hours, it is concluded that pancreatitis is unlikely to progress 
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in severity.11 The surgeon can start making preparations for cholecystectomy and place 
the patient on the sub-acute surgery list, for which the operating theatre reserves a half 
day operating list every fortnight.9,16 
 On a national level, the second scenario is potentially far more cost-effective. 
Realization of this scenario, however, would require several large changes to the status 
quo. Aside from the infrastructural modifications that may be needed to comply with 
(sub-)acute cholecystectomy, a change in the mindset towards the urgency of surgery 
in this setting is paramount. To this end studies like the PONCHO are needed that 
clearly demonstrate the superiority of one strategy over another. In the case of optimal 
timing of cholecystectomy, it will be challenging to explore which strategy is best in the 
setting of a randomized trial. The low number of expected serious surgical complications 
would require very large numbers of patients, even with concessions impairing the study 
quality, such as combined end points. Furthermore, the clinical premise does not lend 
itself easily to form a relevant equipoise that can be studied in the form of a randomized 
trial (‘safe’ or ‘safer’?). Rather, a well-designed prospective study performed in one or 
preferably more high-volume cholecystectomy centers may be more feasible. Patient 
safety in the form of surgical and peri-operative complications should be the focus of 
such a study, but it would also present an opportunity to investigate the (contingent) 
anatomic repercussions of mild pancreatitis, which will be discussed in the following 
paragraph. 
Safety of surgery
Given the low incidence in significant cholecystectomy-related complications (i.e. bile 
duct injury), a primary endpoint focusing on safety of surgery was deemed impractical 
in the PONCHO trial, as this would require thousands of patients. Instead, a combined 
endpoint of readmissions for recurrent gallstone-related disease and mortality was 
chosen. In hindsight, the addition of death to the primary endpoint may have been 
unwarranted, as mortality is a very rare complication in this patient group. This is a 
complexity in general, when a combined endpoint is necessary to design a study of 3 to 
maximal 5 years duration, proper powering and clinical relevant outcome.
 Regarding readmissions for recurrent gallstone-related disease, it is fairly 
obvious that these are more likely to occur when the gallbladder is left in situ for an 
extended period of time. Although the trial has provided much needed evidence for 
same-admission cholecystectomy, ideally the study would have dealt with the safety 
theme as well. The belief that a recent attack of acute pancreatitis increases the difficulty 
of surgery remains one of the two principal arguments to postpone cholecystectomy, 
the other being the logistical advantage of interval cholecystectomy. In our studies, 
none of our findings supported this theory of increased difficulty. In Chapter 3, only 
four cholecystectomy-related complications requiring re-intervention occurred in 263 
patients who underwent the procedure (1.5%). This subject was explored in more depth 
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in Chapter 6. The median overall difficulty grade as reported by the surgeons was a score 
of 6 out of 10, only slightly more difficult than a regular cholecystectomy (defined as 
a score of 5 out of 10). Risk factors for a particularly arduous procedure in our patient 
group did not differ from those described in cholecystectomies for other indications. In 
fact, contrary to the skepticism of same-admission cholecystectomy, our data showed 
that surgery tended to be more difficult when the procedure was postponed.
 However, as remarked at the beginning of this paragraph, the PONCHO trial 
was not powered to detect any differences (or even reliable incidence figures for that 
matter) in the occurrence of bile duct injuries. While older studies in patients with 
mild pancreatitis have reported similar findings, it is nevertheless conceivable that the 
biliary tract in patients with proven choledocholithiasis may present a surgically more 
hostile territory than in patients with simple cholecystolithiasis.10,17,18 Still, there are 
currently no indications that mild pancreatitis directly leads to increased surgical risk, 
much less that this risk can be averted by postponing cholecystectomy for a few weeks 
(i.e. interval cholecystectomy). As such, we believe the technical difficulty of surgery to 
be only marginally increased at most, and should not be an argument for postponing 
cholecystectomy for the trained gastrointestinal surgeon. 
 To increase our comprehension on the circumstances which significantly 
affect biliary anatomy, or more specifically lead to bile duct injury, studies are needed 
that take into account indication of cholecystectomy (i.e. pancreatitis, cholecystitis, 
cholecystolithiasis), time between onset of complaints and surgery and the severity 
of symptoms before surgery (e.g. pancreatic necrosis or fluid collections, gangrenous 
gallbladder or perforation). These data can be acquired retrospectively, but to assemble 
a representative cohort it would be necessary to perform such a study on a multicenter 
or even national scale. Furthermore, as proposed at the end of the previous paragraph, 
prospective studies including patients with all types of pancreatitis (mild, moderate and 
severe) are needed to investigate how pancreatitis itself influences biliary anatomy.
Difficult cholecystectomy
In Chapter 7, we explored surgical management of patients in which cholecystectomy is 
complicated by severe inflammation or dense adhesions of and around the gallbladder. 
Traditionally, conversion is advised in these situations to reduce the risk of iatrogenic bile 
duct injury. However, with increasing experience and confidence in their laparoscopic 
skills, surgeons from around the world are developing laparoscopic alternatives. Although 
a variety of methods have been described (routine drain use or not, coagulation of the 
remnant gallbladder wall, open or closed gallbladder and cystic stumps), the published 
results on surgical and postoperative complications are promising. It should be noted 
that these results are mostly from case series and the surgical prowess required to safely 
complete a laparoscopic subtotal cholecystectomy may be beyond the skillset of the 
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average surgeon. Nevertheless, these are interesting developments in the surgical world, 
in which the boundaries of laparoscopy are pushed forward.
Postoperative gallstone related complications
Another issue that remains incompletely settled is the occurrence, and more importantly, 
prevention of postoperative gallstone-related complications. As the short- and long-term 
management of mild biliary pancreatitis is becoming increasingly well defined, preventing 
postoperative events will present a challenging but interesting area for future research. 
While cholecystectomy, especially in combination with endoscopic sphincterotomy, 
substantially reduces the risk of new gallstone-induced morbidity, some patients will 
nevertheless develop postoperative symptoms.8,9,19 In the PONCHO cohort, 10% of 
patients required additional postoperative hospital care while 15% reported to have 
experienced gallstone colics after surgery (Chapter 5). No risk factors for the occurrence 
of postoperative symptoms could be identified. Whether these are the result of pre-
existent choledocholithiasis, or gallstones iatrogenically forced into the common bile 
duct during surgery, is unclear. As the latter may be the case, the most logical moment 
for the examination of persisting choledocholithiasis would be directly postoperatively, 
using modalities highly sensitive for intraductal gallstones (i.e. endoscopic ultrasound or 
magnetic resonance cholangiopancreatography). Intraoperative cholangiography should 
theoretically also be an effective method, but studies comparing routine IOC with no 
IOC have found no benefit in preventing postoperative events.20,21 Prospective, large-
scale studies in which perioperative choledocholithiasis is routinely investigated using 
both imaging and biochemical data may help improve identifying patients at risk of 
developing postoperative gallstone-related complications. While the natural discourse 
of retained common bile duct stones is interesting (How often does this occur? How 
many of these stones pass spontaneously? Which ones cause symptoms?), the expected 
yield is unfortunately quite low. In the PONCHO trial, only round 3% of patients 
developed symptoms serious enough to warrant readmission. All other symptoms were 
either self-limiting or managed conservatively through the outpatient clinic. Therefore, 
while single-center prospective studies on the subject should be encouraged, the clinical 
significance of postoperative gallstone complications may be too low to invest our scarce 
time and financial resources in the form of a national study. Alternatively, we can accept 
this as a fact and use this knowledge to inform our patients of the possible outcomes 
after cholecystectomy.
Timing of cholecystectomy in severe pancreatitis
Lastly, as briefly discussed in Chapter 8, the role of cholecystectomy in patients with 
severe pancreatitis remains a subject of so far completely unresolved debate. Based on 
the findings of a small number of studies, surgery during the acute phase of necrotizing 
pancreatitis is widely discouraged.4,22,23 Current guidelines recommend delaying 
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cholecystectomy in patients with severe disease until all symptoms have subsided, which 
is usually around 6 weeks after pancreatitis onset.13,14 
 In last two decades, however, very little research has been done on how to provide 
intermediate and long-term prevention from new gallstone-related complications, 
or whether this should be done at all. What are the risks and characteristics of new 
biliary events? Does necrotizing pancreatitis affect biliary anatomy? Is the combination 
of necrosectomy and cholecystectomy in the same operation warranted? In times of 
open necrosectomy this was feasible, but the surgeon tended to be preoccupied with 
necrosectomy and should admit that cholecystectomy might have been feasible and 
safe, but, to his own regret, forgotten to perform en passant. Should a patient recovering 
from a life-threatening episode of necrotizing pancreatitis be exposed to the risks and 
psychological stress of cholecystectomy, or does endoscopic sphincterotomy suffice? 
If cholecystectomy is to be delayed until after all symptoms have subsided, should 
sphincterotomy be performed as a bridge to surgery? These are important clinical 
dilemmas that can be addressed retrospectively (the first issue), prospectively (the second 
issue) or through randomization (the last two issues). Answers to these issues are needed 
to improve care in these vulnerable patients. Like the other points of future research 
discussed in this chapter, these issues require relatively large cohorts. 
 Due to its low incidence, such studies require pooling of resources and 
collaboration between centers on a national or perhaps even international level. A fine 
example is the APEC trial, which is currently being performed in the Netherlands. 
In this national multicenter trial, the effect of early sphincter of Oddi decompression 
on progression of disease severity is investigated. For this study, 232 patients with 
predicted severe disease will be randomized to either early endoscopic sphincterotomy 
or conservative treatment. According to the hypothesis, decompression of the pancreatic 
and biliary ducts during the first few hours after disease onset will reduce the risk of 
pancreatic necrosis and its subsequent complications (i.e. infection of said necrosis or 
peripancreatic fluid collections).
 The Dutch Pancreatitis Study Group has successfully performed several of these 
multicenter studies, proving that through cooperation, coordination and endeavor these 
problems can be addressed. There is, however, also a limit to the Study Group’s span of 
control, indicating that for larger studies international collaboration is necessary. This 
certainly puts an extra strain on logistics, finances, data control and collection of follow-
up sheets and daily unexpected events. Lastly, the plethora of regulation around clinical 
studies is making it increasingly difficult to perform studies in a national, let alone 
international setting, although this concern is beyond the scope of this thesis.
Conclusion
In patients with mild biliary pancreatitis, cholecystectomy before discharge reduces the 
risk of readmission due to recurrent gallstone-related disease. This strategy also reduces 
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pancreatitis related sick leave, making this approach preferable from a socioeconomic 
point of view. The true pathophysiological effect of acute pancreatitis on biliary anatomy, 
and thereby difficulty of surgery, remains at least partly unresolved. However, there are 
currently no indications that patients with mild disease have an increased risk of bile 
duct injury when cholecystectomy is performed shortly after resolution of symptoms. 
Furthermore, patients should be informed that cholecystectomy does not completely 
preclude the risk of future gallstone-related disease. In patients with severe pancreatitis, 
cholecystectomy should be postponed until symptoms have subsided, although it should 
be mentioned that the details regarding timing and indication of cholecystectomy (with 
or without previous endoscopic sphincterotomy) remain largely unclear.  
General discussion and future perspectives
179
REFERENCES
1. Papachristou GI, Papachristou DJ, Avula H, Slivka A, Whitcomb DC. Obesity increases the severity of 
acute pancreatitis: performance of APACHE-O score and correlation with the inflammatory response. 
Pancreatology : official journal of the International Association of Pancreatology. 2006;6(4):279-285.
2. Besselink MG, Venneman NG, Go PM, et al. Is complicated gallstone disease preceded by biliary 
colic? Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 
2009;13(2):312-317.
3. da Costa D, Schepers N, Romkens T, et al. Endoscopic sphincterotomy and cholecystectomy in acute 
biliary pancreatitis. The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland. 
2015.
4. Kelly TR, Wagner DS. Gallstone pancreatitis: a prospective randomized trial of the timing of surgery. 
Surgery. 1988;104(4):600-605.
5. Tate JJ, Lau WY, Li AK. Laparoscopic cholecystectomy for biliary pancreatitis. The British journal of 
surgery. 1994;81(5):720-722.
6. Uhl W, Muller CA, Krahenbuhl L, Schmid SW, Scholzel S, Buchler MW. Acute gallstone 
pancreatitis: timing of laparoscopic cholecystectomy in mild and severe disease. Surgical endoscopy. 
1999;13(11):1070-1076.
7. Bakker OJ, van Santvoort HC, Hagenaars JC, et al. Timing of cholecystectomy after mild biliary 
pancreatitis. The British journal of surgery. 2011;98(10):1446-1454.
8. van Baal MC, Besselink MG, Bakker OJ, et al. Timing of cholecystectomy after mild biliary pancreatitis: 
a systematic review. Annals of surgery. 2012;255(5):860-866.
9. da Costa DW, Bouwense SA, Schepers NJ, et al. Same-admission versus interval cholecystectomy 
for mild gallstone pancreatitis (PONCHO): a multicentre randomised controlled trial. Lancet. 
2015;386(10000):1261-1268.
10. Aboulian A, Chan T, Yaghoubian A, et al. Early cholecystectomy safely decreases hospital stay in patients 
with mild gallstone pancreatitis: a randomized prospective study. Annals of surgery. 2010;251(4):615-
619.
11. Mofidi R, Duff MD, Wigmore SJ, Madhavan KK, Garden OJ, Parks RW. Association between early 
systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. 
The British journal of surgery. 2006;93(6):738-744.
12. Bouwense SA, Bakker OJ, van Santvoort HC, et al. Safety of cholecystectomy in the first 48 hours after 
admission for gallstone pancreatitis not yet proven. Annals of surgery. 2011;253(5):1053-1054; author 
reply 1054-1055.
13. Tenner S, Baillie J, Dewitt J, Vege SS. American College of Gastroenterology Guidelines: Management 
of Acute Pancreatitis. The American journal of gastroenterology. 2013;108(9):1400-1415.
14. Working Group IAPAPAAPG. IAP/APA evidence-based guidelines for the management of acute 
pancreatitis. Pancreatology : official journal of the International Association of Pancreatology. 2013;13(4 
Suppl 2):e1-15.
Chapter 10
180
15. Kulvatunyou N, Watt J, Friese RS, et al. Management of acute mild gallstone pancreatitis under acute 
care surgery: should patients be admitted to the surgery or medicine service? American journal of 
surgery. 2014;208(6):981-987; discussion 986-987.
16. Monkhouse SJ, Court EL, Dash I, Coombs NJ. Two-week target for laparoscopic cholecystectomy 
following gallstone pancreatitis is achievable and cost neutral. The British journal of surgery. 
2009;96(7):751-755.
17. Schachter P, Peleg T, Cohen O. Interval laparoscopic cholecystectomy in the management of acute 
biliary pancreatitis. HPB Surg. 2000;11(5):319-322; discussion 322-313.
18. Sinha R. Early laparoscopic cholecystectomy in acute biliary pancreatitis: the optimal choice? HPB : 
the official journal of the International Hepato Pancreato Biliary Association. 2008;10(5):332-335.
19. Mustafa A, Begaj I, Deakin M, et al. Long-term effectiveness of cholecystectomy and endoscopic 
sphincterotomy in the management of gallstone pancreatitis. Surgical endoscopy. 2014;28(1):127-133.
20. Ford JA, Soop M, Du J, Loveday BP, Rodgers M. Systematic review of intraoperative cholangiography 
in cholecystectomy. The British journal of surgery. 2012;99(2):160-167.
21. Ito K, Ito H, Whang EE. Timing of cholecystectomy for biliary pancreatitis: do the data support 
current guidelines? Journal of gastrointestinal surgery : official journal of the Society for Surgery of the 
Alimentary Tract. 2008;12(12):2164-2170.
22. Mier J, Leon EL, Castillo A, Robledo F, Blanco R. Early versus late necrosectomy in severe necrotizing 
pancreatitis. American journal of surgery. 1997;173(2):71-75.
23. Nealon WH, Bawduniak J, Walser EM. Appropriate timing of cholecystectomy in patients who present 
with moderate to severe gallstone-associated acute pancreatitis with peripancreatic fluid collections. 
Annals of surgery. 2004;239(6):741-749; discussion 749-751.
APPENDICES
Nederlandse Samenvatting
Appendices
182
NEDERLANDSE SAMENVATTING
In de artikelen in dit proefschrift worden de huidige behandelstrategieën van milde 
biliaire pancreatitis vanuit een chirurgisch perspectief geëvalueerd, met als doel 
potentiele verbeterpunten te identificeren. Hiervoor brachten wij in kaart 1) de klinische 
en economische gevolgen van het verrichten van cholecystectomie vóór ontslag, 2) de 
prevalentie van galsteen gerelateerde complicaties na chirurgie en of dezen voorkomen 
kunnen worden, 3) factoren die het technisch uitvoeren van cholecystectomie kunnen 
compliceren en 4) chirurgische opties voor het uitvoeren van een dergelijke moeizame 
cholecystectomie om te gaan. Ten slotte bespraken wij de huidige inzichten met 
betrekking tot de behandeling van patiënten met ernstige, necrotiserende pancreatitis 
en wat de rol van cholecystectomie bij deze patiënten is.
Hoofdstuk 2 is een uiteenzetting van de beschikbare literatuur over biliaire pancreatitis 
en de behandeling hiervan. Grofweg 80% van de patiënten heeft te kampen met een 
relatief milde vorm van de ziekte, en kan na ongeveer een week ziekenhuisopname in 
goede conditie met ontslag. Bij de overige 20% kunnen pancreasnecrose (het afsterven 
van alvleesklierweefsel) en orgaanfalen (verminderde functie van hart, longen of nieren 
of een combinatie hiervan) leiden tot levensbedreigende situaties. Deze patiënten liggen 
vaak maanden opgenomen met een zeer hoge zorgbehoefte. Ondanks de verbeteringen 
in ondersteunende zorg technieken blijft de kans op sterfte in deze patiëntengroep hoog, 
zeker wanneer het ziektebeeld verder gecompliceerd wordt door bacteriële infecties van 
het pancreas of omliggend weefsel.
 Uit internationale studies blijkt de algehele incidentie van acute pancreatitis 
in de afgelopen twintig jaar langzaam maar zeker blijft toenemen. Deze stijging wordt 
deels toegekend aan een verhoogd percentage van mensen met galstenen. Galstenen 
ontstaan doorgaans in de galblaas door het samenklonteren van de galkristallen. De 
meest voorkomende oorzaak van pancreatitis is wanneer een galsteen door de galwegen 
is gemigreerd en het gezamenlijke afvoerkanaal van de galwegen en het pancreas verstopt 
(‘biliaire pancreatitis’). Galstenen komen vaker voor bij vrouwen, waardoor zij een 
tweevoudig verhoogd risico op het ontwikkelen van acute pancreatitis hebben. Het vroeg 
uitvoeren endoscopische retrograde cholangiopancreatografie (ERCP; een onderzoek 
van de galwegen om het afvoerkanaal van de gal- en pancreaswegen te ontstoppen) heeft 
geen invloed op de uitkomst bij patiënten met de milde vorm van de ziekte. Of deze 
behandeling in het vroege stadium zin heeft bij patiënten met (voorspeld) ernstige ziekte 
wordt momenteel onderzocht. Wanneer uit bloed- of radiologisch onderzoek blijkt dat 
de galwegen verstopt zijn, kan ERCP electief uitgevoerd worden. Alleen wanneer bij een 
vermoeden op een bijkomende bacteriële infectie van de galwegen, wordt aangeraden 
om de ERCP per direct uit te voeren.
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 Door via ERCP de uitgang van de galwegen te verruimen (‘sfincterotomie’ 
of ‘papillotomie’ van de papil van Vater) kunnen toekomstige stenen makkelijker 
de galwegen passeren, wat het risico op een volgende episode van acute pancreatitis 
verkleint. Sfincterotomie is echter minder effectief als bescherming op de lange termijn 
dan het verwijderen van de galblaas (cholecystectomie). Bij patiënten die vanwege 
co-morbiditeit geen operatie kunnen ondergaan kan sfincterotomie als definitieve 
behandeling overwogen worden.
Hoewel de behandeling van biliaire pancreatitis de afgelopen decennia duidelijk is 
verbeterd, zijn sommige aspecten met betrekking tot het uitvoeren van cholecystectomie 
nog niet geheel helder. Met name het moment van operatie is een betwist onderwerp. In 
Hoofdstuk 3 staan de resultaten van de PONCHO trial (Pancreatitis van biliaire Origine: 
optimale timiNg van CHOlecystectomie), waarin dit aspect verder is uitgediept. In 
deze nationale, multicenter studie werden patiënten met milde biliaire pancreatitis 
gerandomiseerd tussen cholecystectomie vóór ontslag (‘vroege cholecystectomie’, 
N=128) of cholecystectomie na een interval van 25 tot 30 dagen (‘interval 
cholecystectomie’, N=136). Het primaire eindpunt van acute heropname vanwege 
galsteen gerelateerde problematiek of mortaliteit kwam significant minder vaak voor in 
de ‘vroege cholecystectomie’ groep (6 patiënten in de vroege groep versus 17 patiënten 
in de interval groep; p=0.002). Dit kwam met name door een reductie in het aantal 
recidief pancreatitiden (3 versus 12 patiënten; p=0.03). Daarnaast bleek meer dan de 
helft van de patiënten in de interval groep (51%) galsteenklachten te rapporteren in 
de wachttijd tot operatie, waar dit maar 3% van de patiënten betrof in de vroege groep 
(p<0.001). Chirurgische complicaties kwamen weinig voor: in beide groepen werd 
één patiënt behandeld voor postoperatieve gallekkage en ontwikkelde één patiënt een 
bloeding. Aan de hand van deze resultaten concludeerden wij dat cholecystectomie vóór 
ontslag op een veilige manier het risico op een nieuw optreden van galsteenproblematiek 
verlaagt ten opzichte van de huidige praktijk van interval cholecystectomie.
Hoofdstuk 4 gaat verder in op de timing van cholecystectomie vanuit een economisch 
oogpunt. In deze studie werden de gemaakte kosten van alle patiënten in de PONCHO 
trial geanalyseerd vanuit een medisch en sociaal perspectief. Tot deze kosten hoorden 
ligdagen in het ziekenhuis, operatiekosten, kosten van beeldvorming en andere 
ingrepen zoals endoscopie en bezoeken aan de Spoedeisende Hulp en de polikliniek. 
Daarnaast werd rekening gehouden met pancreatitis-gerelateerd ziekteverzuim. Vanuit 
het medisch perspectief bleek vroege cholecystectomie marginaal duurder dan interval 
cholecystectomie (€144). Dit verschil kwam met name door het gecompliceerd beloop 
met hierdoor lange opnameperiodes van zes patiënten in de vroege groep. Daarentegen 
meldden de patiënten in de vroege groep minder ziekteverzuim, waardoor deze strategie 
een economisch voordeel van €234 per patiënt met zich meedroeg. Samenvattend bleek 
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vroege cholecystectomie in het kader van de PONCHO trial de meer effectieve strategie, 
maar ook aantrekkelijker vanuit economisch oogpunt.
Hoewel cholecystectomie het risico op nieuwe galsteen-gerelateerde complicaties sterk 
verlaagt, leiden achtergebleven stenen in de galwegen bij een klein percentage patiënten 
alsnog tot problemen. In Hoofdstuk 5 onderzochten we binnen de PONCHO trial het 
aantal, type en hevigheid van deze postoperatieve problemen. Van alle participanten 
werd het postoperatief zorggebruik uitgezocht. Daarnaast ontvingen alle patiënten 
voorafgaand aan de operatie een speciaal dagboek met instructies gedurende zes 
maanden galsteenkolieken bij te houden. Tijdens deze follow-up periode bleek bij 
25 van de 262 patiënten (10%) aanvullende zorg nodig. Van deze patiënten werden 
7 (3%) heropgenomen vanwege galsteenproblematiek: 4 met recidief pancreatitis, 2 
met galsteenkolieken en 1 met een obstruerende steen in de ductus choledochus. In de 
overige gevallen werd de zorg via de polikliniek geleverd.
 Met betrekking tot de galsteendagboeken rapporteerden 28 van de 191 
respondenten (15%) postoperatieve koliekaanvallen in de thuissituatie. Dit was in de 
helft van alle gevallen een enkele aanval. Het merendeel van de aanvallen, bij 22 van de 
28 patiënten (79%) trad binnen twee maanden na cholecystectomie op. In slechts 4 van 
de 191 gevallen (2%) werden klachten in de laatste maand van follow-up gerapporteerd. 
 Risicofactoren voor het ontwikkelen van postoperatieve complicaties konden 
niet worden geïdentificeerd. Hoewel het risico op deze complicaties veel lager is in 
vergelijking met de risico’s van het niet uitvoeren van cholecystectomie, moet de patiënt 
voorafgaand aan de operatie van deze mogelijke complicaties op de hoogte zijn gesteld. 
Op de technische aspecten van cholecystectomie na milde pancreatitis werd verder 
ingegaan in Hoofdstuk 6. Bij alle patiënten in de PONCHO trial werden prospectief data 
verzameld met onder andere betrekking tot de moeilijkheidsgraad, aan- of afwezigheid 
van adhesies en ervaring van de operateur. Moeilijkheidsgraad werd op een schaal van 
0-10 (makkelijk-moeilijk) door de meest ervaren operateur gerapporteerd. In deze studie 
onderzochten we of het mogelijk was een ‘moeilijke cholecystectomie’ te voorspellen aan 
de hand van bekende risicofactoren. Onder ‘moeilijke cholecystectomie’ werd verstaan: 
een moeilijkheidsgraad in het 75ste percentiel (een 8 of hoger), de noodzaak tot conversie 
van scopisch naar open, een subtotale cholecystectomie of een operatieduur in het 75ste 
percentiel (75 minuten of langer). Aan de hand van deze criteria was er sprake van 
een ‘moeilijke cholecystectomie’ bij 82 van de 249 patiënten (33%). Onafhankelijke 
voorspellers van dit gecombineerde eindpunt bleken na multivariate analyse 1) een 
mannelijk geslacht (Odd’s Ratio [OR] 1.80, 95% CI 1.04-3.13; p=0.037), 2) status na 
sfincterotomie (OR 1.79, 95% CI 1.01-3.16; p=0.046) en 3) uitstel van cholecystectomie 
tot twee weken na opname (OR 1.81, 95% CI 1.04-3.16; p=0.036). Na correctie voor 
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ervaring van de operateur (minstens 100 laparoscopische cholecystectomieën) verviel 
het effect van deze risicofactoren. 
In extreme gevallen leidt een heftige ontstekingsreactie tot verminderde herkenbaarheid 
van de structuren die voor cholecystectomie van belang zijn. In combinatie met straffe 
verklevingen kan men niet anders dan de galblaas slechts gedeeltelijk te verwijderen. In 
dergelijke gevallen werd tot voor kort geadviseerd de laparoscopische procedure te staken 
en de subtotale cholecystectomie via laparotomie af te maken. In de literatuur wordt echter 
in toenemende mate gerapporteerd over het laparoscopisch afmaken van de procedure 
als alternatief voor conversie. Hoofdstuk 7 is een overzicht van deze literatuur tot januari 
2012 over de laparoscopische subtotale cholecystectomie. Met de zoektermen ‘partial’, 
‘subtotal’ en ‘incomplete’ en ‘cholecystectomy’ werd een systematische zoektocht in 
Pubmed en de Cochrane bibliotheek verricht. Gekozen uitkomsten waren galwegletsel, 
gallekkage, symptomatische galstenen in de overgebleven galblaas, postoperatieve 
ERCP en andere interventies en mortaliteit. Alleen studies met patiënt series werden 
geïncludeerd. Na selectie bleven 15 artikelen met in totaal 625 patiënten over voor het 
review. Meerdere technieken voor laparoscopische subtotale cholecystectomie werden 
beschreven. In 10% van de gevallen is alsnog geconverteerd tot een open procedure. Bij 
eveneens 10% van de patiënten werd postoperatief gallekkage beschreven, wat bij slechts 
1 patiënt berustte op galwegletsel. Recidief symptomen kwamen voor bij 2% van de 
patiënten. Postoperatieve ERCP werd verricht bij 8% van de patiënten, overige ingrepen 
bij 4%. Van de 625 patiënten overleden 3 (0.005%), waarvan 2 aan een hartinfarct en 
1 ten gevolge van pneumosepsis. 
 Op basis van deze bevindingen lijkt laparoscopische subtotale cholecystectomie 
een goed en veilig alternatief voor conversie.
In de voorgaande hoofdstukken lag de focus op de behandeling van patiënten met 
milde pancreatitis. Galstenen zijn echter ook in veel gevallen de oorzaak van ernstige 
pancreatitis. Waar cholecystectomie bij patiënten met milde ziekte van belang is 
voor het voorkomen van recidief of andere galsteen-gerelateerde complicaties, speelt 
de procedure en timing hiervan een minder grote rol bij patiënten met ernstige 
pancreatitis. Hoofdstuk 8 is een samenvatting van de huidige inzichten in de algemene 
en chirurgische behandeling van necrotiserende pancreatitis. Aangezien verschillende 
soorten complicaties in de verschillende stadia van de ziekte voor kunnen komen, 
droegen wij een model aan met behandelstrategieën per stadium. De aanbevelingen 
van de American Gastroenterological Association en de International Association of 
the Pancreas / American Pancreatic Association werden in dit model verwerkt. Met 
betrekking tot zaken waar geen duidelijke consensus over bestaat werden de meningen 
van de internationale co-auteurs en de Pancreatitis Werkgroep Nederland aangedragen 
als ‘expert opinie’. 
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 Bij opname wordt, naast ruime intraveneuze vochttoediening, geadviseerd de 
patiënten de eerste 72 uur nauwgezet klinisch en biochemisch te vervolgen. Hoewel in 
de afgelopen jaren verscheidene methoden zijn aangedragen om bij opname de ernst van 
de ziekte te voorspellen, zijn slechts van beperkte waarde gezien hun matige accuratesse. 
Behandeling met profylactische antibiotica leidt niet tot een reductie in incidentie van 
infectie van peripancreatische necrose en wordt derhalve niet geadviseerd. Antibiotica 
worden pas ingezet bij microbiologisch bewezen bacteriële infecties. De behandeling blijft 
zo lang mogelijk medicamenteus, maar indien de patiënt onder maximale antibiotische 
en ondersteunende therapie klinisch verslechtert, dient een invasieve interventie te 
worden overwogen. Idealiter gebeurt een dergelijke interventie in de setting waar een 
multidisciplinair team te allen tijde beschikbaar is, bestaande uit minstens een chirurg, 
een MDL arts, een radioloog en een intensivist. Benadering via de opstap methode 
wordt geadviseerd, waarbij de eerste interventie bestaat uit endoscopische of percutane 
drainage van het geïnfecteerde vocht. Mocht drainage onvoldoende soelaas bieden, 
kan endoscopische of video-geassisteerde percutane debridement van het geïnfecteerde 
necrotisch weefsel worden overwogen. De klinische uitkomst van patiënten met 
necrotiserende pancreatitis is de afgelopen twintig jaar langzaam maar zeker verbeterd, 
onder andere door deze multidisciplinaire opstap benadering. 
 Cholecystectomie wordt pas aangeraden nadat alle tekenen van ontsteking goed 
en wel onder controle zijn. Dit kan tot wel 6 tot 12 maanden na aanvang van de ziekte 
zijn. Data met betrekking tot de indicatie en timing van cholecystectomie in deze groep 
zeer kwetsbare patiënten zijn schaars. Een eenduidig beleid kan derhalve niet uit de 
beschikbare literatuur worden gefiltreerd. De arts zal per geval moeten beoordelen in 
hoeverre cholecystectomie raadzaam en haalbaar is.
Conclusies
Biliaire pancreatitis blijft een significant probleem in de Westerse gezondheidszorg. 
Naar aanleiding van een grote hoeveelheid studies binnen het ziektebeeld is de 
indicatiestelling rondom cholecystectomie en sfincterotomie sterk verduidelijkt en 
hiermee de uitkomsten van de patiënten. De resultaten van de PONCHO trial hebben 
laten zien dat cholecystectomie vóór ontslag gezondheidswinst kan opleveren doordat 
via deze strategie aanzienlijk minder recidieven zullen optreden in vergelijking met 
interval cholecystectomie. Ook het aantal galsteenkolieken in de wachttijd tot operatie 
wordt via deze strategie geminimaliseerd. Bovendien bleek de behandelmethode ook 
economisch aantrekkelijker doordat patiënten sneller terug aan het werk konden. 
Hoewel cholecystectomie de best mogelijke risicoreductie geeft wat betreft recidief 
galsteenproblematiek, is de behandeling geen sinecure. Een klein aantal patiënten zal 
toch na de procedure klachten ervaren. Deze klachten laten zich moeilijk voorspellen en 
kunnen sterk in ernst varieren. Patiënten dienen van dit risico op de hoogte te worden 
gesteld voordat overgegaan wordt tot operatie.
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 In tegenstelling tot wat door sommigen gedacht werd, hebben we geen 
aanwijzingen kunnen vinden dat relatief vroeg opereren verhoogde kans op operatieve 
complicaties geeft. Sterker nog, uit een van de nevenstudies bleek het uitstellen van de 
operatie tot na twee weken na opname een onafhankelijke voorspeller van een moeizame 
operatie. Bij dergelijke moeizame operaties kan, mits bekwaam, de chirurg kiezen om 
de procedure laparoscopisch voort te zetten, met vergelijkbare complicatierisico’s als 
conversie.
 De rol van cholecystectomie bij patiënten met ernstige (necrotiserende) 
pancreatitis is onvoldoende onderzocht. Geadviseerd wordt de procedure pas in gang 
te zetten wanneer alle tekenen van inflammatie zijn uitgedoofd, maar de indicatie en 
timing zullen per geval in goed overleg tussen arts en patiënt moeten worden beoordeeld.
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DANKWOORD
Aan het begin van vrijwel ieder proefschrift is een lijst met stellingen te vinden met de 
belangrijkste bevindingen van het betreffend onderzoek. Vaak worden die bevindingen 
aangevuld met een paar citaten die de auteur nauw aan het hart liggen, variërend van 
Johan Cruyff wijsheden tot Star Wars filosofie. Nou staat de Radboud Universiteit 
Nijmegen slechts twee citaten van niet-wetenschappelijke aard toe, maar tijdens het 
schrijven van dit proefschrift ben ik enkele gezegden tegengekomen waarvan ik twee te 
toepasselijk vond om ze ongenoemd te laten.
Ten eerste wordt in het Engels weleens gezegd ‘no piece of writing is ever finished, only 
abandoned’. De variatie op dit gezegde van de Amerikaanse schrijver Chuck Palahniuk 
komt waarschijnlijk nog dichter bij de werkelijkheid, maar elke promovendus zal de 
essentie van deze uitspraak maar al te goed bevatten. Een manuscript voelt, na weken 
of maanden werk, nooit echt af. ‘Zijn dit de goede vragen?’ en ‘zijn dit de goede 
antwoorden?’ en talloze andere vragen blijven door je heen schieten, waardoor het lastig 
kan zijn het overzicht te behouden. Gelukkig sta je er als promovendus, als het goed is 
tenminste, niet alleen voor en krijg je soms uit de meest onverwachte hoeken de nodige 
ondersteuning of sturing.
Dat brengt mij tot het tweede gezegde: ‘nanos gigantum humeris insedent’. Deze is extra 
leuk omdat hij ook letterlijk vrij waarheidsgetrouw is. De figuurlijke betekenis zal ik 
kort toelichten. De coördinatie van de PONCHO trial heb ik in 2013 van (destijds 
arts-onderzoekers) Nicolien Schepers en Stefan Bouwense overgenomen. Zij hebben het 
gedachtegoed uitgewerkt van door de wol geverfde post-docs als Djamila Boerma, Marc 
Besselink en Hjalmar van Santvoort, op hun beurt weer ingewijd door internationale 
zwaargewichten zoals professoren Hein Gooszen en Marco Bruno. Het succes van de 
Pancreatitis Werkgroep Nederland valt, mijns inziens, voornamelijk toe te schrijven 
aan de bundeling van krachten en het uitwisselen van de inmiddels enorme kennis op 
het gebied van het opzetten, uitvoeren en uitwerken van klinisch onderzoek. In één 
woord: samenwerking. Ik ben me dan ook zeer bewust van het feit dat de studies in dit 
proefschrift zeker niet alleen mijn persoonlijke verdienste zijn en dat ik een groot aantal 
mensen hiervoor dank verschuldigd ben. Dus hier gaan we.
Allereerst mijn dank aan en respect voor de patiënten en hun families die in een tijd van 
ziek zijn en onzekerheid hebben willen meewerken aan dit onderzoek. 
 Mijn dank gaat uiteraard uit naar alle co-auteurs van de trial en de nevenstudies 
voor de samenwerking. 
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Geachte promotor prof. dr. H.G. Gooszen, beste Hein. Beter dan wie dan ook zal jij 
begrijpen dat de afronding van mijn proefschrift een belangrijke mijlpaal voor mij is. 
Het is ook de afronding van een zeer onzekere periode, waarbij het nu eindelijk voelt 
alsof ik weer de regie over mijn carrière heb. In de hele periode stond je voor me klaar 
met advies en ondersteuning. Niet alleen rondom het onderzoek, maar vooral ook met 
het solliciteren. Nooit zwaarmoedig, altijd met een lach. Als onderzoeker heb ik van je 
geleerd om altijd (altijd) kritisch te blijven ten aanzien van je eigen werk, want alleen 
dan kom je echt verder. Als persoon heb je me het vertrouwen gegeven waarmee ik, ook 
in het licht van tegenslagen, mijn eigen weg heb kunnen kiezen. Voor beide, maar met 
name het laatste, ben ik je voor altijd dankbaar. 
 Hoe onze wegen hebben gekruist zou men in het Engels ‘serendipity’ noemen: 
een samenloop der omstandigheden met een onverwachte, positieve uitkomst. In mijn 
geval heb ik er niet alleen een promotie maar ook een goede vriend aan over gehouden.
Copromotoren Dr. M.G.H. Besselink en dr. H.C. van Santvoort. Marc en Hjalmar, the 
unstoppable force en the immovable object. Een tegenstrijdiger duo kan haast niet, maar 
samen hebben jullie het pancreatitis onderzoek naar een hoger niveau getild en de PWN 
wereldberoemd gemaakt. Het is een eer om jullie als copromotoren te hebben!
 Beste Marc, aan jou heb ik mijn periode als onderzoeker te danken. Je hield het 
tempo van mijn studies hoog: als ik op vrijdagochtend een manuscript ter beoordeling 
stuurde, kreeg ik het vrijdagmiddag voorzien van commentaar terug. Hoe je dat blijft 
doen met alle  onderzoekers die je begeleidt is me een raadsel, maar ik ben je er zeer 
erkentelijk voor. Dank voor het vertrouwen in mij en alle hulp tijdens het onderzoek!
Beste Hjalmar, wat heb ik veel van je geleerd tijdens de PWN vergaderingen en het 
opschrijven van PONCHO. Altijd kritisch, perfectionistisch en met je begrip voor de 
krachten en beperkingen van klinisch wetenschappelijk onderzoek kan ik met recht 
zeggen dat ik onder jouw begeleiding een betere onderzoeker ben geworden. Dankzij 
jou ben ik het onderzoek veel meer gaan waarderen en ben ik enthousiast geworden om 
ook in de toekomst wetenschappelijk actief te blijven. Heel veel dank daarvoor.
Dr. D. Boerma, beste Djamila, PONCHO is natuurlijk jouw idee en zonder PONCHO 
geen promotie. Het was geweldig om deze trial af te mogen maken. Ik ken geen enkele 
andere studie die zo rechttoe-rechtaan en direct klinisch toepasbaar is, en heb altijd met 
heel veel plezier aan de studie gewerkt en de resultaten gepresenteerd. Ik hoop in de 
toekomst nog meer biliaire studies met je te kunnen doen in het St. Antonius.
Mijn hartelijke dank aan de leden van de manuscript commissie voor het beoordelen 
van mijn manuscript: prof. dr. P.D. Siersema, prof. dr. O.R.C. Busch en prof. dr. W.M. 
Prokop, en de opponenten. 
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Bijna-dr. Th.L. Bollen, beste Thomas, ten eerste veel dank voor het reviseren van de 
scans van de PONCHO patiënten. Veel belangrijker, aan jou (en aan Elvin) heb ik mijn 
opleidingsplek in het St. Antonius te danken. Door jou had ik nog net op tijd mijn 
brief bij dr. van Heesewijk; twee maanden later zat ik oude scans voor The Magician 
te openen in IMPAX. Ik kijk er naar uit om de komende jaren door je teruggefloten te 
worden op exotische diagnoses!
Dr. M.G. Dijkgraaf, beste Marcel, enorm veel dank voor je hulp met de statistiek bij 
PONCHO, maar vooral ook met de kosteneffectiviteitsanalyse! Een ‘drukke agenda’ 
is in jouw geval een understatement, en toch heb je tijd voor me gemaakt voor beide 
studies. Met je ‘erop-en-erover’ aanpak bij de revisies hebben we twee prachtige 
publicaties in toptijdschriften weten te bewerkstelligen. Mijn hartelijke dank en ik hoop 
in de toekomst weer met je samen te kunnen werken.
Dr. O.J. Bakker, beste Olaf, ik heb enorm veel van je geleerd tijdens het schrijven van 
ons review in de BJS. Korte zinnen en to-the-point, advies waar ik nog heel regelmatig 
baat bij heb. Veel werk, maar een prachtige kans om in de pancreatitis literatuur te 
duiken en met enkele internationale coryfeeën samen te werken. De extra beloning was 
bovendien een eerste plaats als ‘most read article’ van de BJS in 2015, waar ik erg trots 
op ben!
De (oud) onderzoekers van de PWN: 
Doctor Stefan Bouwense! Het was me een genoegen om samen met jou het eerste 
auteurschap te delen. Ondanks alle drukte altijd enthousiast om over PONCHO te 
sparren en altijd geïnteresseerd in hoe het met de sollicitatieperikelen stond. Onze 
telefoongesprekken voor beide gelegenheden heb ik erg gewaardeerd!
Nicolien Schepers, onvermoeibaar heb je je ingezet voor de PWN! De hoge 
inclusiesnelheid en response rates van de vragenlijsten zijn absoluut aan jou te danken. 
Een jaar lang PONCHO draaiende houden en een nieuwe trial opzetten, het is 
indrukwekkend hoeveel jij met al je harde werken gedaan hebt gekregen. Af en toe ten 
koste van jezelf, maar ik heb er, zeker met de komst van Pieter, veel vertrouwen in dat jij 
en Rein daar in de toekomst beter op gaan letten. 
Sandra van Brunschot. Het hele reilen en zeilen van de PWN heb jij persoonlijk 
mogelijk gemaakt. Jij durfde altijd ook de minder makkelijke beslissingen te nemen, 
maar altijd voor het goed van de PWN. En ondertussen dag en nacht bereikbaar blijven 
voor inclusies in zeer ingewikkelde patiëntpopulaties. Ik wens je heel veel succes met het 
afronden van TENSION!
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Janneke van Grinsven, Juffrouw Jannie/the Grinch/van Grinsbergen. Wij zaten altijd 
eigenlijk wel op een lijn. Niet alleen op de stoffige onderzoekskamer blijven zitten, maar 
ook af en toe met elkaar gezellige dingen doen, of het nou in Nijmegen, Amsterdam of 
Wenen is. Mooie tijden waren het!
Bob Hollemans, mijn go-to-guy voor alle statistische ondersteuning. Multivariate 
analyses, predictienomogrammen, noem het maar op. Als ik iets voor je kan betekenen 
bij de nevenstudies van de PANTER FU dan hoor ik het natuurlijk graag. Heel veel 
succes met de volgende sollicitatieronde!
Yama Issa, hoewel we weinig direct met elkaar hebben samengewerkt hadden we vanaf 
het begin een goeie klik. Erg veel respect voor je doorzettingsvermogen om ’s werelds 
lastigste trial vol te krijgen, nu nog even doorzetten om hem ook op te schrijven. 
Xavier Smeets, Noortje Hallensleben, Sven van Dijk, Rens Kempeneers. Nu de meer voor 
de hand liggende studies wel zo’n beetje zijn uitgewerkt zal het pancreatitis onderzoek 
in de toekomst waarschijnlijk wel wat ingewikkelder worden. Ik ga mijn best doen om 
jullie daar in bij te staan en weer wat meer betrokken te raken met de lopende studies. 
Prof. dr. M.J. Bruno en prof. dr. H. Van Goor. Beste Marco en Harry, veel dank voor 
al jullie werk en onvermoeibare inzet als voorzitters van de PWN. De vergaderingen 
en AA overleggen zijn erg waardevolle momenten voor ons arts onderzoekers en ik had 
altijd het gevoel met meer kennis en beter inzicht van deze bijeenkomsten weg te lopen.
De (oud) onderzoeksverpleegkundigen van de PWN Vera Zeguers, Anneke Roeterdink, 
Stefan Jans en Hetty van der Eng voor al jullie harde werk in het verzamelen van 
patiëntgegevens.
Dr. B.C. Vrouenraets en alle chirurgen in het OLVG West. Beste Bart, in een parallel 
universum gaat dit proefschrift niet over pancreatitis maar lymfekliermetastasering bij 
coloncarcinoom. Niet alleen mijn eerste stappen als zelfstandig arts maar ook mijn 
eerste ervaring met wetenschappelijk onderzoek heb ik bij jullie op kunnen doen (2500 
lymfeklieren handmatig meten op de zaterdag, ook dat is wetenschap!). Mijn hartelijke 
dank voor jullie betrokkenheid en geweldige steun tijdens maar vooral ook na mijn jaar 
bij jullie.
Dr. van Heesewijk, dr. van Es, dr. Keijsers en alle radiologen, assistenten en laboranten 
van de afdeling Radiologie in het St. Antonius Ziekenhuis. Vanaf moment één heb ik 
me thuis gevoeld in de groep, en dat is zeker niet vanzelfsprekend. Op de afdeling wordt 
hard doorgewerkt, maar als jongste assistent kan je altijd rekenen op de ondersteuning 
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die je nodig hebt en de sfeer is altijd goed. Een veiliger opleidingsklimaat is haast niet 
denkbaar. Ik heb enorm veel zin in de komende paar jaren!
Henk Sleijffer en Chaim Wannet en iedereen van Sportschool Bep Kneppers. De 
afgelopen paar jaar heb ik er heel wat stress en frustratie uit kunnen boksen op de 
Palmstraat. Heel veel respect voor jullie toewijding aan de sportschool en dank voor alle 
trainingen!
De KGB en KGBabes (en KGBabies). We kennen elkaar inmiddels zo’n 20 jaar en onze 
vriendschap wordt alleen maar hechter. Een voor allen en allen voor een, zo hebben 
we dat altijd gevoeld en zo zal het altijd blijven. Onze band is werkelijk uniek en het is 
geweldig om te zien hoe de KGB een begrip aan het worden is in al onze kringen. Heel 
veel dank voor hoe jullie de afgelopen tijd voor Breg en mij hebben klaar gestaan, het 
betekent enorm veel voor mij. 
Mijn paranifmen dr. Jeroen Tielbeek en Ernst Jan Bos. Sinds jaar en dag komen we bij 
elkaar om werk, onderzoek en het leven te bespreken. Maar vooral ook omdat het altijd 
gezellig is en EJ goed kan koken. Natuurlijk zijn jullie de aangewezen personen om me 
bij de verdediging bij te staan. Op nog vele jaren!
Ruud, Dorine, Eelco, Wietske & Hayo en de gehele familie Wentrup en de Nes. Dank 
voor jullie interesse in mijn onderzoek en natuurlijk al jullie hulp in Valaurie afgelopen 
september. Geweldig om nu ook officieel bij jullie enorme, hechte, openhartige, gastvrije 
(getikte) familie te horen! 
 Dorine, heel erg bedankt voor de bijdrage aan dit proefschrift.
Rein-Jan de Nes, heel veel dank voor het drukken van mijn manuscript!
Familie da Costa en van Bokhorst, ik ben altijd zo vreselijk blij met en trots op jullie 
geweest. Zomers in Italië, winters in Vermont, veel van mijn beste herinneringen zijn 
met jullie. Ik hoop heel erg in de toekomst nog veel met elkaar te kunnen blijven doen!
Mijn zussen en broer Fee & Corné, Alba en Georgie, Bel & Nikki en Dak. Heel erg veel 
dank voor al jullie ondersteuning de afgelopen periode. Ik ben misschien niet altijd even 
uitgesproken in mijn waardering voor jullie, maar jullie weten dat ik gek op jullie ben. 
Het is heerlijk om in dezelfde stad te wonen en elkaar zo vaak te kunnen zien, en om de 
kleintjes zo te zien opgroeien. I love you guys!
Bellie, super bedankt voor het ontwerpen van de kaft!
Dankwoord
195
Pap en mam, onvoorwaardelijk staan jullie me al mijn hele leven bij. Alle grote 
beslissingen die ik heb genomen heb ik kunnen nemen door en met jullie steun. Al 
vanaf jongs af aan hebben jullie me gestimuleerd om het beste uit mezelf te halen, dit 
proefschrift is daar een onderdeel van. Ik ben jullie immens dankbaar voor de manier 
waarop jullie me hebben opgevoed (en dat blijven doen). 
Mijn allerliefste Breg. Met jou, door jou, dankzij jou en nu voor jou. Al vijf jaar maak 
je mij zo gelukkig en mijn leven zo eindeloos veel leuker, afgelopen zomer hebben we 
dat met al onze beste vrienden kunnen vieren in Valaurie. De mogelijkheid om dit 
proefschrift te schrijven heb ik 100% aan jou te danken: met jou zette ik tijdslijnen uit, 
maakte ik de financiële planning, jij maakte me aan het lachen in tijden van frustratie 
en teleurstelling en, last but certainly not least, was mijn hoofdsponsor. Ik ken niemand 
die zo gul, hartelijk, grappig en intens lief is als jij, en ik heb het geluk jou mijn vriendin 
(vrouw!) te mogen noemen! Ik kijk heel erg uit naar al onze toekomstige avonturen. I 
love you!
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CURRICULUM VITAE
De auteur van dit proefschrift werd op 31 januari 1983 in Leiden geboren. Van 1986 
tot 1993 woonde hij op Curaçao, waarna het gezin terug verhuisde naar Nederland. 
Na zijn Gymnasium te hebben gehaald in 2002 te hebben gehaald aan het Stedelijk 
Gymnasium Leiden, werd David met een klein beetje geluk ingeloot voor de studie 
Geneeskunde aan het Leids Universitair Medisch Centrum. Tussen oktober 2007 en 
juli 2008 deed hij zijn wetenschappelijke stage bij de afdeling Neurochirurgie in het 
Alfred Hospital te Melbourne, Australië. Na twee jaar co-schappen te hebben gelopen 
in Den Haag verhuisde hij naar Amsterdam waar hij twee jaar ANIOS Chirurgie was 
(eerst één jaar in het Sint Lucas Andreas Ziekenhuis, opleiders dr. E.P. Steller en dr. B.C. 
Vrouenraets, daarna een jaar in het Academisch Medisch Centrum, opleider prof. dr. 
O.R.C. Busch). Via zijn co-promotor dr. M.G. Besselink werd hij in de gelegenheid 
gesteld om te beginnen bij de Pancreatitis Werkgroep Nederland als coördinator van de 
PONCHO trial (Pancreatitis of biliary origin: Optimal timiNG of CHOlecystectomy). 
De studies die uit deze trial voortkwamen vormen de basis van dit proefschrift, dat 
hij met veel plezier onder begeleiding van zijn promotor prof. dr. H.G. Gooszen heeft 
geschreven.
 Sinds januari 2016 is hij in opleiding tot radioloog in het St. Antonius 
Ziekenhuis, Nieuwegein, met als opleiders dr. H.W. van Es, dr. J.P.M. van Heesewijk en 
dr. R.G.M. Keijsers.
 David woont in Amsterdam met zijn vrouw Bregje.
